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I0AKH ITHACA
l a v  Pyeis o tov Tnyyaiiio 71a  ttiv  IBaKq, 
v a  eoxeaca vavca jiaicpvs 0 5po|ios,
TEjiaxos rcepuiereiEs, 7Ep.axos yvaxjEis.
Taos Acaorp'U'yovas icoa tods KuicAamas, 
tov  0d|iq)jievo noaeiScova (ir| (poPaoai,
TETOia axov Spopo aoD TtoxE aoD 8ev 0a  ppeis, 
av  fiEv' T| OKE\jrr| ood u^nAri, av  ekXekth 
<yuYiavT|ois to  7tvED|ia Kai to  000(10 ood ayyi^Ei. 
Tods AaiarpDTOvas ko i tods KdkAcotcos, 
tov  crypio IIooEiScova 6ev 0 a  ODvavTT|aeis, 
av  6ev tods kodPoveis pes o tt|v  \|/uxn ood, 
av  t| \|toxti ood §ev tods orqvei Epnpos ood.
Na EDxeaai vavai paicpDs o Spopos.
IIoAAa Ta KaAoicaipiva rcpcoia va etvat
noD ps xi EDxocpicrrnai, pe u  Xa Pa
0a pjicaveis oe AipEvas JCpcoroEificopEvoDs
v a  orapaTnaEis a ' epnopeia Ooivikiko,
koi tes koAes TipcqpaTEiEs v' aicoicrriaEis,
OEVTEtpta koi KopaXXta, KEXpiprcapia k1 ePevods,
kol T|8oviKa pDpco8ixa Ka0E Aoyns,
oao pnopEis mo aq>0ova "q 8ovim  pDpcoStKa
oe noAeos AiyuimaKEs noAAss v a  nas,
va pa0Eis koi va pa0sis cot'tods otiodSoopevods.
riavra aro vod ood vaxeis tt]v I0aicn.
To cp0aoipov ekei eiv' o Ttpoopiapos god.
AAAa pT| pta^Eis to  to^ei8i 8ioAod.
KaAAiTEpa xpovia noAAa v a  SiapKEasi 
koi YEpos m a  v' apa^Eis aro  vr|ai, 
tiAodoios ps o o a  kep8ioes otov Spopo, 
pr) npoaSoKcovras jiAodtti v a  oe Scooei ti I0aKT].
H I0aicn o' e8cooe t ’ oopcao to£ei8i.
Xoopis odttiv  8ev 0aP7aivEs otov 8popo.
AAAa 8ev exei va oe 8cooei ma.
Kt av  racoxiKTi rqv ppeis, r\ I0aicr| 8ev oe teAooe. 
E toi ootpos tiod etives,
PE TOOTl TtElpa,
t|8t| 0 a  to  KaToAaPEs r\ IBokes t i  onpatvoDV.
K. Kapacprjs
When you start on your journey to Ithaca, 
then pray that the road is long, 
full of adventure, full of knowledge.
Do not fear the Lestrygonians
and the Cyclopes and the angry Poseidon.
You will never meet such as these on your path, 
if your thoughts remain lofty, if a fine 
emotion touches your body and your spirit.
You will never meet the Lestrygonians, 
the Cyclopes and the fierce Poseidon, 
if you do not carry them within your soul, 
if your soul does not raise them up before you.
Then pray that the road is long.
That the summer mornings are many, 
that you will enter ports seen for the first time 
with such pleasure, with such joy!
Stop at Phoenician maikets,
and purchase fine merchandise,
mother-of-pearl and corals, amber and ebony,
and pleasurable perfumes of all kinds,
buy as many pleasurable perfumes as you can;
visit hosts of Egyptian cities,
to learn and learn from those who have knowledge.
Always keep Ithaca fixed in your mind.
To arrive there is your ultimate goal.
But do not hurry the voyage at all.
It is better to let it last for long years; 
and even to anchor at the isle when you are old, 
rich with all that you have gained on the way, 
not expecting that Ithaca will offer you riches.
Ithaca has given you the beautiful voyage.
Without her you would never have taken the road.
But she has nothing more to give you.
And if you find it poor, Ithaca has not defrauded you.
With all the great wisdom you have gained, 
with so much experience,
you must surely have understood by then what Ithacas mean.
C. Cavafys *
* Rae Dawen. The complete poems of Cavafy. The Hoggarth Press, 1971.
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SUMMARY
Little research has been conducted into the role of 
protease inhibitors and iron-binding proteins in 
periodontal diseases, despite their possible implication in 
the modulation of the local inflammatory process. This 
thesis aimed to investigate the major protease inhibitors 
a2-macroglobulin (a2-M) and a1-antitrypsin (al-AT) and the 
iron-bindings proteins transferrin (TF) and lactoferrin 
(LF) in gingival crevicular fluid (GCF), in relation to 
periodontal disease status.
Preliminary experiments were performed to establish new or 
modify existing enzyme linked immunosorbent assays (ELISA) 
for the assessment of these proteins in GCF. The 
simultaneous quantification of a2-M, al-AT, TF and LF in 
the same GCF sample was the ultimate objective. Initial 
attempts resulted in the establishment of two competitive 
ELISAs for the assessment of a2-M and TF in GCF. In an 
effort to improve detectability limits, the establishment 
of sandwich ELISAs for the detection of these proteins and, 
in addition, of al-AT, LF and albumin (Alb) was achieved. 
Application of the sandwich ELISA methodology resulted in 
an approximately 10 fold decrease in the detectability 
limits compared to the competitive ELISAs. Consequently, 
the assessment of all five proteins in the same GCF sample 
was possible in later studies.
xx i
The clinical studies conducted in this thesis include 
cross-sectional studies on gingival crevicular washings 
(GCWs) and GCF and longitudinal studies on GCF. GCF 
samples were obtained using paper strips for 30s and GCF 
volume was assessed using the Periotron 6000.
LF is contained specifically and in abundance in 
neutrophils (PMNs) but not in other leucocytes and only in 
trace amounts in serum. PMNs are widely implicated in the 
pathogenesis of destructive periodontal diseases. The aim 
of the cross-sectional study on GCWs was, therefore, to 
examine whether LF in the crevice could act as a marker of 
crevicular polymorphonuclear leucocytes (PMN). A positive 
and significant association was obtained indicating that LF 
has potential as a PMN marker in the gingival crevice.
The aim of the cross-sectional studies on GCF was to test 
the ability of GCF protease inhibitors (a2-M, al-AT) and 
iron-binding proteins (TF, LF) to distinguish between 
healthy, gingivitis and periodontitis sites. The absolute 
amounts (ng/30s) of each protein were significantly higher 
at diseased (gingivitis and periodontitis) when compared to 
healthy sites. However, gingivitis could not be 
differentiated from periodontitis sites. When results were 
expressed as concentrations (ng/jxl GCF), the predominately 
serum derived a2-M, al-AT and TF demonstrated an increase 
in diseased (gingivitis and periodontitis sites) compared 
to healthy sites whereas the PMN derived LF demonstrated a
xxii
decrease in its concentration in diseased sites. However, 
only the changes in GCF a2-M concentration were 
statistically significant depicting the higher degree of 
variability that was observed when results were expressed 
as concentrations.
The aim of the experimental gingivitis study was to 
establish the dynamics of GCF protease inhibitors and iron- 
binding proteins during experimentally induced gingivitis. 
This would provide information on the effect of gingival 
inflammation on the levels of these proteins in the 
crevice. a2-M, al-AT and TF revealed a very similar 
pattern during the experimental gingivitis trial, 
reflecting their common origin in GCF. Their levels 
increased significantly from baseline. This was attributed 
to increased permeability of the subepithelial vasculature 
and is supported by the simultaneous rise in GCF volume. 
In addition, local production of these proteins by resident 
cells of the periodontium could also be implicated. 
Vascular permeability was maintained for at least one week 
after the end of the experimental gingivitis period and 
this contributed to increased levels of these proteins in 
the crevice one week after the reinstitution of oral 
hygiene. The PMN derived LF demonstrated a different 
overall picture rising significantly during the 
experimental gingivitis trial but dropping rapidly to 
almost baseline levels after the reinstitution of oral
xxiii
hygiene measures and when chemotactic stimuli for PMNs were 
removed.
The final clinical study involved a three month duration 
longitudinal trial of periodontitis patients on maintenance 
care. The aim of this study was to investigate whether 
incipient periodontal disease breakdown could be associated 
with changes in GCF protease inhibitor or iron-binding 
protein levels. In addition, the potential of clinical 
indices to act as predictors/indicators of significant 
attachment level change was investigated. Duplicate 
attachment level (AL) measurements were taken using the 
Florida Probe and a custom fabricated stent from a total of 
384 sites. The lower variability of duplicate AL 
measurements using the Florida probe, resulted in earlier 
detection of small changes in attachment level. When the 
tolerance method was used to detect significant AL change, 
3.9% of the sites lost attachment. When a less stringent 
criterion of AL change of ^lmm was used 9.9% of the sites 
lost attachment during the three-month observation period. 
With the exception of subject average probing depth, 
baseline clinical parameters failed to predict attachment 
level change. Fourteen active periodontitis sites that 
demonstrated significant attachment loss during the three 
month observation period were paired to stable 
periodontitis sites within the same patient according to 
baseline scores of gingival inflammation and probing depth. 
The levels of protease inhibitors and iron-binding proteins
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(ng/30s and ng/^ ig Alb) in GCF failed to differentiate 
between active and stable periodontitis sites at baseline 
and three months.
In conclusion, assessment of different GCF constituents is 
possible, although existing methodology may have to be 
modified to help overcome problems associated with the low 
volumes of GCF obtained when non-invasive sampling 
procedures are used. Constituents of different origin in 
GCF may respond differently according to periodontal 
disease status. This was demonstrated in these studies for 
the mainly serum derived a2-M, al-AT and TF when compared 
to the PMN derived LF. The degree of gingival inflammation 
of the tissues adjacent to the crevice/pocket seems to 
influence the levels of protease inhibitors and iron- 
binding proteins in gingival crevicular fluid to a greater 
extent than probing attachment loss.
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CHAPTER 1
Introduction
1.1 General Introduction
During the past decade research on periodontal disease has 
evolved enormously. Carefully designed clinical studies 
and appropriate statistical analysis of epidemiological 
data, have led to the development of new concepts regarding 
the epidemiology and progression of periodontal disease. 
Instruments have been developed, using current technology, 
to help the clinician overcome problems associated with 
clinical measurements of the periodontium. In addition, 
classical concepts of the pathophysiology of periodontal 
disease have been transformed by advances in basic science. 
Substantial research has been directed towards 
understanding basic mechanisms of the pathogenesis of 
periodontal diseases. The ultimate goal is that the 
diagnosis, treatment and prevention of periodontal disease 
is based upon aetiology rather than experience.
The literature review that follows aims to address basic 
issues of clinical and experimental periodontology that 
apply today. Moreover, it aims to provide background 
information which led to the investigations pursued in this 
thesis.
Initially, this literature review deals with aspects of 
clinical periodontology. The objective is to aid the 
understanding of the clinical entity under investigation, 
the material to be used in these studies (gingival
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crevicular fluid), and the methods used for the clinical 
assessment of the periodontium. Finally, the inadequacy of 
clinical criteria alone, to diagnose or predict active
periodontal disease, is reviewed.
The second part deals with the pathogenesis of periodontal 
disease. Current concepts are summarised and some 
mechanisms of interest are presented in detail. Background
information on protease inhibitors and iron-binding
proteins is provided, together with their relevance to
periodontal diseases.
1.2 Definitions
1.2.1 The 'normal' periodontium: Clinical and
histological appearance
Supporting structures of the teeth are known collectively 
as the periodontium, from the Greek words 'peri' meaning 
around, and 'odontos' of the tooth. They comprise the
alveolar bone, the periodontal ligament, the root cementum 
and the gingivae which together form a functional unit the 
'attachment apparatus' (Lindhe, 1990).
The normal periodontium is characterised, clinically, by a 
gingival unit which is pale pink in colour, has a scalloped 
outline, is firm in texture, fills the entire space between
adjacent teeth and does not bleed on gentle probing
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(Wennstrom, 1988). In health, a gingival sulcus rarely 
exists. Histologically, no inflanunatory infiltrate is 
present and only a few polymorphonuclear leucocytes can be 
seen traversing the connective tissue and junctional 
epithelium. The alveolar bone is located 1mm apical to the 
cementoenamel junction. This classical picture of the 
'normal' periodontium has recently been an issue of debate, 
as investigators have found that an inflammatory 
infiltrate, comprising of both polymorphonuclear leucocytes 
and small round mononuclear cells is always present in 
gingival biopsies from clinically healthy gingiva (Seymour, 
Powell & Aitken, 1983a; Seymour et al., 1983b; Brecx et 
al., 1987). Therefore, the term 'clinically healthy' 
compared to 'normal' periodontium is preferable (Wennstrom, 
1988) .
1.2.2 Periodontal disease: Clinical features and
epidemiology
The term periodontal disease, if used in the general sense, 
should denote all diseases which could affect the 
periodontium. As the periodontium comprises tissues of 
different origin (mesenchymal and ectodermal), an array of 
systemic conditions with oral/periodontal manifestations 
could be included (Kinane & Davies, 1990). However, in 
this text, the term periodontal disease will only be used 
to describe gingivitis and periodontitis, which are 
inflammatory processes of the periodontium associated with
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the presence of dental plaque (plaque-associated 
periodontal disease).
In gingivitis, pathological changes are confined to the 
superficial periodontal tissues i.e. the gingivae, and are 
clinically manifested by a change in colour (redness) and 
appearance (swelling) of the gingivae, together with an 
increased tendency to bleeding on gentle probing. 
Periodontitis affects the deeper structures of the 
periodontium (bone, periodontal ligament and cementum), 
resulting in loss of periodontal support, and is frequently 
associated with the presence of periodontal pockets. 
Radiographically bone loss is apparent. At least four 
different forms of periodontitis have been defined (Page & 
Schroeder, 1982). It is generally accepted that forms of 
periodontitis affecting children and young adults are rare 
and differ from those commonly seen in older individuals. 
These are termed as prepubertal and juvenile periodontitis 
respectively. Whether these forms of periodontitis present 
as typical plaque associated disorders is debatable, 
especially as far as prepubertal periodontitis is concerned 
where most, if not all, of the cases have genetic basis. 
Periodontitis affecting the adult population is defined as 
rapidly progressive and adult periodontitis depending 
mainly on the severity and age of onset of the disease.
Early epidemiological studies indicated that gingivitis is 
widespread among children and young adolescents (James,
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1963). Similarly, Marshall-Day, Stephen and Quigley (1955) 
reported that the prevalence of periodontitis, as indicated 
by radiographic bone loss, reached approximately 100% by 
the age of 40, while the prevalence of gingivitis without 
involvement of the deeper structures of the periodontium 
reduced with age. Finally, Russell (1963) reported that 
age and oral hygiene could explain most periodontal disease 
variance in several ethnologically different populations. 
Thus the concepts arose that: a) periodontitis is a global 
disease affecting high proportions of the population; b) 
the disease starts as gingivitis at an early age which if 
left untreated will develop to periodontitis; and c) most 
of the variance in periodontal disease is associated with 
deficient oral hygiene and age. These concepts dominated 
periodontal literature until recently, when a more thorough 
analysis of epidemiological data was made. When the extent 
and severity of periodontal involvement were taken into 
consideration a different overall picture of the prevalence 
and progression of destructive periodontal disease was 
evident. Recent cross-sectional studies have shown that 
although a periodontium of reduced height becomes common 
with increasing age, relatively few subjects in each age 
group suffer from advanced periodontal destruction. These 
subjects account for most of the sites which are severely 
periodontally involved (Yoneyama et al., 1988; Papapanou, 
Wennstrom & Gordhal, 1988; Jenkins & Kinane, 1989). For 
example, Papapanou et al. (1988) reported that 75% of the 
total sites with previous attachment loss of at least 6mm
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occurred in 23% of the individuals examined. Similar 
findings were reported by Loe et al. (1986) who conducted 
a 15 year long study of the natural history of periodontal 
disease in Sri Lanka. These investigators identified a 
group of subjects, comprising 8% of the total sample, who 
showed rapid progression of periodontal disease, as defined 
by tooth mortality rates and interproximal attachment 
levels. In the same study, however, 11% of the subjects 
did not show progression of periodontal disease beyond 
gingivitis. Longitudinal studies have in addition shown, 
that relatively few sites undergo extensive periodontal 
destruction within a given observation period (Haffajee et 
al., 1983a, b; Lindhe, Haffajee & Socransky, 1983). Lindhe 
et al. (1983) reported that during a six year follow up of 
64 Swedish subjects, showing signs of previous periodontal 
destruction but not receiving active periodontal treatment, 
only 3.9% and 11.6% of their sites showed attachment loss 
greater than 2mm from baseline at 3 and 6 years 
respectively. Similar percentages (3.2%) of sites 
exhibiting periodontal attachment loss were reported in the 
same study for a group of American subjects who were 
followed over a 1 year period. Moreover, it seems that 
relatively few individuals account for the sites that show 
active periodontal destruction over an observation period. 
Thus, Lindhe et al. (1989) in a recent study reported that 
70% of the sites that deteriorated by 3mm or more during a 
2 year monitoring period, occurred in only 12% of the 265 
Japanese subjects that were followed longitudinally.
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The current view, therefore, is that periodontal disease is 
subject related, with a small subset of individuals within 
a given population suffering from advanced periodontal 
destruction, and with relatively few subjects and sites 
undergoing active periodontal destruction within a given 
period. In addition, in the absence of treatment, the mere 
presence of inflammatory periodontal lesions does not 
necessitate their progression (Papapanou, 1989).
1.2.3 Gingival crevicular fluid: Production, methods 
of collection and volume determination
Gingival crevicular fluid (GCF) is an inflammatory exudate 
or preinflammatory transudate present in the gingival 
crevice. Its components are derived mainly from: a)
microbial sources; b) interstitial fluid and locally 
produced factors of host origin; c) plasma; and, d) tissue 
degradation/turnover products (Cimasoni, 1983).
Production of GCF due to an inflammatory increase in the 
vascular permeability of the subepithelial vasculature was 
shown in early studies (Brill & Bjorn, 1959; Egelberg, 
1966a). Egelberg (1966a) in an experiment in dogs, showed 
that chemical (topical application of histamine) or 
mechanical stimulation (massage of the marginal gingivae 
with a ball burnisher or scraping with a blunt probe) of 
the gingival unit will result in increased vascular 
permeability and increased GCF flow. Moreover, heavy
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vascular labelling (by deposition of carbon particles) was 
observed in the stimulated areas. In an earlier study 
Brill and Bronnestam (1960) had already shown the presence 
of serum proteins in GCF from humans using 
immunoelectrophoresis.
Production of GCF in clinically healthy gingivae seems to 
be governed by different mechanisms. Alfano (1974) in his 
original hypothesis suggested that in clinically healthy 
gingivae, during initial plague accumulation, 
macromolecules from gingival plaque may diffuse through the 
endothelial cells until they reach the barrier of the 
basement membrane. Accumulation of macromolecules at the 
basement membrane area is responsible for the creation of 
an osmotic gradient and induction of GCF flow. Later, 
Pashley (1976) developed a mathematical model which 
explains GCF production in both health and disease. He 
suggested that net GCF production can be accounted for by 
relative differences in: a) passage of fluid from
capillaries into the tissues; b) uptake by lymphatics; and 
c) filtration through the junctional epithelium into the 
gingival crevice. These processes are in turn governed by 
differences in the filtration coefficients of the membranes 
delineating the different compartments as well as 
differences in hydrostatic and oncotic pressures between 
capillaries, lymphatics, tissue and sulcular areas. 
Bickel, Cimasoni and Andersen (1986) attempted to verify 
the above model and studied the contribution of serum in
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GCF production during early (pre-inflammatory) plaque 
accumulation by assessing albumin concentration in GCF and 
its ratio to that of serum. They reported no recovery of 
fluid from healthy gingivae and low concentrations of 
albumin during pre-inflammatory plaque accumulation, 
supporting the osmotic gradient model of Alfano (1974). 
With increasing plaque accumulation, both the albumin GCF 
concentration and its ratio to that of serum, increased. 
At chronically inflamed sites GCF:serum albumin ratio of 
approximately 1 was obtained.
Sampling methods commonly employed for the collection of 
GCF vary greatly and reflect the type of analysis to be 
performed on the sample and the amount of fluid required. 
They include, the absorbent paper strips or paper points, 
the capillary tubes or micropipettes and the gingival 
washings (Cimasoni, 1983). The most commonly used method 
is the paper strip (Golub et a l . ,  1976; Villela et al., 
1976; Condacci, Cimasoni & Ahmad-Zadeh, 1982; Cimasoni & 
Giannopoulou, 1988; Griffiths, Curtis & Wilton, 1988; 
Curtis et a l . ,  1990; Giannopoulou et a l . ,  1990, 1992;
Lamster, Hartley & Oshrain, 1990). Capillary tubes 
(Ishikawa et a l . ,  1972; Lah et a l . ,  1986; Larivee, Sodek & 
Ferrier, 1986) or micropipettes (Eisenhauer et a l . ,  1983) 
are used when a large amount of fluid is required, whereas 
gingival crevicular washings are employed when cellular 
elements of the fluid are studied (Skapski & Lehner, 1976; 
Baehni et a l . ,  1975; Salonen and Paunio, 1991). Choice and
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standardisation of the sampling procedure is particularly 
important as different protocols will influence the 
quantity and constituents of GCF recovered. Cimasoni 
(1983) concluded that capillary tubes or micropippetes are 
difficult to handle and may cause irritation of the 
gingival tissues especially in the healthy crevice. Thus, 
the paper strip seems to be the method of choice when 
microamounts of fluid are to be collected and when healthy 
as well as diseased crevices are to be studied.
Egelberg (1966b) has shown that the insertion of a paper 
strip in the crevice will cause a degree of gingival 
irritation and induce vascular permeability. Thus, when 
paper strips are used for the collection of gingival 
crevicular fluid several factors must be taken into 
consideration. A number of recent reports have focused on 
the effect of sampling time and sampling repetition, on GCF 
flow rate when using paper strips and have shown that GCF 
volume tends to be depleted by repeated sampling (Binder, 
Goodson & Socransky, 1987; Curtis et a l ., 1988; Lamster et 
a l . ,  1989; Persson & Page, 1990). Although in most cases 
repeated sampling resulted in a reduction in total amounts 
of GCF constituents (Persson & Page, 1990; Lamster et a l . ,  
1989; Binder et a l . ,  1987), some investigators reported an 
increase or a steady flow rate (Binder et a l . ,  1987; 
Villela et a l . ,  1987). This discrepancy could have however 
been related to lengthy sampling periods (Villela et a l . ,  
1987) or deep intracrevicular sampling techniques (Binder
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et al., 1987). When repeated sampling for 30 seconds was 
employed, GCF constituents did not return to baseline 
levels even 60 minutes after the initial sampling (Lamster 
et al., 1989). Despite the above evidence some 
investigators have chosen to discard the first GCF sample 
and use a subsequent sample for analysis (Binder et al., 
1987).
The effect of sampling time has also been investigated 
(Persson & Page, 1990; Cao & Smith, 1989). Persson and 
Page (1990) employed four sampling times (5, 10, 20 and 30 
seconds) and four different sampling sequences, thus 
alternating the order by which samples of different time 
periods were taken. They suggested that 5s or 10s first 
time sampling of a crevice is adequate whereas lengthier 
sampling periods (20s or 30s) tend to dilute aspartate 
aminotransferase activity. However, Cao and Smith (1989) 
have shown that myeloperoxidase activity is higher in 30s 
compared to 5s samples from the same crevice when these are 
taken a week apart. Standardisation of the length of the 
strip inserted in the crevice is also an issue to be taken 
into consideration as deeper insertion will result in 
higher flow rates (Mann, 1963). In conclusion, although a 
general consensus concerning sampling procedures does not 
exist, it seems that sampling for 30s or less with a paper 
strip would be the method of choice as it minimises 
irritation of the gingival tissues and simultaneously 
provides enough sample for subsequent analysis.
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Volume assessment of GCF collected on paper strips can be 
performed by assessing the wetted area of the strip, by 
weighing prior and after sample collection or by the use of 
the Periotron (Harco Electronics, Winnipeg, Canada). The 
area of the strip wetted can be assessed directly using a 
microscope fitted with a graticule (Egelberg & Attstrom, 
1973) or after staining with ninhydrin (Egelberg, 1964). 
Although staining facilitates viewing and assessment of the 
wetted area, it renders the sample unsuitable for analysis. 
Weighing prior to and after GCF sample collection (Cimasoni 
& Giannopoulou, 1988) seems to be suitable for assessing 
volumes beyond the measuring range of the Periotron. The 
Periotron is an electronic device used to assess GCF 
volume. Both weighing of the strip and the use of the 
Periotron, offer the advantage of being compatible with 
subsequent biochemical analysis of the GCF sample. The 
Periotron 6000, the latest version of the Periotron, has 
been extensively used by investigators of GCF and it has 
proven satisfactory for the assessment of GCF volume 
(Cimasoni, 1983). However, assessing minute amounts of GCF 
by any of the above methods (volumes of 0.01-0.2^,1) is 
demanding and could be subject to uncontrollable errors 
(Lamster et al., 1988a).
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1.3 Clinical assessment of the periodontium
1.3.1 Introduction
Clinical assessment of the periodontium is currently 
performed using indices that distinguish between healthy 
tissues, gingival inflammation and destructive periodontal 
disease. Such indices are based on visual observation, 
palpation/percussion of teeth, the use of the periodontal 
probe and radiographic examination. More recently GCF flow 
has also been used to supplement other clinical criteria. 
Oral hygiene status and plaque accumulation assessment is 
performed on a separate basis via plaque indices. 
Generally accepted criteria for an ideal index include 
simplicity, validity, sensitivity, reproducibility and 
amenability to statistical analysis (Hazen, 1974).
1.3.2 Assessment of oral hygiene
Oral hygiene indices are based on the measurement of the 
tooth surface area covered by dental plaque and/or the 
thickness of the material in the area measured (Table 1.1). 
Among the earliest indices for the assessment of 
accumulation of plaque/debris are the 'simplified' Oral 
Hygiene Index (OHI) (Greene & Vermillion, 1964) as well as 
the plaque index of Quigley and Hein (1962). Since then 
numerous indices have been developed to assess plaque 
accumulation (reviewed by Fischman, 1986). One of the most
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Table 1.1 Commonly used plaque indices.
Index Reference Score Comments
Oral Hygiene 
Index (OHI)
Greene & Vermillion, 1964 0-3 Assessment of 
the tooth area 
covered by 
'soft debris'
Plague Index Quigley & Hein, 1962 0-5 Assessment of 
tooth area 
covered by 
dental plague
Plague Index 
(PI)
Silness & Loe, 1964 
Loe, 1967
0-3 Assessment of 
the thickness 
of plague at 
the gingival 
margin
widely used indices is the plaque index (PI) described by 
Silness and Loe (1964) which was first used to assess the 
association between oral hygiene and periodontal condition 
in pregnant women. This index was more fully described by 
Loe (1967) and scores plaque accumulation from 0 to 3. The 
Plaque Index can be used to score individual sites as 
single site scores, teeth as averages of four sites per 
tooth (buccal, lingual and interproximal) and individuals 
or groups of teeth, the latter two being based on site 
scores divided by the number of sites assessed. This index 
remains one of the most widely used indices although 
attention has been given to its subjective nature as well 
as its disruptive character when distinguishing between 
scores of 0 and 1. The use of a single examiner throughout 
clinical trials when using this index has been recommended 
(Fischman, 1986). The advantage of the plaque index is 
that it allows for assessment of very subtle changes in 
plaque accumulation (Lindhe, 1990). In addition, it has 
been suggested (Fischman, 1986) that the PI is suitable 
when plaque/ gingivitis relationships are to be considered.
1.3.3 Assessment of gingival inflammation
Gingivitis indices rely upon one or more of the following 
criteria: gingival colour, gingival contour, gingival
bleeding, extent of gingival involvement and GCF flow 
(Fischman, 1988). Such indices (Table 1.2) were initially 
developed for use in epidemiological surveys (reviewed by
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Table 1.2 Commonly used gingival indices.
Index Reference Score Comments
Papillary, 
Marginal, 
Attached Index 
(PMA)
Schour & Massler, 1947 0-4 Visual
assessment of 
gingival tissues
Gingival Index 
(GI)
Loe & Silness, 1963 
Loe, 1967
0-3 Visual
assessment of 
gingival tissues 
combined with 
bleeding on 
probing (scores 
2-3)
Sulcus bleeding 
Index (SBI)
Muhlemann & Mazor, 1958 
Muhlemann & Son, 1971
0-5 Visual
assessment of 
gingival tissues 
combined with 
bleeding on 
probing 
(scores 2-5)
Papillary 
bleeding index 
(PBI)
Muhlemann, 1977 0-4 Assessment of 
the severity of 
bleeding on 
probing of the 
interdental 
papilla (score 
1-4)
Bleeding Index 
(BI)
Ainamo & Bay, 1975 Dichotomous 
scoring of 
bleeding on 
probing after 
10s
Modified PBI Barnett et al., 1980 0-3 Assessment of 
the time
elapsing for the 
appearance of 
bleeding after 
probing
Modified GI 
(MGI)
Lobene et al., 1986 0-4 Visual
assessment of 
the severity and 
extent of 
gingival 
inflammation
Ciancio, 1986) and in a very early attempt Schour and 
Massler (1947) introduced the PMA index in order to measure 
the extent of gingival inflammation to the papillary (P), 
marginal (M) and attached (A) gingival units. The 
Periodontitis Index (Russell, 1956) and the Periodontal 
Disease Index (Ramfjord, 1959) incorporated scores for the 
assessment of gingival inflammation at the lower parts of 
their scales, reflecting the notion, dominating at the 
time, that gingivitis precedes periodontal destruction. 
More recent attempts to assess gingival inflammation 
include indices that are based on visual changes and/or 
bleeding on probing of the gingival unit, like the Gingival 
Index (GI) (Loe & Silness, 1963; Loe, 1967), the sulcular 
bleeding index (SBI) (Muhlemann & Mazor, 1958; Muhlemann & 
Son, 1971), the papillary bleeding index (PBI) (Muhlemann, 
1977; Barnett, Ciancio & Mather, 1980) and the gingival 
bleeding index (Ainamo & Bay, 1975). The Gingival Index of 
Loe and Silness ( 1963), when it was first introduced, 
provided a conceptual change in the assessment of gingival 
inflammation as it scores both its severity and location 
and has been widely accepted and used. Consistent with the 
PI, the GI scores inflammation as 0-3. Scores 2 and 3 
incorporate the bleeding on gentle pressure component which 
was later modified to bleeding upon probing (Loe, 1967). 
One of the disadvantages of the GI is its invasive nature 
which becomes important in longitudinal studies of 
gingivitis where trauma of the gingival tissues could lead 
to an altered response. Moreover a non-invasive index
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facilitates other procedures, being employed during the 
same appointment such as GCF sampling which is influenced 
by the irritation of the gingival tissues. The GI has 
recently been modified by Lobene et al. (1986) (MGI). The 
bleeding upon probing component was eliminated and the 
lower part of the scale expanded resulting in a scoring 
system of 0-4. This index provides greater sensitivity to 
the earliest changes of gingivitis and by eliminating the 
bleeding upon probing element yields a completely non- 
invasive procedure. Moreover, it correlates well with the 
GI (Lobene et al., 1989) allowing comparisons with other 
studies where the GI has been used for the assessment of 
gingival inflammation and suggesting that relying only on 
visual assessment does not adversely affect reliability. 
Both the GI and MGI can be used to provide information at 
specific sites, teeth, groups of teeth or individuals in a 
fashion similar to the PI.
An advantage of indices incorporating the bleeding upon 
probing component is that they are useful not only in 
assessing gingival inflammation via the visual changes of 
superficial tissues, but could also contribute to the 
assessment of inflammation at the depth of the pocket in 
cases of periodontitis. The use, therefore, of two 
separate indices, when feasible, one for assessing the 
visual changes of the gingival tissues and one for 
assessing bleeding upon probing might be the best 
alternative in cases of periodontitis studies. When
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bleeding upon probing is assessed pressure sensitive probes 
are the instrument of choice as they allow a standardised 
force to be applied in order to test for bleeding.
Brill (1960) was the first to suggest that GCF flow could 
be used for the assessment of gingival inflammation. Since 
then both cross-sectional (Mann, 1963; Egelberg, 1964; Loe 
& Holm-Pedersen, 1965; Borden, Golub & Kleinberg, 1977) and 
experimental gingivitis studies (Loe & Holm-Pedersen, 1965; 
Egelberg & Attstrom, 1973) have been conducted in order to 
assess the association between GCF flow and the degree of 
gingival inflammation, and positive relationships have been 
obtained. When the Periotron (section 1.2.3) was 
introduced, trials aiming to establish the relationship of 
Periotron units to gingival inflammation were conducted 
(Suppipat, Johansen & Gjermo, 1977; Garnick, Pearson & 
Harrell, 1979) and positive correlations with clinical 
signs of gingival inflammation were reported. The 
Periotron was initially designed for chairside use for 
exactly this purpose and in a rather simplistic approach 
the manufacturer assigned different degrees of disease 
severity (from health or incipient gingivitis to 
periodontitis) to increasing Periotron units. This indeed 
could be called the GCF flow index.
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1.3.4 Assessment of probing pocket depth and 
attachment level
Probing pocket depth and attachment level are at present 
the clinical means used to assess destruction of the 
attachment apparatus usually supplemented by radiographic 
examination. They both rely upon the identification of the 
most apical extent of the periodontal pocket and measure 
its distance from either the gingival margin 
(probing/pocket depths) or a fixed reference point which is 
usually the cementoenamel junction (attachment level). 
There are several problems inherent in such measurements 
which include: i) variation in the probing force; ii)
errors in the graduation of the probe; iii) variations in 
the size (diameter) of the probe; iv) errors in probe 
placement; v) errors in reading the probe and data 
recording; and vi) errors in the precision of measurement 
(Jeffcoat et al., 1986). In addition to these physical 
errors, pocket probing depth assessment is complicated by 
biological variation or error as seen with the transient 
fluctuation in gingival margin location over time. When 
assessing attachment level, location of the cementoenamel 
junction may introduce another source of error (Badersten, 
Nilveus & Egelberg, 1984; Clark et al., 1987). Badersten 
et al, (1984) reported that, when assessing attachment 
level at single rooted teeth, using a conventional 
periodontal probe and an occlusal stent, inter and intra 
examiner agreement was within 1mm at approximately 90% of
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the duplicate probings compared to approximately 75% to 84% 
when using the cementoenamel junction as a reference point. 
Clark et al. (1987) pointed out that presence of calculus 
or the subgingival location of the cementoenamel junction 
made its identification impossible in 17% of the sites used 
in their study. Van der Velden (1979) reported that 
variation of the probing force and variation in the 
diameter of the probe will influence the penetration of the 
probe through the junctional epithelium and gingival
tissues. Higher forces yielded deeper probing depths, and 
a plateau in pocket depth measurement was reached at a 
probing force of approximately 1.25 N using a probing tip 
of 0.63mm diameter. Variation in the graduations of the 
probe may also be a source of error (Van der Velden, 1978). 
Probe penetration may also be influenced by the
inflammatory status of the gingiva and deeper penetration 
of the probe was obtained in areas showing signs of
increased inflammation (Armitage, Svanberg & Loe, 1977; 
Caton, Greenstein & Poison, 1981). In order to control 
probing force, pressure sensitive probes have been 
introduced (Van der Velden & de Vries, 1978; Poison et al., 
1980), whereas in an effort to reduce errors related to the 
location/relocation of the probe or the identification of 
the cementoenamel junction, occlusal stents have been used 
(Isidor, Karring & Attstrom, 1984; Badersten et al., 1984; 
Clark et al., 1987). Recent developments of periodontal 
probes tend to address different aspects of the
methodological problems associated with measurement of
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probing depth and attachment level and reflect the current 
trends and considerations of periodontal assessment. 
Jeffcoat et al. (1986) introduced a pressure sensitive 
probe with automated detection of the cementoenamel 
junction. Gibbs et al. (1988) developed an electronic 
pressure sensitive probe, the Florida Probe, which measures 
probing depths to the nearest 0.2mm. The different probe 
handpieces allow pocket depth measurements as well as 
attachment level assessment from a custom-made stent or 
from the occlusal surface (Magnusson et al., 1988a; Osborn 
et al., 1990). An electronic pressure sensitive probe 
described by Birek, McGulloch and Hardy (1987) and its 
later modification, the Toronto probe (Karim, Birek & 
McGulloch, 1990), allows attachment level measurements to 
the nearest 0.1mm under controlled angulation.
1.3.5 Detection of attachment level change
All the indices introduced above represent measures of 
either the transient inflammatory status of the superficial 
structures of the periodontium (gingival/bleeding indices 
and GCF flow) or the oral hygiene status of sites/patients 
(plaque indices). At best, probing depth or better 
attachment level could provide a historical measure of the 
past periodontal disease experience of a site/patient. 
When trying to assess periodontal disease activity at a 
specific site, longitudinal measurements of attachment 
level are therefore required, spaced at appropriate time
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intervals. The variable of interest is then the change in 
attachment level which represents the best estimator, at 
present, of previous/current disease activity. It became 
crucial, therefore, to introduce methods that would allow 
one to define the change in attachment level that safely 
exceeds measurement error. Several studies were conducted 
in an attempt to define measurement error when using a 
conventional periodontal probe to measure probing 
attachment level with or without an occlusal stent (Hafajee 
et a l . ,  1983b; Badersten et a l . ,  1984; Isidor et a l . ,  1984; 
Clark et a l . ,  1987; Best et a l . ,  1990). In an attempt to 
reduce false positive detection of attachment level change 
Hafajee et a l .  (1983b) suggested a criterion of 3 standard 
deviations of the difference of replicate measurements, 
which in their study was assessed to be 2.46mm (SD:0.82mm), 
which was further rounded to 3mm. The 3mm threshold was 
subsequently applied in several studies, although 
application of a threshold derived from one population to 
another, without confirming that the precision of the 
measurement is the same has been criticised (Fleiss et a l . ,  
1991). Refinements in probing attachment level measurement 
techniques described above, aimed to provide a more 
accurate assessment of probing attachment level than manual 
conventional probing. This would reduce variability 
between replicate or sequential measurements allowing for 
lower thresholds of attachment level changes needed for 
deciding that true attachment level change has occurred.
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Hafajee et al. (1983b) described three more sophisticated 
ways of detecting significant attachment level change: the 
regression, the running median and the tolerance methods. 
In the regression method the slope and y intercept of a 
regression line are computed from a linear least squares 
fit of attachment level measurements as a function of time 
and the slope is tested for a significant departure from 0 
while a threshold of projected attachment level change per 
unit time has also got to be exceeded. In the running 
median method attachment level measurements are plotted 
against time and systematic variations can be
differentiated from minor changes by considering the 
medians of 3 successive data points and setting an 
arbitrary threshold based on the variability of replicate 
measurements. Finally, the tolerance method is based on 
standard deviations of replicate, usually 2, measurements 
at each time point. For a pair of attachment level 
measurements to be considered different from the preceding 
pair, attachment level change has to exceed three different 
thresholds. These are derived from population, subject and 
site standard deviations of replicate measurements. 
Badersten et al. (1987) used the regression analysis for 
the identification of attachment level change and in 
addition developed an end point analysis method, in order 
to compensate for the insensitivity of the former to detect 
abrupt changes at the early/late phases of the study. In 
the end-point analysis method, the deeper of the pair of 
initial measurements is compared against the shallower of
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the final pair of measurements and if the change exceeds a 
specified threshold, attachment level change is declared. 
Recently a fourth method has been developed based on the 
cumulative sum of successive measurements (cumsum) (Aeppli 
& Pihlstrom, 1989; Jeffcoat & Reddy, 1991). In the cumsum 
method, differences from baseline are computed for each 
observation, which are subsequently added to obtain a 
sequence of sums which increases or decreases with the 
number of positive or negative changes. If the rate of 
change surpasses a predetermined critical value, a 
significant change is declared.
The most commonly used methods in clinical trials are the 
regression and tolerance methods. The regression method is 
most suitable for assessing linear changes in attachment 
level over a long period of time, whereas the tolerance 
method requires measurements at as few as 2 points in time 
and is more suitable in detecting abrupt differences in 
short periods in time (Haffajee et al., 1983b).
1.3.6 Association of probing attachment loss to 
clinical parameters
Several attempts have been made to correlate clinical 
indices with periodontal disease activity as assessed by 
longitudinal probing attachment level measurements 
(Greenstein & Caton, 1990). Plaque accumulation, due to 
its transient character demonstrates poor association with
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destructive periodontal disease in untreated or maintained 
subjects (Haffajee et al., 1983a; Jenkins et al., 1988; 
Lindhe et al., 1989; Badersten et al., 1990; Kaldahl et 
al., 1990). Thus, Haffajee et al. (1983a), in one of the 
earliest reports on the ability of clinical parameters to 
act as predictors of periodontal destruction, reported a 
specificity and sensitivity of 0.42 and 0.71 respectively, 
for the presence of plaque at specific sites just prior to 
the attachment loss episode. Similar specificity and 
sensitivity values for plaque were obtained just after the 
attachment loss episode. Later, Badersten et al. (1990) 
reported that only 30% of the sites exhibiting plaque ^75% 
of the times they were examined, during a 6 year monitoring 
period, actually demonstrated attachment loss. In a more 
recent investigation, Haffajee et al. (1991) used chi- 
square analysis to demonstrate positive associations 
between percentage of sites exhibiting plaque above certain 
thresholds and the number of subjects exhibiting attachment 
loss over 3mm during the 1 year observation period. Thus, 
the higher the percentages of sites demonstrating plaque 
within a subject the more likely the subsequent probing 
attachment loss. The authors however suggested that this 
association could have been artificial and could be due to 
the strong association of plaque at baseline with baseline 
attachment level which in turn was strongly related to 
subsequent attachment loss.
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Bleeding upon probing has been traditionally treated as an 
index of high diagnostic potential and efforts have been 
made to correlate bleeding on probing as well as gingival 
inflammation to active tissue destruction in periodontal 
diseases. Recent evidence (Lang et al., 1990), however, 
suggests that although absence of bleeding on probing is a 
good indicator for the maintenance of periodontal stability 
(i.e. bleeding on probing has a high negative predictive 
value), it could not be used as an effective 
indicator/predictor of periodontal destruction. This, in 
addition, applies to the presence of gingival inflammation 
(Haffajee et al., 1983a; Lang et al., 1986; Jenkins et al., 
1988; Badersten et al., 1990). However, it has been 
recently demonstrated that there is a positive association 
between percentage of sites within a patient that 
demonstrate bleeding on probing, or demonstrate overt 
gingival inflammation at baseline, and risk of future 
attachment loss (Haffajee et al., 1991). The authors, 
however, suggested that association of both gingival 
redness and bleeding on probing with subject baseline 
attachment level, as described above for plaque scores, 
could perhaps explain their association with future 
attachment loss.
Deeper probing depths at specific sites did not necessarily 
predict/ diagnose periodontal destruction (Haffajee et al., 
1983a; Jenkins et al., 1988). Residual probing depths ^7mm 
showed 50% and 52% diagnostic predictability respectively
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in a 3.5 and 5 year longitudinal study of periodontitis 
patients on maintenance (Badersten et al., 1987; Badersten 
et al., 1990). This indicates that long monitoring periods 
may be required to improve the diagnostic value of clinical 
parameters at specific sites. Mean patient probing depths 
and attachment level above increasing thresholds (Grbic et 
al., 1991; Haffajee et al., 1991) as well as percentages of 
sites within a patient demonstrating probing depths or 
attachment level >3mm (Hafajee et al., 1991) were however 
a risk indicator for subsequent attachment loss suggesting 
that previous periodontal destruction predisposes to future 
periodontal breakdown.
In conclusion, the studies referred to above, have shown 
that clinical assessment of the periodontium can not 
predict or diagnose active periodontal destruction. This 
information has bewildered the clinician who had long 
learnt to rely on clinical diagnostic criteria in 
prognostic assessments. During the past decade significant 
research has focused on the pathogenesis of periodontal 
disease which, in addition to elucidating possible 
mechanisms of periodontal destruction, could perhaps lead 
to the development of laboratory based diagnostic tests. 
The following sections therefore, will focus on the 
pathogenesis of periodontal disease and will introduce in 
more detail some of the possible mechanisms of interest 
which led to the investigations pursued in this thesis.
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1.4 Background information on the aetiology and
pathogenesis of periodontal disease
In early times (Hunter, 1835) the concept of the 
periodontium had not yet evolved, and diseases affecting 
the periodontal tissues were thought to reside either in 
the gums or the alveolar bone, but not in both. Since then 
our understanding of periodontal disease has developed 
greatly, much of this progress occurring during the past 
three decades. Many questions however, concerning the 
aetiology, pathogenesis and progression of periodontal 
disease, still remain unanswered.
Chronic inflammation is the hallmark of periodontal disease 
and it is now established that accumulation of bacterial 
plaque is responsible for the initiation and maintenance of 
the inflammatory process (Loe, Theilade & Jensen, 1965; 
Hellden & Lindhe, 1973; Axelsson & Lindhe, 1978). Loe et 
al. (1965) introduced the experimental gingivitis model to 
investigate the development of gingival inflammation in 
response to accumulation of dental plaque. They recruited 
12 individuals who, after an initial baseline examination, 
refrained from all oral hygiene procedures. All 
individuals enrolled in the study developed clinical signs 
of inflammation, after a period of no oral hygiene ranging 
from 10 to 21 days. The experimental design of this study 
could, however, be criticised, as subjects withdrew from 
oral hygiene measures for variable time periods and thus no
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statistical analysis of the data could be performed. In 
addition, some subjects participating in the study 
exhibited an initial degree of gingival inflammation and 
therefore baseline gingival conditions were not 
standardised. However, these investigators were the first 
to unequivocally show that plaque accumulation leads to 
gingival inflammation and this study remains fundamental. 
Since then the experimental gingivitis model has been 
widely applied by investigators of the developing gingival 
inflammation.
The temporal sequence of the histopathological changes in 
the inflammatory lesion of gingivitis and periodontitis 
have been described by Page and Schroeder ( 1976). Four 
different stages have been proposed: within 2 to 4 days of 
plaque accumulation in the dentogingival region, the 
'initial lesion' develops. This lesion is characterised by 
increased vascular permeability, emigration of 
polymorphonuclear leucocytes (PMN) from the vessels in the 
connective tissue and eventually in the gingival crevice, 
and loss of perivascular collagen. If plaque is left 
undisturbed within 4 to 7 days the 'early' lesion develops. 
At this stage, the predominant infiltrate is small and 
medium size lymphocytes, whereas all other changes 
described in the initial lesion are aggravated (PMN 
emigration, increased vascular permeability, loss of 
perivascular collagen). Moreover, the first cytopathic 
effects on the gingival fibroblasts together with a slight
28
lateral proliferation of the junctional epithelium in its 
coronal portion are now obvious. Two to three weeks of 
plaque accumulation are required, according to this model, 
for the shift to a plasma cell dominated lesion to occur. 
This is the pathognomonic feature of the 'established' 
lesion. As well as increased vascular permeability, the 
continued loss of perivascular collagen and the increased 
exudation, severe cytopathic effects on gingival
fibroblasts are evident with concomitant increase in the 
lateral width of the junctional epithelium, which has now
formed rete pegs extending into the subepithelial
connective tissue. The 'initial' and 'early' lesions
represent the acute stage of gingival inflammation whereas 
the 'established' lesion designates more chronic
gingivitis. The established lesion may (or may not)
eventually convert to the 'advanced' lesion whose
additional feature is the loss of connective tissue 
attachment (Sharpey fibres) and alveolar bone. Ulceration 
of the (now) pocket epithelium may also be present and
osteoclasts can be found at areas of bone resorption. The 
'advanced' lesion is synonymous with periodontitis.
Although the above model has evolved mainly through early 
animal studies (Garant & Mulvihill, 1972; Attstrom, Graf-de 
Beerand & Schroeder, 1975; Schroeder, Graf-de Beer & 
Attstrom, 1975; Schroeder & Lindhe, 1975), it has provided 
a temporal framework for both scientists and clinicians and 
has dominated descriptions of periodontal pathology since
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it was first introduced. One should not, however, forget 
that there is no clear cut division of the phases of an 
inflammatory process in vivo, and all the above changes 
could occur simultaneously, with the more chronic changes 
being superimposed on the more acute. Moreover, recent 
evidence suggests that a much longer period than two to 
three weeks is required for the shift to a plasma cell 
dominated lesion to occur. Thus, Brecx et al. (1988a) who 
conducted an experimental gingivitis study of six month 
duration, reported that although the plasma cell fraction 
of the inflammatory infiltrate in the gingival connective 
tissue increased with time, a period of neglected oral 
hygiene of greater than 6 months may be required to lead to 
a plasma cell dominated lesion. PMNs and lymphocytes 
comprised the greatest part of the connective tissue 
infiltrate even 6 months after cessation of oral hygiene 
measures in their study. It has, therefore, been suggested 
that it is the plasma cell dominance that discriminates the 
advanced from the established lesion and/or active from 
stable periodontitis sites in humans (Seymour, 1991). 
Moreover, as mentioned in section 1.2.1, there is always a 
degree of PMN and lymphoid cell infiltration of the 
connective tissue even after extended periods of optimum 
oral hygiene leading to clinically healthy gingivae (Brecx 
et al., 1987) suggesting that this may be necessary for the 
maintenance of gingival health.
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The initial and early lesions are associated with a 
primarily Gram positive, aerobic microflora in the gingival 
crevice. However, weakening of the junctional epithelium 
and its detachment from the tooth surface allows initial 
subgingival proliferation of the Gram positive plaque and 
colonisation with Gram negative anaerobes and spirochetes 
(Loe et a l . ,  1965; Theilade et a l . ,  1966). It is this type 
of flora that comprises the major periodontal pathogens. 
The 'initial', 'early' and perhaps the 'established' 
lesions can be induced by allowing plaque to accumulate on 
the teeth for a period of two to three weeks (Zachrisson, 
1968; Brecx et a l . ,  1988a). However, the exact mechanisms 
of periodontal destruction as well as the factors that 
control the transition from gingivitis to periodontitis 
('established' to 'advanced' lesion) are not well 
understood.
Bacteria may cause direct damage to the host and in a 
classical infection this would be initiated by the 
microorganisms adhering to and invading the host tissues. 
Bacterial invasion has been shown to occur in cases of 
acute ulcerative gingivitis and the consequences are 
disastrous to the gingival tissues (Listgarten, 1965). 
Some authors have suggested that active invasion of micro­
organisms in the gingival/pocket tissues may also occur in 
cases of advanced periodontitis (Frank, 1980; Saglie et 
al., 1982) although others have challenged these findings, 
and the debate as to whether true invasion or translocation
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occurs, remains to be resolved (Liakoni, Barber & Newman, 
1987; Newman, 1990). Even if true invasion does not occur 
microorganisms may be the cause of direct damage as they 
elaborate a variety of soluble substances which could 
penetrate into the gingival connective tissue and have 
detrimental effects to the host. Such substances include 
the leucotoxin produced by Actinobac iUus 
a-ctinomycetemcomitans (Baehni et al., 1979a), which can 
cause damage to crevicular as well as connective tissue 
PMNs, various enzymes, like phosphatases, aminopeptidases, 
glycosidases, proteinases, hyal uronidase, chondroitin 
sullfliatase etc (Slots, 1981; Nitzan, Sperry & Wilkins, 1978; 
Steffen & Hentges, 1981), as well as waste products of 
bacterial metabolism. However, whether such substances 
would be able to reach effective concentrations within the 
tissues in order to induce damage is highly questionable.
Apart from direct, mainly enzyme related, damage that 
bacteria may cause to the host, indirect damage of the host 
tissues via upregulation of inflammatory and/or 
immunopathogenetic host response mechanisms by bacterial 
derived substances must be considered. Toxic, chemotactic, 
mitogenic and antigenic factors, derived from dental 
plaque, may initiate an inflammatory host response in the 
periodontium. A typical example is lipopolysaccharide 
(LPS) which is a common component of Gram negative bacteria 
and has been shown to penetrate into the gingival tissues
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in dogs through intact crevicular epithelium (Schwartz, 
Stinson & Parker, 1972). Endotoxin, together with other 
bacterial derived substances, may lead to the initiation of 
an inflammatory reaction. A variety of endogenous 
mediators of inflammation, including prostaglandins and 
leucotrienes, lymphokines/cytokines, complement components 
and proteases are then released in the area inducing damage 
to the host tissues (reviewed by Page, 1991). Particularly 
important in this process are interleukin 1 (IL-1) and
tumor-necrosis factor a (TNF-a) which possess potent 
proinflammatory and catabolic capacities (Bevilacqua et 
al., 1985; Richards & Rutherford, 1988; Stashenko et al., 
1987; Meikle et al., 1989). Recent studies have shown the 
presence of IL-la and IL-113 in GCF from patients with 
periodontitis (Masada et al., 1990). Moreover, in a recent 
experimental gingivitis study IL-1 activity in GCF, 
measured using a bioassay, peaked prior to the development 
of clinically detectable inflammation (Kinane et al., 
1992b). Prostaglandins seem also to be implicated (Klein 
& Raisz, 1970) and PGE2 concentration in GCF above certain 
thresholds may be used as an indicator of increased patient 
susceptibility to future periodontal breakdown (Offenbacher 
et al., 1986). A key event in the pathogenesis of 
periodontal disease seems to be the activation and/or 
release within the gingival connective tissue of host- 
derived proteases which are the effectors of periodontal 
destruction as will be reviewed in section 1.6.
33
If the continual (or intermittent) stimulation by plaque is 
maintained an immune reaction of both humoral and cell- 
mediated type may develop which will amplify and perpetuate 
the inflammatory reaction. Antigen presenting cells, 
residing within the gingival connective tissue or 
epithelium, will uptake the antigen and process it, for 
presentation to T and B lymphocytes (B-cells may in 
addition recognise antigen by direct binding to their 
surface immunoglobulin). T-cells (CD4+) will, in turn, be 
activated to produce lymphokines such as IL-2, IL-4 and IL- 
6 and induce an immune response. The major antigen 
presenting cell type is the macrophage but in addition 
Langerhans cells are also important in cross-epithelial 
antigen traffic. Langerhans cells are dendritic HLA-DR+ 
cells found within the epithelium of the gingiva (Moughal, 
Adonogianaki & Kinane, 1992). In a recent experimental 
gingivitis study, Langerhans cell numbers in gingival 
epithelium rose initially, during the early stages of the 
development of gingival inflammation, and subsequently 
dropped to almost baseline levels after 21 days of plaque 
accumulation. Langerhans cells may thus circulate from the 
epithelium to the local lymph nodes where an immune 
response would be elicited (Moughal et al., 1992a).
Specific antibodies against putative periodontal pathogens 
can be detected in both serum and GCF (Kinane et al., 
1992a).
In conclusion, there is evidence that bacteria may cause 
damage indirectly by stimulating the host response 
(Shenker, 1987; Seymour, 1991; Genco, 1992). However, the 
exact mechanisms leading to periodontal destruction, are 
interwoven, extremely complex and in a constant state of 
reevaluation.
Depression of the host immune response during the initial 
stages of exposure to dental plaque is another pathway 
suggested to lead to periodontal destruction in a model 
produced by Shenker (1987). Autoimmunity, mainly to 
collagen components, has also been speculated as 
contributing to periodontal breakdown (Ftis, Singh & Dolby, 
1986; Hirsch et al., 1988;) although it is more possible 
that autoantibodies detected in periodontal disease are 
derived from natural antibodies whose function is the 
elimination of dead cells and damaged tissue constituents 
(Anusaksathien & Dolby, 1991).
1.5 Polymorphonuclear leucocytes
1.5.1 Introduction
The PMN is a short lived cell with a characteristic 
appearance: it has a lobulated nucleus and numerous
granules within its cytosole. PMN granules are
distinguished into two main types the primary (azurophil), 
forming first during myelopoesis, and the secondary
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(specific) which appear later in maturation (Bainton, 
Ullyot & Farquhar, 1971). PMN granule constituents are 
summarised in Table 1.3 (Falloon & Gallin, 1986). The 
primary PMN granules contain microbicidal enzymes, neutral 
proteases, acid hydrolases and bactericidal cationic 
proteins. The secondary granules are twice as numerous as 
the primary granules (Bainton et al., 1971) and contain 
mainly lysozyme, collagenase and lactoferrin. A third type 
of granules (C particles) contain gelatinase. The two 
major granule types (primary and secondary) serve different 
functions, with the secondary granules serving the 
environmental modification or external secretory function, 
whereas the primary granules act more as lysosomes fusing 
with the phagosome during phagocytosis and providing the 
necessary digestive enzymes (Henson, 1971b; Leffel & 
Spitznagel, 1975; Wright & Gallin, 1979).
PMNs in the circulation are attracted to a site of host 
defence via chemotactic mechanisms which could be elicited 
from microbially derived substances. PMNs initially adhere 
to the vessel wall, migrate through the endothelium and are 
chemotactically driven towards the stimulus. PMN 
trafficking is regulated by adhesion molecules either 
stimulated or constitutively expressed on endothelial 
cells. These molecules include intercellular adhesion 
molecule 1 (ICAM-1) and endothelial leucocyte adhesion 
molecule 1 (ELAM-1). The ligands for these molecules on 
PMNs (molecules of the CD11 family) seem to be located on
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Table 1.3 Polymorphonuclear leucocyte granule contents.
Class of 
constituent
Microbicidal
enzymes
Neutral serine 
proteases
Metalloproteinases 
Acid Hydrolases
Other
Azurophilic
granules
Myeloperoxidase
Lysozyme
Elastase 
Cathepsin G 
Proteinase 3
N-acetyl-b-
glucosaminidase
Cathepsin B 
Cathepsin D 
13-Glucoronidase 
13-Glycerophosphatase 
a-Mannosidase
Bactericidal 
cationic proteins
Specific
granules
Lysozyme
Collagenase
Lactoferrin 
Vitamin B12-binding 
proteins
Cytochrome b 
Histaminase 
FMLP receptors 
C3bi receptors
From Falloon and Gallin (1986)
the surface of the secondary PMN granules which fuse with 
the external membrane during chemotaxis providing receptors 
and the surface membrane required (Gallin, 1984; Todd et 
al., 1984; Hoffstein, Freidman & Weissmann, 1982). During 
this process secondary granule constituents are released in 
the area and it has been shown that PMN secondary granule 
contents are released earlier and more readily than primary 
granules during in vitro PMN stimulation (Bentwood & 
Henson, 1980). Moreover, PMN secondary granules have been 
shown to be preferentially released, over primary granules, 
during both adherence in vitro and migration through 
epithelium in vivo (Wright & Gallin, 1979). When PMNs 
arrive at the area of defence, phagocytosis is facilitated 
by the opsonisation of particles either via antibody or 
complement. CR3, the receptor for C3bi, the C3b hydrolysis 
product, is also located in the secondary granules (O'Shea 
et al., 1985). Both primary and secondary PMN granule 
release may, in addition, occur during fusion of lysosomes 
with incompletely formed phagocytic vacuoles, during 
adherence of the neutrophil on non-phagocytosable surfaces 
or during uptake of additional particles into a preformed 
phagolysosome (Henson, 1971a and 1971b) and upon cell 
lysis/death.
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1.5.2 Polymorphonuclear leucocytes in the pathogenesis 
of periodontal disease
The polymorphonuclear leucocyte (PMN) is the predominant 
leucocyte within the gingival crevice in both health and 
disease. PMNs from the circulation are attracted to the 
area via chemotactic stimuli elicited from dental plaque 
(Hellden and Lindhe, 1973) and PMNs can be seen traversing 
the gingival connective tissue in inflammation (Brecx et 
al., 1988a; Seymour et al., 1983a; Moughal et al., 1992b). 
Thus, Attstrom and Egelberg (1970), in an experiment on 
dogs, have shown that carbon labelled peripheral blood 
neutrophils from the circulation migrate in the gingival 
crevice and their migration rate seems to be higher in 
inflamed crevices. PMN numbers increase in the gingival 
crevice with the development of experimental gingivitis 
(Kowashi, Jaccard & Cimasoni, 1980; Thurre et al., 1984) 
and more PMNs are found in periodontitis compared to 
gingivitis sites although their viability and function 
assessed by trypan blue exclusion and ability to 
phagocytose, were decreased in the former (Thurre et al., 
1984). As in other tissues, migration of leucocytes from 
the vessels into the gingival connective tissue, and 
through the junctional epithelium into the gingival 
crevice, is controlled via adhesion molecules. In a recent 
experimental gingivitis study Moughal et al. (1992b), 
showed that vessels in the gingival connective tissue 
express ELAM-1 and ICAM-1 in health and in gingival
inflammation and PMNs were found in greater abundance in 
areas expressing intense ELAM-1 and ICAM-1 staining. In 
addition, crevicular and junctional epithelium stained 
strongly positive for ICAM-1, suggesting the importance of 
this adhesion molecule in allowing PMN migration in the 
gingival crevice.
PMNs in the gingival crevice form the first line of defence 
against periodontal pathogens. This is illustrated by the 
fact that qualitative and quantitative deficiencies result 
in gross periodontal destruction (Wilton et al., 1988, 
Kinane & Davies, 1990). Wilton (1986) summarised the 
stimuli leading to PMN degranulation (Table 1.4) and 
concluded that these stimuli occur in the crevice and that 
secondary granule release is more likely. PMNs will 
therefore release the contents of their granules during 
emigration towards the gingival crevice as well as during 
phagocytosis or upon encounter of antigen antibody 
complexes. Thus, PMNs have been shown to interact in vivo 
with oral bacteria and to release their intralysosomal 
contents to the extracellular environment (Taichman et al., 
1977; Tsai et al., 1978). The lysosomal release was 
increased by incubation with serum (heat inactivated or 
not) indicating that opsonization by complement components 
and immunoglobulins could enhance the process. Scanning 
electron microscopy studies (Baehni et al., 1977, 1978;
Taichman et al., 1977) indicated that lysosomal release 
occurred under similar circumstances to those described by
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Table 1.4 Stimuli leading to lysosomal granule release by 
neutrophils._____________________________________________
GRANULE EXOCYTOSIS
STIMULUS
Azurophilic Specific
During phagocytosis 
(regurgitation) during 
feeding + + + + +
non-specific adherence + + +
by attachment to surface- 
bound immune complexes or 
non-opsonised bacteria + + + + + +
bacterial toxins e.g. 
leucocidin
+ + + + + +
as a response to membrane 
binding by adherent cells of 
IgG, IgA, C3b, C5a, 
chemotaxins and opsonised 
bacteria
+ + +
calcium ionophore + + + +
concanavalin A — + + +
HETE — + +
adherence to surfaces in the 
presence of Ca** and during in 
vivo and in vitro migration + + + +
on cell death and subsequent 
lysis
+ + + + + +
From Wilton (1986)
Henson (1971a, b), i.e. reverse endocytosis, regurgitation 
during feeding and cell death. It seems therefore that 
although the PMN has a protective role, the interplay 
between microbial plaque components, complement, immune 
complexes and PMNs, initiates the release of PMN 
intracellular contents, including potent proteases, during 
inflammation which may cause damage to the periodontal 
tissues (Ishikawa et al., 1982; Wilton, 1986; Deguchi et 
a i m ,  1990, Altman et al., 1992). Thus the PMN appears to 
have both a protective and potentially destructive role in 
the pathogenesis of periodontal disease. Two models have 
been proposed in order to justify this somewhat 
contradictory statement.
The first model, proposed by Wilton (1986), involves 
crevicular PMN function which he suggests, can be viewed as 
a two phase system: fluid and surface. In the fluid phase, 
PMNs may phagocytose plaque bacteria while their granule 
content release (mainly secondary) may help this process by 
inhibiting plaque bacteria adherence and re-adherence. 
Enzymes released during this process are readily 
neutralised by protease inhibitors present in the area. In 
contrast when PMNs attach to the plaque surface or the 
sulcular and junctional epithelium, PMN granule enzyme 
release as well as the release of oxygen metabolites, takes 
place in a closed environment, inaccessible to naturally 
occurring protease inhibitors (Wright & Silverstein, 1984).
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The second model which has been proposed by Page and 
Schroeder (1982) involves gingival connective tissue PMNs. 
The authors hypothesise that two compartments exist for PMN 
function: the gingival connective tissue and the
pocket/crevice. If the epithelial barrier is disrupted 
(perhaps by adhesion and degranulation of crevicular PMNs 
as described in the previous model), then an open entrance 
for bacterial components and metabolites which flood the 
gingival connective tissue is established, and the 
chemotactic gradient driving PMN emigration towards the 
crevice/pocket is disturbed. The effect is that PMNs now 
move randomly within the gingival tissue encounter 
microbial derived substances in the connective tissue 
compartment, and together with other activated systems and 
host cells cause periodontal damage. When the epithelial 
barrier and chemotactic gradient is re-established the 
inflammatory process subsides, as PMNs are again driven 
towards the crevice/pocket where they encounter bacteria 
and bacterial substances. Although both the above models 
are over simplifications of the processes leading to 
periodontal destruction they provide paradigms of the PMN 
contribution to the pathogenesis of periodontal disease.
In conclusion, PMNs seem to play a central role in the 
pathogenesis of periodontal disease. Periodontal disease 
activity episodes could be associated with increased PMN 
emigration and activation both within the gingival 
connective tissue as well as in the gingival crevice and it
41
has been suggested that crevicular PMN numbers could be a 
useful indicator of acute inflammatory processes in this 
area (Fine & Mandel, 1986; Curtis et al., 1989)
1.6 Proteinases
1.6.1 Introduction
Proteolytic enzymes may be termed 'peptide bond hydrolases' 
(peptidases=proteases) and further classified into one of 
the two major classes: a) endopeptidases (proteinases) and; 
b) exopeptidases, depending on the location of activity of 
the enzyme against its substrate (Rappay, 1989). The 
enzymes of the first category cleave bonds in their 
substrate away from the end of the polypeptide chain, 
whereas the exopeptidases cleave their substrate only one 
or two residues from the end of the polypeptide chain. In 
the case of endopeptidases the essential catalytic group of 
the enzyme forms the basis for their classification into 
cysteine (formerly thiol), serine, aspartic (formerly 
carboxyl), metallo and finally proteinases of unknown 
catalytic class.
1.6.2 Proteinases in the pathogenesis of periodontal 
disease
Exopeptidases have received limited attention by 
periodontal disease investigators. In contrast,
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endopeptidases have been extensively investigated, due to 
their biological functions and their possible implication 
to the pathogenesis of periodontal disease. These potent 
proteinases are the effectors of periodontal damage. Their 
main source are the polymorphonuclear leucocytes and 
monocytes/macrophages but other host cells may also 
contribute (fibroblasts, epithelial cells) (Fig. 1.1) 
Mechanisms of their release have been reviewed in sections
1.5.1 and 1.5.2.
As shown in Table 1.5, over the past two decades numerous
studies have been conducted in order to assess
endopeptidase activity/amount in GCF. These studies 
include both experimental gingivitis, cross-sectional
studies and longitudinal studies before and after
periodontal treatment. In most cases assessment of 
proteinase activity has been attempted via the use of 
either native proteins (earlier studies) or chromogenic and 
fluorogenic substrates, although immunoassays have also 
been used for the assessment of the amount of the enzyme. 
An association with disease severity has been attempted in 
several of these studies and a positive association or a 
reduction of proteinase levels with treatment has in most 
cases been obtained (Table 1.5). Endopeptidase activity, 
including collagenase (Uitto, Turto & Saxen, 1978), 
elastase-like and trypsin-like (Uitto, 1987), as well as 
serine and cysteine proteinases (Eley & Cox, 1990, 1991), 
have also been detected in homogenates of gingival tissue.
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Figure 1.1 Proteinases are released by several cells 
resident at or arriving at the site of inf lamination 
including polymorphonuclear leucocytes (PMN) and 
macrophages (Macro). Release of such enzymes contributes 
to tissue damage. The activity of such enzymes is 
regulated by inhibitors including a2-macroglobulin, al- 
antitrypsin, al-antichymotrypsin and tissue inhibitors of 
metalloproteinases (From Evans & Whicher, 1992)
M<f>:macrophage; A Z G : azurophilic granules (1°); SPG: secondary granules
(2°); CP: C particles; Cap: Cathepsin; CGS: collagenase; GT: gelatinase 
al-AT: al-antitrypsin; a2-M: a2-macroglobulin; al-AC: al-antichymotrypsin 
TIPM: tissue inhibitor of metalloproteinases;
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Moreover, tissue plasminogen activator activity associated 
with the epithelium lining of the crevice has been recently 
shown (Schmidt, Cohen & Chambers, 1991).
Table 1.6 lists properties of the endopeptidases 
/proteinases studied in the gingival crevice and it is 
obvious that all of them could be implicated in the 
amplification of the inflammatory process. These 
proteinases could contribute to connective tissue damage 
which is critical to the development of periodontal
destruction. Crude polymorphonuclear leucocyte extracts 
have been shown to induce ulcerations of the crevice
epithelium in rabbits in vivo (Ishikawa et a i m ,  1982) and 
purified PMN elastase can cause in vitro enlargement of the 
intracellular spaces in the oral epithelium of the gingivae 
and collagen loss in the underlying connective tissue 
(Cergneux et a i m ,  1982).
As shown in Table 1.5 collagenase is one of the most 
extensively studied proteinases in relation to periodontal 
disease due to its obvious implication in its pathogenesis 
via the degradation of collagen. The fibroblast and PMN 
type collagenases share the unique property of being able 
to cleave type I, II and III collagens in the helical
domain. The PMN collagenase has a higher molecular weight
than the fibroblast type and cleaves preferentially type I 
collagen in contrast again to the fibroblast type 
collagenase which prefers type III collagen (Mallya et al.,
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Table 1.6 Properties of endopeptidases (proteinases) 
detected in the gingival crevice.
Class Proteinase Function Reference
Cysteine Cathepsins
B,H,L
Collagen & 
proteoglycan 
degradation
Latent collagenase 
activation
Degradation of 
bone organic 
matrix
Maciewicz k 
Etherington, 1988; 
Nguyen et al., 1990
Eeckhout k Vaes 1977
Delaisee et al., 1980 
Everts et al., 1988
Serine Elastase Elastin, collagen 
& immunoglobulin 
degradation
Cleavage of
complement
components
Latent collagenase 
activation
Janoff k Scherer, 1968 
Starkey et al., 1977 
Solomon et al., 1978
Venge, 1978 
Cawston et al., 1981
Cathepsin G Collagen
degradation
Cleavage of
complement
components
Latent collagenase 
activation
Starkey et al., 19 77 
Venge, 1978
Sorsa et al., 1990
Mast cell 
tryptase
Latent collagenase 
activation
Cleavage of
complement
components
Gruber et al., 1988 
Schwartz et al., 1983
Plasminogen
activator
Collagenase 
activation via 
plasmin generation
Degradation of 
fibronectin
Cawston et al., 1981 
Eeckhout k vaes, 1977
Quigley et al., 1987
Aspartic Cathepsin D Degradation of 
collagen breakdown 
products
Evanson, 1971
Metallo Collagenase Native collagen 
degradation
General protein 
substrates
Ohlsson, 1978 
Fields et al., 1990
Gelatinase IV/V collagen and 
basement membrane 
degradation
Wilhelm et al., 1989 
Hibbs et al., 1985
1990). Interstitial collagenases also show activity 
against general proteinase substrates (Fields et al., 
1990). Gingival fibroblasts have been shown to produce 
interstitial type collagenase (Heath et al., 1982) and this 
ability is also shared by periodontal ligament fibroblasts 
(Overall & Sodek, 1987) and is induced (together with 
gelatinase activity), at least as far as gingival 
fibroblasts are concerned, by IL-1 (Richards & Rutherford, 
1988; Meikle et al., 1989), TNF-a (Meikle et al., 1989) and 
concanavalin A (Overall, Wrana & Sodek, 1991). 
Interstitial type collagenases are also produced by 
macrophages, endothelial cells and keratinocytes (Fig. 
1.2). Many of the proteinases released in the gingival 
crevice, as well as being able to induce direct damage to 
the host may also activate interstitial collagenases 
inducing further periodontal damage (Table 1.6). 
Particularly important in this process seems to be 
plasminogen activator, which due to its ability to 
transform plasminogen into the active enzyme plasmin, 
activates latent collagenases.
The implication of proteases of bacterial origin in 
periodontal destruction cannot be excluded and several 
putative periodontal pathogens including P. gingivalis and 
A .actinomycetemcomitans demonstrate proteolytic/ 
collagenolytic activity (Slots, 1981; Robertson et al., 
1982; Birkedal-Hansen et al., 1988; Scheinken, 1988). 
Whether such enzymes could penetrate the periodontal
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/ Macrophages PMN 
B & T cells 
Keratinocytes 
Langerhans cells 
Fibroblasts
Collagenase 
Gelatinase 
Plasminogen activators 
Stromelysin and other 
matrix metalloproteinases
\\
Cytokines and
other mediators
Figure 1.2 Antigens or inflammatory mediators may induce 
resident cells of the periodontium to release 
metalloproteinases (from Kinane 1992).
PMN: polymorphonuclear leucocyte.
tissues and maintain sufficient concentrations therein to 
contribute to periodontal destruction is questionable 
(Kelstrup & Theilade, 1974; Birkedal-Hansen et al., 1988). 
Moreover, recent studies have shown that the predominant 
collagenases in the gingival crevice are of mammalian 
origin, evidenced by the breakdown of collagen into three 
and one quarter collagen fragments, which is characteristic 
of the function of vertebrate collagenases (Villela et al., 
1987; Sorsa et al., 1990).
1.7 Protease inhibitors
1.7.1 Introduction
Modulation of proteinase activity in biological fluids and 
tissues is accomplished by protease inhibitors either 
locally produced or circulating in plasma. The major 
plasma protease inhibitors are a2-macroglobulin (a2-M) , al- 
antitrypsin (a1-AT) and al-antichymotrypsin. a2-M and al- 
AT account for approximately 90% of serum's protease 
inhibiting capacity (Ohlsson, 1978a) and consequently these 
particular protease inhibitors have received most attention 
in periodontal research. In addition, specific
metalloproteinase activity inhibition within the tissues is 
accomplished by the family of the tissue inhibitors of 
metalloproteinases (TIMP).
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a2-M is a proteinase inhibitor with outstanding properties 
(reviewed in Starkey & Barrett, 1977). It is a tetramer of 
identical subunits (182 kDa) which are covalently linked 
forming half-molecules, which in turn are non-covalently 
associated to form the native molecule (725 kDa). a2-M has 
a very wide range of inhibitory function and is active 
against endopeptidases of all the catalytic types (serine-, 
cysteine-, aspartic- and metallo-). Only active enzymes 
react with a2-M and cleave the tetramer in the bait region 
producing a conformational change of the molecule which 
then irreversibly entraps the endopeptidase and inactivates 
it. The enzyme, however, although entrapped in the a2-M 
molecule can retain its activity against low molecular 
weight peptides like chromogenic and fluorogenic substrates 
(Starkey & Barrett, 1977). a2-M proteinase complexes, once 
formed, are rapidly removed from the circulation (half-life 
of approximately 10 min) (Ohlsson & Laurell, 1976) or 
tissues by macrophages via receptor mediated endocytosis 
(Feldman et al., 1983). The free and bound form of the 
inhibitor are referred to as the 'slow' and 'fast' form 
respectively, based on their electrophoretic mobility. 
This altered mobility of the inhibitor is probably due to 
its conformational change when reacting with an 
endopeptidase (Starkey & Barrett, 1977). In addition, the 
change in a2-M isoelectric point from 5.0 to 6.0, 
associated with complex formation, could be used for the 
demonstration of the free and bound form of the inhibitor 
in complex biological fluids (Ohlsson & Skude, 1976).
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al-AT has a much lower molecular weight (approximately 55 
kDa) than a2-M and is active mainly against serine 
proteinases, elastase being the typical example (Kueppers, 
1973). It is also called al-proteinase inhibitor as it has 
been suggested that the former name may be misleading, 
because trypsin inhibition is functionally much less 
important than the inhibition of other serine proteases 
like elastase (Travis & Salvesen, 1983). The inhibition of 
the protease is performed, in contrast to a2-M, by binding 
of the active site of the enzyme (1:1 molar ratio). The 
enzyme is then transferred to a2-M and eliminated (Ohlsson, 
197la,b) . The half life of the complex in the circulation 
is considerably longer (half life lh) than that of a2-M 
(Ohlsson & Laurel, 1976).
al-AT is a genetically polymorphic protein, the phenotypes 
characterised by different electrophoretic mobilities. The 
normally migrating M variant is the commonest in man 
whereas the slow S and Z gene products are associated with 
reduced plasma concentration of the inhibitor. al-AT 
deficiency (S and Z phenotypes) has been associated with 
chronic inflammatory disorders characterised by 
uncontrolled proteolysis such as pulmonary emphysema 
(Kueppers, 1973).
Both a2-M and al-AT are mainly serum derived glycoproteins, 
their serum concentrations being approximately 2mg/ml 
(Johansson, 1979). Their main site of production is the
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liver. al-AT is regulated as an acute-phase reactant 
whereas a2-M is a serum acute-phase protein in rat and 
rabbit but not in man (Starkey & Barrett, 1977). In 
addition, both al-AT and a2-M can be locally produced at 
the site of inflammation. al-AT is produced by 
monocytes/macrophages (Perlmutter et al., 1985; Bauer, 
Ganter & Gerok, 1988) and there is evidence of its 
production by human polymorphonuclear leucocytes and 
storage within their primary granules (Mason et al., 1991) .
a2-M is also produced at the cellular level by monocytes 
and macrophages (Hovi, Mosher & Vaheri et al., 1977; White, 
Janoff & Godfrey, 1980; Bauer et al., 1988) as well as 
fibroblasts (Budek et al., 1986). It has recently been 
suggested that the transition of human monocytes into 
macrophages in vitro is accompanied by a strong induction 
in the production and secretion of a2-M (Bauer et al., 
1988) and this may be important in vivo.
In addition to their well known protease inhibiting 
properties, it has been suggested that both a2-M and al-AT 
could modulate several inflammatory and immunological 
processes. As reviewed recently by James (1980, 1990) in 
vitro evidence suggests that a2-M could modulate/inhibit 
immune responses via several pathways. This could possibly 
occur through inhibition of proteolytic dependent 
reactions, binding of important effector molecules like 
mitogens and cytokines and blocking of cell receptors. 
Suppression of immunological and inflammatory mechanisms
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has also been ascribed to al-AT. Experimental evidence 
implicates the latter inhibitor in the regulation of 
lymphocyte responses, complement activation and neutrophil 
migration (reviewed by Breit & Penny, 1980). It has, for 
example, been shown that both a2-M and al-AT could inhibit 
natural killing and antibody dependent cell mediated 
cytotoxicity and that a2-M subunits may be particularly 
effective (Ades et a l . ,  1982; Gravagna et a l . ,  1982; 
Dickinson et a l . ,  1985). al-AT has been recently shown to 
inhibit FMLP induced neutrophil chemotaxis and this is 
probably related to its protease inhibitory capacity 
(Stockley et a l . ,  1990). a2-M has also been found to 
inhibit lymphocyte responses to several lectins (Miyanaga 
et a l . ,  1982) and to bind recombinant interleukin-lb (Borth 
et a l . ,  1990). The evidence reviewed by James (1980, 1990) 
and Breit and Penny (1980), similarly to the above 
mentioned individual studies is, however, based on in vitro 
observations and should therefore be viewed with care 
(Munck-Petersen, 1990). The implication however of a2-M 
and al-AT in immunological reactions cannot be excluded and 
further research in the field may elucidate their in vivo 
relevance to inflammatory and immunological processes.
1.7.2 Protease inhibitors in the gingivae
In contrast to proteases, protease inhibitors have been 
investigated less extensively in relation to periodontal
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disease and some conflicting reports exist in the 
literature.
a2-M and al-AT in the gingival tissues are derived from the 
circulation as well as from monocytes/macrophages and 
gingival fibroblasts. Production of a2-M by gingival 
fibroblasts which were cultured to confluence from gingival 
explants has been demonstrated by Condacci et al. (1988). 
The synthesis of a2-M was demonstrated by incorporation of 
a radiolabelled amino acid into newly synthesized protein. 
It was suggested by the authors that local production may 
be an important mechanism for the control of proteolysis in 
the gingival tissues and the crevice, as this high 
molecular weight inhibitor would be readily available in 
the area. In a more recent report from the same group 
(Giannopoulou et al., 1990), an attempt was made to provide 
in vivo evidence of the local production of a2-M using the 
experimental gingivitis model. GCF was used as the study 
material and the excretion coefficient (a2-M to albumin 
ratio in GCF corrected for the a2-M to albumin ratio in 
serum) to test for local a2-M production. Although the 
authors conclude that local production occurs, this study 
suffers from the lack of sufficient statistical analysis, 
the use of crude means for calculation of the ratios and 
the assumption that increase/decrease in the a2-M/albumin 
ratio would be due to changes in a2-M levels only, whereas 
albumin consumption in the crevice is also quite possible. 
Nevertheless, local in vivo a2-M production is likely to
occur, as suggested from the in vitro studies (Hovi et al., 
1977; White et al., 1980; Budek et al., 1986; Bauer et al., 
1988; Condacci et al., 1988) and in addition to gingival 
fibroblasts (Condacci et al., 1988), mature macrophages may 
also contribute (Bauer et al., 1988).
In addition to the major serum protease inhibitors, a2-M 
and al-AT, specific regulation of metalloproteinase 
activity within the tissues is also accomplished by the 
family of tissue inhibitors of metalloproteinases (TIMP). 
These are a family of low molecular weight inhibitors (29 
kDa) and fibroblasts (Heath et al., 1982) as well as 
mononuclear phagocytes (Campbell et al., 1991) are probably 
responsible for TIMP production within the tissues.
TIMP production by gingival fibroblasts is upregulated by 
transforming growth factor B1 (TGF-B1) and suppressed by 
concanavalin A, a lectin which may mimic physiological 
pathways of cellular activation (Overall et al., 1989; 
Overall et al., 1991). In addition to suppressing TIMP 
production by gingival fibroblasts at the transcriptional 
level concanavalin A also induces collagenase production 
(Overall et al., 1989; Overall et al., 1991). Therefore, 
interactions between cytokines, potent inducers of cellular 
differentiation /activation, and resident cells of the 
periodontium, may determine whether repair or destruction 
of periodontal tissues will occur. However, although TIMP 
is present within the tissues, it has been shown that
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collagenase binds preferentially to a2-M (Cawston & Mercer, 
1986) and this fact taken together with the ability of 
several serine proteinases, including elastase, to destroy 
TIMP's protease inhibitory capacity (Okada et al., 1988), 
emphasises the importance of a2-M as a protease inhibitor 
within the tissues (Docherty & Murphy, 1990). In addition 
the mechanisms inducing/suppressing TIMP production would 
also apply to a2-M and al-AT because, as mentioned above, 
differentiation of blood monocytes to tissue macrophages is 
followed by a strong induction of the production of these 
inhibitors (Bauer et al., 1988). This would result in the 
availability of a2-M and al-AT within the tissues through 
local production as well as serum.
As discussed in section 1.6 release of proteases in the 
gingivae and the crevicular area promotes inflammatory 
reactions and contributes to connective tissue damage via 
several pathways, the metalloproteinases playing a 
significant role. In contrast, protease inhibitors would 
serve as modulators of protease function in the area and 
together with their possible immune suppressive properties 
would hamper the inflammatory process. All the host 
derived endopeptidases shown to be released in the gingival 
crevice can been inhibited by the combined function of a2-M 
and al-AT. In fact, gingival collagenase inhibition by a2- 
M has been demonstrated (Birkedal-Hansen et al., 1974) and 
PMN collagenase is in addition inhibited by al-AT (Ohlsson 
& Olsson, 1977). Human serum was also shown to inhibit
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bacterial collagenase providing indirect evidence that 
plasma proteinase inhibitors are effective against 
bacterial proteases (Gibbons & McDonald, 1961).
1.7.3 Serum protease inhibitors and periodontal 
disease status
When the association between al-AT deficiency and pulmonary 
emphysema was established an attempt was made to 
investigate whether a similar association existed in 
periodontal disease. Peterson and Marsh (1979)
investigated al-AT phenotypes in a group consisting of 100 
subjects with no signs of periodontal disease and 50 
subjects who suffered from periodontal disease of varying 
severity. Although no correlations could be observed 
between al-AT serum concentrations and periodontal disease 
severity, the periodontitis patient group demonstrated 
higher frequency of al-antitrypsin MZ and MS phenotypes in 
serum when compared to the control group. The hypothesis 
that an association between al-AT deficiency and incidence 
of periodontal disease could exist was investigated further 
by Sandholm, Saxen and Koistinen (1981) in a group of 19 
juvenile periodontitis patients. Juvenile periodontitis 
was chosen as the clinical entity to be investigated 
because of its low prevalence, which is similar to that of 
al-AT deficiency. In contrast to the study of Peterson and 
Marsh (1979) all patients in the latter study proved to be
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of the most common phenotype MM. al-AT and a2-M 
concentration in serum was within the normal range in this 
group of juvenile periodontitis patients. The authors 
therefore concluded that juvenile periodontitis is not 
related to al-AT deficiency. In a more recent study 
(Zafiropoulos et al., 1988) the findings of the previous 
investigators (Sandholm et al., 1981) were verified as the 
concentration of al-AT in serum was not found to differ in 
juvenile and rapidly progressive periodontitis patients 
when compared to periodontally healthy controls. This was 
also the case for a2-M serum levels (Zafiropoulos et al., 
1988) which had, in addition, been shown to be within the 
normal range in a group of 25 juvenile periodontititis 
patients in a previous study (Sandholm & Saxen, 1983). An 
association has also been sought between a2-M serum 
concentration and periodontal disease status, as determined 
by mean subject gingival index and probing depths in a 
group of 86 subjects (Skaleric et al., 1987). Although the 
authors suggest that a positive causal association exists 
between periodontal disease and serum a2-M levels, the very 
low, albeit significant, correlation coefficient is a 
reflection of the great number of subjects used (r^O.26, 
p<0.05), and has weak biological significance.
In conclusion, it seems that little can be gained from 
examining protease inhibitor levels in serum either for 
identifying high risk groups or determining periodontal 
disease status. As protease release is a local event in
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periodontal disease, occurring predominately at sites of 
inflammation and/or periodontal disease activity it would 
appear more pertinent and fruitful to investigate protease 
inhibitors in the gingival crevice and tissues.
1.7.4 Protease inhibitors in gingival crevicular fluid
The most widely investigated inhibitor in the gingival 
crevice is a2-M, although recent reports have also focused 
on al-AT and its complex to neutrophil elastase.
Probably the first report on the presence of a2-M and al-AT 
in the gingival crevice is that of Ohlsson et al. (1974). 
These authors demonstrated the presence of both inhibitors 
in healthy and inflamed 'crevicular material' using an 
electroimmunoassay and reported higher concentrations in 
the sample eluate from inflamed when compared to healthy 
gingivae. When examining al-AT using crossed
immunoelectrophoresis, these authors (Ohlsson et al., 1974) 
observed considerable heterogeneity in its migratory 
pattern and took this as an indication that the protease 
inhibitor was complexed to proteases. As elastolytic 
activity was still evident in samples from both healthy and 
inflamed gingivae, the authors concluded that the protease 
inhibitory capacity of al-AT was saturated.
In a contemporary study, Scheinken and Genco (1977) 
reported that the concentration of al-AT and a2-M in GCF
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from inflamed sites is approximately 70% of that of serum 
for both inhibitors and a similar ratio, although slightly 
higher, was obtained in a later study by Tollefsen and 
Saltvedt (1980). The ratio of al-AT to transferrin in GCF 
and serum from patients with gingivitis and periodontitis 
has also been compared and higher mean ratios have been 
obtained in GCF. This did not, however, correlate with the 
severity of gingival inflammation (Asman, Bergstrom & 
Soder, 1981).
Condacci et al, (1982) investigated a2-M in gingival 
crevicular washings during an experimental gingivitis 
period and in individual GCF samples before and after 
periodontal treatment. Radial immunodiffusion was used to 
assess total (bound and unbound) a2-M concentration in the 
gingival washings which was shown to increase with the 
development of gingival inflammation and to drop gradually 
after the reinstitution of oral hygiene measures and the 
resolution of gingivitis. Using an electroimmunoassay, 
absolute amounts of total a2-M (bound and unbound) were 
shown to drop with treatment and the resolution of gingival 
inflammation in GCF samples from 11 patients although the 
specific content (a2-M p,g/mg of GCF) was shown to increase. 
The free and bound form of the inhibitor were also assessed 
in separate GCF samples from the same patients using 
isoelectric focusing followed by crossed 
immunoelectrophoresis and although free and bound form was 
invariably detected prior to treatment, after treatment
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only the bound form of a2-M was observed. The reason for 
the presence of free a2-M in the inflamed and its absence 
from the healthy crevice could not be explained by the 
authors. The presence of free a2-M in inflamed sites in 
this study, could be due to serum contamination of the GCF 
sample in inflamed sites. This is quite possible as long 
sampling periods (paper strips 3-5 min) were employed.
In a more recent study Skaleric et al. (1986) reported that 
GCF a2-M concentration is lower in sites with more gingival 
inflammation and higher proportion of periodontal 
attachment loss. In contrast, however, to Condacci et al. 
(1982) no bound a2-M was found in GCF from inflamed sites. 
The authors hypothesize that any bound form of the 
inhibitor is removed by macrophage receptor mediated 
endocytosis. However, this is difficult to accept. 
Significant amounts of proteases are released within the 
gingival crevice, mainly by degranulating /phagocytosing 
polymorphonuclear leucocytes. This process would be 
enhanced by the invasive GCF sampling procedure applied in 
this study (microcapillary tubes for the collection of 2^ ,1 
of GCF). In addition, adherence of PMNs on the glass 
surface of the microcapillary tubes, used in this study for 
GCF collection, would lead to degranulation and release of 
lysosomal proteinases. Thus, any free a2-M would readily 
bind to proteases. Mononuclear phagocytes and macrophages 
are scarce in the gingival crevice (Skapski & Lehner, 1976) 
and therefore the mechanism of removal of these complexes
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suggested by the authors does not apply. The small number 
of patients/sites (n=14) participating in this study and 
the use of an invasive GCF sampling technique dictate 
further research if the bound/free a2-M ratio in the 
gingival crevice is of interest.
Sengupta, Lamster and Khocht (1988) also assessed the 
effect of treatment on absolute amounts of GCF a2-M levels 
using ELISA methodology. Similarly to Condacci et al. 
(1982) they reported a significant reduction in a2-M 
absolute amounts after treatment. This was also the case 
in a more recent study of the same group (Lamster et al., 
1990). The latter investigators (Lamster et al., 1990) 
also sought to establish within subject correlations 
(intraclass correlations) for GCF a2-M as well as other GCF 
constituents of the local inflammatory response including 
lysosomal enzymes and immunoglobulins. The high intraclass 
correlations obtained for a2-M and immunoglobulins in GCF 
led the authors to conclude that although these proteins 
might be locally produced their levels seem to be highly 
influenced by systemic factors, most probably their serum 
concentration levels.
Sibraa et al. (1991) have attempted to devise a method 
which, with modification, could be used for chairside GCF 
acute phase protein level assessment, including a2-M and 
al-AT. Direct and indirect immunodot were evaluated using 
either 125I or enzyme labelled antibody/colorimetrics as a
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marker. al-AT was not readily detectable in GCF samples 
using this methodology. a2-M demonstrated lower
concentrations in diseased sites.
Two recent reports (Zafiropoulos et al., 1991; Huynh et 
al., 1992) have focused on al-AT/elastase complex
assessment in GCF using a commercially available kit 
(Merck), based on enzyme linked immunosorbent assay (ELISA) 
methodology. This ELISA methodology reflects elastase 
concentration in GCF, which avidly binds to al-AT. In 
contrast, the inhibitor will also bind to other available 
serine proteinases like Cathepsin G and plasminogen 
activator and metalloproteinase like collagenase (Ohlsson 
& Olsson, 1977). Thus assessment of the al-AT/elastase 
complex in GCF via ELISA methodology will only partly 
reflect the bound form of the inhibitor and will not 
provide information on the true bound/free al-AT ratio. 
Nevertheless, these reports add a different dimension to 
al-AT research.
Zafiropoulos et al. (1991) demonstrated a positive 
association between GCF al-AT/elastase complex 
concentration and several black pigmented Bacteroides 
species with P. gingivalis (formerly B .gingivalis) showing 
the highest association with the complex. The association 
of GCF al-AT/elastase complex with bacterial species 
associated with periodontal disease may reflect higher PMN 
activity at sites colonised with higher numbers of putative
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periodontal pathogens. Clinical parameters however 
demonstrated weak correlations with GCF al-AT/elastase 
complex concentration.
Huynh et al. (1992) reported higher GCF concentration of 
al-AT/elastase complex in stable gingivitis, adult 
periodontitis and rapidly progressive periodontitis when 
compared to healthy sites, where in most cases the levels 
of the complex were below the detectability limit of the 
assay. al-AT/elastase levels were higher, when compared to 
both healthy and stable sites, in an additional 11 sites 
where progressive attachment loss during the two month 
observation period was detected.
Perhaps the only recent report on simultaneous assessment 
of a2-M and al-AT in GCF is that of Giannopoulou et al. 
(1992) who assessed these protease inhibitors during 
experimental gingivitis. Although this study mainly 
focuses on determining whether bound or free elastase 
exists in GCF, some interesting information appears in 
relation to the two inhibitors. Both absolute amounts and 
concentrations of a2-M and al-AT were shown to increase 
with the development of gingival inflammation. This is in 
contrast to previous reports (Skaleric et al., 1986; Sibraa 
et al., 1991) including one from the same group (Condacci 
et al., 1982) who have shown that GCF a2-M concentration 
decreased in more diseased sites. This could be due to the 
different methods of GCF collection employed: Condacci et
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al. (1982) collected GCF using filter paper strips for 3 to 
5 min; Sibraa et al. (1991) used filter paper strips for 
an undefined period of time (or until 1/3 of the paper 
strip was visibly wet); finally, Skaleric et al. (1986) 
sampled using microcapillary tubes and collected 2p,l of 
GCF. These methods of GCF collection are thought to 
irritate the gingival tissues (Cimasoni, 1983; Persson & 
Page, 1990) and could thus increase vascular permeability 
in the area which could adversely affect GCF a2-M 
concentration in an uncontrollable manner. In contrast, 
Giannopoulou et al. (1992), collected GCF using a much less 
invasive technique (paper strips for 30s) and thus 
concentration of GCF constituents in GCF samples obtained 
in this study probably reflect better the true situation in 
the crevice.
In conclusion, although several attempts have been made to 
assess a2-M and al-AT in GCF and to associate them with 
periodontal disease status at specific sites, few reports 
have focused on the simultaneous assessment of both 
inhibitors in GCF. Such data would provide information on 
the protease inhibitory potential at specific sites. In 
addition inconsistencies exist as far as a2-M is concerned 
regarding its concentration in GCF and its association with 
periodontal disease status. Finally, with the exception of 
the study of Huynh et al. (1992) no reports of a 
longitudinal nature exist in the literature which would 
elucidate the relationship of protease inhibitor levels
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with active periodontal destruction. a2-M and al-AT have 
important regulating functions on the activity of 
destructive proteases and in several processes of both 
inflammatory and immunological relevance such that further 
research in the area is justified (see Aims; section 1.9).
1.8 Iron-binding proteins: The transferrins
1.8.1 Introduction
The transferrins are a group of iron-binding proteins 
involved in iron transport and include transferrin (TF) and 
lactoferrin (LF).
TF and LF are glycoproteins with a molecular weight of 
approximately 80kDa. TF is mainly serum derived with a 
plasma concentration of approximately 2mg/ml (Johansson, 
1979). The main site of production of TF is the liver 
although monocytes/macrophages (Stecher & Thorbecke, 1967) 
and T lymphocytes (Lum et al., 1986) may also contribute in 
TF synthesis within the tissues. Plasma TF is regulated as 
a negative acute-phase reactant, its concentration 
decreasing during the acute phase of inflammation. LF is 
a highly cationic protein, structurally similar to TF 
(Metz-Boutigue et al., 1984), but immunologically distinct. 
LF is mainly a protein of external secretions and it is 
present in milk, tears as well as saliva (Masson, Heremans
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& Dive, 1966). It is also contained, specifically and in 
abundance, within PMN secondary granules (Spitznagel et 
al., 1974) but not in other leucocytes (Bennet & 
Kokocinski, 1978) and only in trace amounts in serum 
(Hetherington, Spitznagel & Quie, 1983). LF is produced at 
the promyelocyte stage (Rado et al., 1984) while mature 
PMNs lose their ability to synthesise LF.
TF and LF have high affinity for iron and bind two ferric 
ions per molecule. LF binds more avidly to iron than TF 
(Aisen & Leibman, 1972) and retains its iron binding 
ability even at low pH (up to approximately pH 2) (Masson 
& Heremans, 1968) whereas TF's affinity for iron falls with 
even a moderate pH drop.
The main function of TF is the transport of iron between 
sites of absorption, storage, utilization and excretion 
(Aisen, 1980). It is now well established that all cells 
requiring iron, express a TF receptor and transport of iron 
into the cells is performed via receptor mediated 
endocytosis. Upon iron donation apo-TF (iron free) is 
released to the environment via a reverse mechanism 
(Dautry-Varsat, 1986). One of the very early recognised 
functions of LF is its ability to inhibit bacterial growth 
by binding iron and creating an iron limiting environment. 
This may be particularly important at sites of inflammation 
where the lowered pH may limit the affinity of iron to TF. 
It has also been shown that LF may have bactericidal
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properties independent of iron deprivation (Arnold et al., 
1982). A recent report suggests that LF and lysozyme may 
act in synergy to induce killing of Gram negative bacteria 
and this is associated with the ability of LF to bind to 
bacterial lipopolysaccharide (Ellison & Giehl, 1991). Lack 
of LF seen in individuals with PMN secondary granule 
deficiency, is associated with increased incidence of 
infections (Breton-Gorius et al., 1980). Finally, both TF 
and LF have been shown to bind to oral isolates (Beighton 
et al., 1992; Ellison & Giehl, 1991). In addition, LF by 
binding to bacteria may reduce their hydrophobicity, and 
diminish their ability to adhere and readhere, thus 
rendering them susceptible to phagocytosis (Wilton, 1986).
During the past two decades a number of additional 
properties of both TF and LF have been investigated and 
their implication in immunological and inflammatory 
mechanisms is now recognised (Brock, 1989). TF is 
implicated in lymphocyte transformation and subsequent 
proliferation (Brock & Rankin, 1981) and although it has 
been proposed that TF per se may mediate these events 
(Brock & Mainou-Fowler, 1983), it is more probable that TF 
functions as an iron donor (Brock, Mainou-Fowler & Webster, 
1986). TF production by activated helper T-cells has been 
shown and it has been suggested that TF could function in 
an autocrine regulatory manner (Lum et al., 1986). LF has 
been shown to bind to macrophages, some investigators 
claiming through a specific receptor (Bartal, Padeh &
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Passwell, 1987; Birgens, 1991), and to increase their 
proliferation rate in mice (Oria et a l . ,  1988). Moreover, 
there is evidence showing that LF may inhibit the 
production of prostaglandins and interleukin-1 by 
monocytes/macrophages (Zucali et a l . ,  1989; Pelus et al., 
1979; Bartal et a l . ,  1987) and may enhance PMN adhesiveness 
and modulate their chemotaxis (Oseas et a l . ,  1981; Gallin, 
1984). LF has also been implicated in the regulation of 
myelopoesis by suppressing the production of granulocyte- 
macrophage colony stimulating factor (GM-CSF), probably by 
its ability to inhibit interleukin-1 production (Zucali et 
a l . ,  1989). Both LF and TF may act as iron scavengers at 
sites of inflammation and thereby inhibit the production of 
free hydroxyl radical formation which could otherwise cause 
damage to the host tissues (Britigan et a l . ,  1989). LF due 
to its affinity for iron even at low pH, may be more 
effective in this process particularly in infectious and 
diseased tissue where pHs are variable. TF in contrast is 
more suited, by its narrow pH iron-binding range, to 
function in the pH regulated plasma and tissues.
1.8.2 Iron-binding proteins in periodontal disease
Despite the evidence reviewed in the previous section both 
LF and TF have received very limited attention from 
investigators of periodontal disease.
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In an early experimental gingivitis study Norman and 
coworkers (1979) were not able to demonstrate any 
significant change in serum TF, compared to baseline, 3 and 
21 days after cessation of all oral hygiene measures in 
eight healthy volunteers.
The presence of TF in GCF was initially demonstrated by 
Brill and Bronnestam (1960) using immunoelectrophoresis. 
Schenkein and Genco (1977) assessed TF levels in GCF from 
diseased sites using radial immunodiffusion and reported 
that it occurred at levels of approximately 70% of that of 
serum which are similar to those reported for a2-M and al- 
AT by the same investigators. This is in contrast to the 
findings of Asman et al. (1981) who reported that the 
dilution of al-AT in GCF is higher than that of TF when 
compared to serum.
The importance of PMNs in the pathogenesis of periodontal 
disease has already been discussed in section 1.5 together 
with PMN granule characteristics and the stimuli for their 
release. LF has been used as a marker when investigating 
possible mechanisms of PMN secondary granule release in 
response to whole dental plaque, Gram positive, as well as 
Gram negative isolates (Baehni e t  a l . ,  1977; Baehni e t  a l . ,  
1978; Tsai e t  a l . ,  1978). In an interesting in vitro study 
(Baehni e t  a l . ,  1979b), primary and secondary granule 
release from polymorphonuclear leucocytes was assessed 
following stimulation from autologous whole dental plaque
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collected during a 21 day experimental gingivitis episode. 
PMNs responded in a dose dependent manner when incubated 
with increasing amounts of dental plaque. LF release from 
secondary granules was significantly higher when PMNs were 
incubated with day 21 compared to day 3 plaque, whereas 
myeloperoxidase release, indicating primary granule 
exocytosis, did not demonstrate the same pattern. 
Moreover, it has been shown that PMN phagocytosis of 
Treponema denticola leads to LF release (Hurlen et al., 
1984).
As LF is an exclusive constituent of PMN secondary 
granules, and is contained only in trace amounts in serum, 
it has been suggested that GCF LF could prove a useful 
marker of crevicular PMNs (Fine & Mandel, 1986; Curtis et 
al., 1989). In addition, it has been suggested that it 
could act in synergy with TF to produce an iron limiting 
environment which would inhibit bacterial growth (Curtis et 
al., 1989).
Despite the above evidence LF has only been assessed in one 
study to date by Friedman et al. (1983). These 
investigators reported higher LF concentration in pooled 
GCF from gingivitis, periodontitis and juvenile 
periodontitis patients when compared to healthy controls. 
No reports exist in the literature on the presence of LF in 
discrete GCF samples and its association with periodontal 
disease status/activity at specific sites.
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In conclusion, information on GCF iron-binding proteins is 
scarce. In view of their possible combined function and 
implication in the inflammatory process quantification of 
GCF iron binding proteins may provide information on their 
role in periodontal inflammation. In addition the 
possibility of LF acting as an exclusive PMN marker in the 
gingival crevice renders its assessment in GCF particularly 
pertinent (see Aims; section 1.9).
1.9 Aims
The objectives of the series of investigations undertaken 
in this thesis are:
1) Preliminary experiments:
To establish new, or modify existing, methods for the 
quantification of protease inhibitors (a2-macroglobulin and 
al-antitrypsin) and iron-binding proteins (transferrin and 
lactoferrin) in microamounts of gingival crevicular fluid. 
The development of techniques to permit simultaneous 
quantification of these proteins in the same GCF sample was 
the ultimate objective.
2) Clinical studies:
I) Cross sectional studies:
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a) To examine whether lactoferrin could act as a crevicular 
polymorphonuclear leucocyte marker.
b) To test the ability of GCF protease inhibitors and iron- 
binding proteins to distinguish between healthy, gingivitis 
and periodontitis sites.
II) Experimental gingivitis study:
To establish the dynamics of GCF protease inhibitors and 
iron-binding proteins during experimentally induced 
gingivitis and to provide a profile of their changes as 
inflammation develops.
III) Longitudinal study of periodontitis patients on 
maintenance care:
To investigate whether incipient periodontal disease 
breakdown could be associated with GCF protease inhibitor 
or iron-binding protein levels. In addition, the potential 
of clinical conditions to act as predictors/indicators for 
significant attachment level change was investigated.
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CHAPTER 2
Subjects, clinical methods, 
design and statistical analysis
2.1 Subjects
Prior to the commencement of each of the following studies 
ethical approval was granted from the local ethical 
committee. Individuals participating in these studies were 
informed of the protocol and consent was obtained.
These individuals had no history of systemic conditions 
which could influence the course of periodontal disease nor 
were they on medications that could affect its 
manifestations, such as chronic antibiotic use, phenytoin 
and other calcium channel blockers.
2.1.1 Cross-sectional studies on gingival crevicular 
fluid and gingival crevicular washings
Subjects attending the Periodontal Department of the 
Glasgow Dental Hospital were enrolled in these studies. 
GCF samples were collected from a total of 62 patients (27 
males, 35 females) with an age range of 20 to 57 years. 
Forty one of these individuals suffered from advanced 
periodontal disease as determined by clinical and 
radiographic examination (APD category), whereas the 
remaining 21 subjects could be classified as periodontally 
healthy with no attachment loss, pocket depths  ^3mm and no 
significant gingival inflammation (H category). An 
additional twenty one individuals (7 males; 14 females) 
with an age range of 20 to 52 years participated in the
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study on GCWs. Sixteen of these individuals belonged to 
the APD category whereas the remaining five were 
periodontally healthy.
2.1.2 Experimental gingivitis study
Six healthy dental students (5 males, 1 female; age range 
of 22 to 23 years) were enrolled in this study. These 
students demonstrated no clinically detectable periodontal 
attachment loss or pocketing >3mm in any site. Dental 
students were preferred because of their high degree of 
dental awareness and compliance.
2.1.3 Longitudinal study of periodontitis patients on
maintenance phase of therapy
Thirty eight periodontitis patients on a maintenance phase 
of therapy (17 males; 21 females), with an age range 26 to 
68 years, attending the Periodontal Department of the 
Glasgow Dental Hospital consented to participate in this 
study. Study inclusion criteria were that these patients:
a) had been diagnosed in the past as suffering from 
advanced periodontal disease (CPITN scores of 4 in at least 
four sextants) and had received a full course of 
periodontal treatment in the Glasgow Dental Hospital;
b) were on maintenance for at least 1 year;
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c) were still showing signs of persisting periodontal 
disease, defined as residual pocketing of  ^4mm and
bleeding on probing in at least 4 non-adjacent sites.
Pocketing was measured, during a recruiting appointment, 
with a PC12 (Prisma, UK) periodontal probe and recorded 
using a standard periodontal pocket chart. These patients 
were followed over a period of three months.
2.2 Clinical methods
2.2.1 Clinical indices
One examiner (EA), with the help of an assistant, was used 
throughout these studies to record all clinical indices.
2.2.1.1 The Modified Gingival Index
The Modified Gingival Index (MGI) (Lobene et al. 1986) vas 
used to assess gingival inf lamination and is described 
below:
0 Absence of inf lamination.
1 Mild inflammation; slight change in colour, little 
change in texture of any portion but not the entire 
marginal or papillary gingival unit.
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2 mild inflammation; criteria as above but involving the 
entire marginal or papillary gingival unit.
3 Moderate inflammation; glazing, redness, oedema, 
and/or hypertrophy of the marginal or papillary 
gingival unit.
4 Severe inflammation; marked redness, edema and or 
hypertrophy of the marginal or papillary gingival 
unit, spontaneous bleeding, congestion or ulceration.
This index differs from the commonly used Gingival Index 
(Loe & Silness, 1963) in that it eliminates the bleeding 
upon probing/pressure component, and provides increased 
sensitivity in the lower region of the scoring scale. The 
MGI was, therefore, preferred because it permits non- 
invasive evaluation of the severity of gingival 
inflammation, and thus facilitates GCF sampling. In the 
experimental gingivitis study whole mouth MGI scores (WMGI) 
refer to the average MGI of all sites assessed within a 
subject. In all other studies, unless otherwise stated, 
site scores refer to a single MGI recording.
2.2.1.2 The Plaque Index
The plaque index (PI) of Silness and Loe, (1964) was used 
for recording plaque accumulation. The scoring system for 
this index is as follows:
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0 No plaque in the gingival area.
1 A film of plaque adhering to the free gingival margin 
and adjacent area of the tooth. The plaque may only 
be recognised by running a probe across the tooth 
surface.
2 Moderate accumulation of soft deposits within the 
gingival crevice, on the gingival margin and/or 
adjacent tooth surface, which can be seen by the naked 
eye.
3 Abundance of soft matter within the gingival crevice 
and/or on the gingival margin and adjacent tooth 
surface.
In the experimental gingivitis study whole mouth PI scores 
(WPI) refer to the average PI of all surfaces assessed 
within a subject. In all other studies, unless otherwise 
stated, site scores refer to a single site PI recording.
2.2.1.3 Probing depth and attachment level measurements
In the cross-sectional studies on GCF and GCWs, 
probing/pocket (PD) depth was recorded to the nearest mm 
using a Williams periodontal probe.
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The Florida Probe (Florida Probe Corporation, Florida, USA) 
(Gibbs et al., 1988) was used for probing depth and 
attachment level (AL) recording in the longitudinal study 
of periodontitis patients on maintenance care. This is an 
electronic pressure sensitive probe set at 20g. The 
Florida Probe records PD/AL to the nearest 0.2mm. The 
system consists of a pocket depth and an attachment level 
('stent') handpiece, a foot switch, computer interface and 
portable personal computer (Fig. 2.1). The measurements of 
PD and AL are made electronically, using the 'pocket depth' 
(Fig. 2.2) and 'attachment level, stent' (Fig. 2.3) 
handpieces respectively, and transferred automatically to 
the computer when the foot switch is pressed. Recordings 
are displayed on the computer screen which was turned away 
from the operator in order to allow 'blind' measurements. 
In addition, measurements were recorded on paper by the 
assistant. The probe tip has a diameter of 0.4mm, no 
visible graduations along its length and it reciprocates 
through a sleeve. The edge of the sleeve is the reference 
from which measurements are recorded.
A fixed reference point is required for attachment level 
measurements. The Florida Probe 'stent' handpiece has a 
2mm diameter disc at the edge of its sleeve which, during 
attachment level measurement, is seated on a custom made 
soft acrylic stent covering the crowns of the teeth. These 
stents were constructed for both upper and lower arches for 
each patient from a 2mm thick silicone layer using a
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Figure 2.1 The Florida Probe: the system consists of a
pocket depth and attachment level ('stent') handpiece, a 
foot switch, a computer interface and a portable personal 
computer.
Figure 2.2 The Florida Probe 'pocket depth' handpiece.
F i g u r e  2 . 3  The Florida Probe 'stent' handpiece.
modification of the method described by Isidor, Karring and 
Attstrom, (1984). The stents were made on individually 
cast models using a vacuum forming unit. The stent was 
then trimmed to cover approximately the coronal one third 
of the crowns of the teeth at the sites selected for the 
study. At other sites as much as possible of the stent was 
preserved in order to assist location and retention. 
Grooves approximately 1mm deep, 2mm wide and 1mm high were 
cut, about 1mm away from the apical edge of the stent, at 
the sites to be used in the study, using an inverted cone 
bur and a low speed handpiece. The grooves were then 
marked with a permanent pen for ease of identification. 
The disc of the probe handpiece was located in these 
grooves during AL measurements. Attachment level was 
assessed relative to the point at which the probe handpiece 
disc was seated on the stent (Fig. 2.4). In this way, 
attachment level measurements do not rely on careful 
location of the cementoenamel junction (CEJ). The 
identification of the CEJ is often complicated by its 
subgingival location or the presence of restorations. 
Buccal/lingual AL measurements were taken at the tooth's 
largest curvature. Interproximal AL recordings were taken 
at the mid point between the contact point and the adjacent 
line angle. The grooves on the stent were located 
relatively to these points.
PD is recorded when the probe sleeve is brought into 
contact with the gingival margin (Fig. 2.5). Care was
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F i g u r e  2 . 4  Attachment level measurement using the Florida 
Probe 'stent' handpiece.
F i g u r e  2 . 5  Probing depth measurement using the Florida 
Probe 'pocket depth' handpiece.
taken for the probe tip to be parallel to the long axis of 
the tooth. PD measurements were taken at the same points 
as AL recordings.
2.2.1.4 Change in attachment level
Attachment level change between two points in time was 
assessed using a modification of the tolerance method of 
Haffajee et al., (1983b). Duplicate AL measurements at 
each time point provide a measure of examiner error. The 
standard deviation of duplicate measurements of a site, 
both at the first and second time points, were pooled to 
produce the 'site standard deviation'. Differences between 
all duplicate measurements for all sites selected for the 
study within a patient, were used to compute the mean 
difference of duplicate measurements for each individual. 
The standard deviation of the mean difference was termed 
the 'patient standard deviation'. Patient standard 
deviations were averaged to derive a 'population standard 
deviation'. For the mean of the second pair of AL 
measurements to be considered significantly different from 
the mean of the first pair, attachment level change:
a) had to exceed the 'population threshold' (which was 2 
population standard deviations);
b) had to exceed the 'patient threshold' (which was 3 
patient standard deviations); and finally
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c) had to be greater or equal to the 'site threshold' 
(which was 3 site standard deviations).
Significant attachment level gain or loss was assessed 
retrospectively on completion of the study using the above 
method.
2.2.1.5 Attachment level grading
An attachment level grading system was produced. This 
represents the direction and extent of attachment level 
change at specific sites during the longitudinal study of 
periodontitis patients on maintenance care. Individual 
sites were classified in 1 of 5 categories (grades) of 
attachment level change. Sites demonstrating significant 
attachment gain or loss over the observation period, using 
the tolerance method, were classified as grade 1 and 5 
respectively. A much less stringent criterion of AL change 
of ^lmm was also used. Sites demonstrating AL gain or loss 
between baseline and three months (recall) of ^lmm, without 
any other criterion being considered (section 2.2.1.4), 
were classified as grade 2 and grade 4 sites respectively. 
All other sites were classified as grade 3 sites. In this 
way a range of AL change grades, varying from 1 (most 
improvement) to 5 (most deterioration), was produced. The 
above grading system is an adaptation of the method 
described by Jenkins, MacFarlane and Gilmour, (1988).
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2.2 1.6 Bleeding on probing
Bleeding upon probing (BOP) was scored dichotomously using 
the Florida Periodontal Probe. Scoring was performed 
within 30s of probing.
2.2.1.7 Suppuration
Presence or absence of suppuration was recorded after 
applying gentle pressure on the gingival wall of the pocket 
at an apico-coronal direction using a ball burnisher.
2.2.2 Sample collection
2.2.2.1 Gingival crevicular fluid sampling
Whatman grade 4 (Whatman Labsales Ltd., Maidstone, Kent) 
paper strips (2x13mm) were used for GCF collection. 
Although Whatman grade 3 chromatography paper is 
recommended by some authors (Griffiths, Curtis & Wilton, 
1988), this type of paper could not be used, as it was 
impossible to obtain a zero reading with the Periotron 6000 
when the strips were dry. The Whatman grade 4 paper strips 
were cut manually using a steel ruler and scalpel. Rubber 
gloves were worn during their preparation in order to avoid 
contamination of the strips by substances from the 
operators hands. A line was drawn on each strip at 8mm, 
indicating the length of the paper strip to be inserted
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between the Periotron jaws and that part of the strip to be 
used for GCF sampling. The strips were then placed in 
glass universal bottles for autoclaving and storage.
In the clinic, GCF was sampled after the PI and MGI scores 
were taken but prior to any other clinical recordings which 
could cause irritation of the tissues and serum 
contamination of the sample. Such recordings included PD 
or AL measurements, BOP, suppuration etc. The individual 
crevicular site was gently air-dried in an apico-coronal 
direction and any visible supragingival plaque was removed. 
The area was carefully isolated with cotton wool rolls and 
saliva ejector to avoid saliva contamination of the 
samples. The paper strip was introduced into the crevice 
until mild resistance was felt, whilst care was taken to 
avoid mechanical injury of the tissues (Fig. 2.6). The 
strip was left in the crevice for 30s, and then transferred 
to the chairside located Periotron 6000 (Harco Electronics, 
Winnipeg, Canada) (Fig. 2.7) for volume determination. It 
was then stored in labelled individual sterile 1ml 
microcentrifuge tubes, and placed on ice until all sampling 
was completed. The strips were subsequently transported to 
the laboratory and stored frozen at -30°C (in initial 
studies) or -70°C, until further processing.
In the longitudinal study on maintenance periodontitis 
patients the procedure was slightly modified. A pencil dot 
was drawn on the sampling part of the strip at 1mm length
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F i g u r e  2 . 6  Gingival crevicular fluid sampling.
F i g u r e  2 . 7  The Periotron.
from its edge indicating the length to be introduced in the 
pocket. In this way a standardised length of the paper 
strip was inserted in the crevice/pocket.
2.2.2.2 Gingival crevicular washing sampling
Gingival crevicular washings were obtained using a 
modification of the Skapski and Lehner method (1976). The 
teeth were isolated with saliva ejector and cotton rolls 
and any visible supragingival plaque was removed. Aliquots 
of 20p,l of sterile phosphate buffered saline (PBS) were 
ejected and reaspirated in the crevice 3 times using a 20 
[il micropippete, fitted with a flat ended pipette tip 
(Labsystems, UK), resting interdentally on the surface of 
the tooth (Fig. 2.8). The gingival washings were then 
stored in labelled, individual, sterile 1ml microcentrifuge 
tubes, labelled, and placed in ice until completion of GCW 
sampling. GCWs were transferred to the laboratory and 
stored at 4°C until further processing.
2.2.2.3. Blood sampling
In the experiments requiring human serum, a 10ml venus 
blood sample was collected, from the antecubital fossa, in 
glass bottles. Blood samples were transferred to the 
laboratory and stored at 4°C until centrifuging at 3000rpm 
(12min) for serum recovery.
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F i g u r e  2 . 8  Gingival crevicular washing.
2.2.3 Selection of periodontal sites
2.2.3.1 Cross-sectional studies on gingival crevicular 
fluid and gingival crevicular washings
Sites to be sampled were selected by clinical inspection 
and the use of pre-existing pocket charts and/or 
radiographs. In this way, periodontal probing, which could 
cause irritation of the tissues and serum contamination of 
the sample, was avoided.
2.2.3.2 Experimental gingivitis study
GCF samples were obtained from the mesial aspect of the 
upper first premolars. These teeth did not demonstrate any 
attachment loss and were free of any dental restorations.
2.2.3.3 Longitudinal study of periodontitis 
patients on maintenance care
A conventional pocket chart, constructed on a recruiting 
appointment using a PC12 periodontal probe, was used for 
site selection in this study. All non-adjacent sites, 
(accessible to GCF sampling and attachment level recording) 
exhibiting pocketing ^ 4mm on the pocket chart were 
selected for this study. Interproximal sites were 
preferred to mid-buccal or mid-lingual sites due to their 
higher chance of demonstrating attachment loss (Haffajee et
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al.r 1983a). Mesial sites were preferred to distal sites 
as they are more accessible. On the upper posterior 
molars, palatal sites were preferred to buccal sites and on 
the lower teeth buccal/labial sites were preferred to 
lingual sites as these sites are less prone to saliva 
contamination of the GCF sample.
2.3 Clinical design
2.3.1 Cross-sectional studies on gingival crevicular
fluid and gingival crevicular washings
In all cross-sectional studies, as the term implies, 
samples were obtained and clinical recordings made at one 
time point. Clinical indices used in these studies were 
the MGI, PD and GCF volume. In order to establish the 
levels of GCF protease inhibitors and iron-binding proteins 
in relation to the clinical presentation of the sites 
sampled, sites were categorised into one of three Clinical 
groups: 'healthy', 'gingivitis' and 'periodontitis'. Sites 
with MGI scoring of 0 or 1 and PD not exceeding 2mm were 
categorised as 'healthy'. MGI between 2 and 4, and PD less 
than or equal to 3mm were the criteria for the 'gingivitis' 
sites, whereas sites with PD exceeding 3mm were designated 
'periodontitis' sites.
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2.3.2 Experimental gingivitis study
The experimental gingivitis model introduced by Loe, 
Theilade and Jensen (1965) was adapted for use in these 
studies. Subjects were enrolled in the trial 10 days prior 
to the commencement of the experimental gingivitis period 
(day -10), when their MGI and PI were recorded. Oral 
hygiene instruction and prophylaxis were then given. Ten 
days later (day 0/baseline) all oral hygiene procedures 
were ceased for 3 weeks. Clinical indices were recorded 
and GCF was sampled on days 0, 7, 14 and 21 of the
experimental gingivitis period and 1 and 2 weeks after the 
reinstitution of oral hygiene measures. Clinical indices 
used in this study were the MGI, PI and GCF volume. Whole 
mouth MGI and PI recordings were also made. GCF was 
collected from the upper first premolars.
2.3.3 Longitudinal study of periodontitis
patients on maintenance care
All patients in this study were seen at three appointments: 
i) initial recruitment appointment; ii) baseline 
appointment (0 months); and iii) recall appointment (3 
months). No instrumentation was carried out during the 
course of this study. At the initial recruitment 
appointment a medical history form was completed by the 
patient and the pocket charting, to be used for site 
selection, was constructed. An alginate impression was
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taken and from the resulting cast, a soft acrylic stent for 
attachment level measurements was constructed (section 
2.2.1.3). Subsequently, the patient was recalled for the 
baseline appointment. During this appointment and in the 
following order:
a) the consent form was signed by the patient and the 
clinician in charge, and the medical history form was 
confirmed;
b) PI and MGI recordings were taken first;
c) GCF samples were then taken from the preselected sites 
and GCF Periotron readings recorded;
d) the first set of AL measurements at the sites sampled 
was subsequently made. During this procedure bleeding on 
probing and suppuration were also registered. The stent 
was then removed;
e) after changing patient position and reapplying the stent 
the duplicate set of AL measurements was made;
f) Finally PD was assessed;
The same procedure was followed at three months.
2.4 Statistical Analysis
All statistical analyses were performed on an IBM PC 
computer using the Minitab or SPSS/PC statistical package.
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In the cross-sectional study on GCWs, associations between 
PMN numbers or LF in the washings and the clinical indices 
(MGI, PD and GCF volume) were determined by the non- 
parametric Spearman rank correlation coefficient. The 
association between LF levels and PMN numbers in GCWs was 
assessed by the Pearson correlation coefficient on the log10 
transformed data.
In the cross-sectional studies on GCF the site was 
considered as the statistical unit. a2-M, al-AT, TF and LF 
levels in GCF were markedly skewed and required logarithmic 
transformation in order to satisfy their distributional 
requirements prior to statistical analysis. Due to this 
skewed distribution, the geometric mean and 95% confidence 
intervals are shown rather than the standard error or 
standard deviation. Significant differences in a2-M, al- 
AT, TF and LF levels among the clinical groups were 
determined by one way analysis of variance and two sample 
t-tests. As three comparisons were made among clinical 
groups when using the two sample t-tests, significance 
level was set at 0.025 (0.05/V3 *0.025, where 3=number of 
comparisons) in order to compensate for multiple 
comparisons (Brown & Swanson Beck, 1988).
In the experimental gingivitis study data was analyzed 
using repeated measures multivariate analysis of variance 
and the MANOVA procedure on the SPSS/PC statistical package 
(Norusis, 1990). Both subject and site were considered as
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the experimental unit. When the subject was considered as 
the unit, GCF constituent levels from the two sites were 
averaged within each subject. In order to satisfy the 
distributional requirements of the data for the tests a 
log10 transformation was required (log10(l+x), x=original 
data value). In an attempt to investigate which days 
demonstrated significantly elevated GCF protease inhibitor 
and iron-binding protein levels since baseline, individual 
paired t-tests were employed on the log10 transformed data, 
comparing baseline levels of each protein to each 
subsequent day, considering the subject and site as the 
experimental unit. Significance level for the paired t- 
tests was set at 0.02 (0.05/^5, where 5=nu&ber of
comparisons made).
A further transformation of the data to z scores vas used 
in this study. The z scores for each protein are produced 
by subtracting each data value from the grand meai of the 
protein and dividing by its standard deviation. This 
results in a new variable for each protein whici has a 
grand mean of 0 and standard deviation of 1. In this way 
differences in overall level among the four proteins are 
removed and focusing on the pattern of change is cliowed.
In the longitudinal study of periodontitis patients on 
maintenance care, analysis of the clinical findiigfs was 
performed considering both subject and site as the 
experimental unit. When the subject was considerec as the
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experimental unit, clinical indices within the subject were 
averaged, and one score for each clinical index (MGI, PI, 
GCF volume, AL change, BOP and S) produced per patient. 
BOP and S scores (0 = absence or negative and 1 = presence 
or positive) averages produced scores, ranging from 0 to 1, 
with the decimal digits being equivalent to the percentage 
of bleeding or suppurating sites per subject. Subjects 
were ranked according to their mean attachment level scores 
(rank 1= most improvement or maximum mean attachment gain; 
rank 38= most deterioration or maximum mean attachment 
loss), as well as by their mean baseline MGI, PI, PD, BOP, 
GCF volume and S scores, and Spearman rank correlation was 
employed to assess associations between clinical indices 
and attachment level change. In order to examine whether 
true associations between the clinical indices and 
attachment level change were being masked by the inclusion 
of a large number of stable sites the two best (maximum 
attachment gain) and two worst sites (maximum attachment 
loss) per patient were compared.
Baseline clinical indices scores, including MGI PD and GCF 
volume, for the two best and two worst sites per patient 
were averaged and paired tests (t-test for GCF volume; sign 
tests for the clinical indices) were used to compare for 
differences between best and worst sites within each 
subject. When the sites were considered as independent, 
Spearman rank correlations were used to test for 
associations between attachment level grade and clinical
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indices. Sites demonstrating significant attachment gain 
were compared with the sites demonstrating significant 
attachment loss, when considered as independent, using the 
Mann-Whitney test.
GCF protease inhibitors and iron-binding protein levels 
were compared between periodontally active and matched 
stable control sites, within each patient, using paired t- 
tests on the log10(l+x) data both at baseline and recall 
appointments. Repeated measures MANOVA procedures were 
also applied, on the baseline and recall appointments 
separately, in order to test for differences between active 
and stable sites, simultaneously for all four proteins.
The model was extended and repeated measures MANOVA 
incorporating the four proteins while testing for site 
(stable versus active), appointment (baseline versus 
recall) and site by appointment effects was run on the 
logio(l+x) transformed data. If bl and b2 represent the 
responses for each protein (a2-M, al-AT, TF and LF) at 
baseline, at the active and stable sites respectively, and 
rl and r2 similarly at recall, then the null hypotheses for 
these effects represent:
a) stable versus active: (bl+rl)-(b2+r2)=0
b) baseline versus recall: (bl+b2)-(rl+r2)=0
c) site by appointment: (bl-b2)-(rl-r2)=(bl-rl)-(b2-r2)=0
90
Of the above, the most potentially useful would be the site 
by appointment effect, as it compares the change (6) 
between baseline and recall at active versus stable sites.
In order to illustrate the diagnostic potential of a test 
based on the levels of protease inhibitors and iron-binding 
proteins in GCF, a 2x2 table based on the data of a2-M, al- 
AT, TF and LF at the recall appointment from active and 
stable sites was formulated. A combined test based on the 
values of the four proteins, a2-M, al-AT, LF and TF was 
applied. Thus, the test was considered positive when a 
site demonstrated a2-M, al-AT, TF, and LF levels beyond a 
designated threshold value. These threshold values 
represent the geometric means of a2-M, al-AT, TF and LF 
levels (ng/30s) at active sites at the recall appointment. 
All four conditions should apply simultaneously in order 
for the test to be considered positive, whereas if the 
levels of any one of the proteins dropped below the 
designated threshold values the test was considered 
negative. Specificity and sensitivity values and positive 
and negative predictive values were calculated using 
standard methods as shown in Table 2.1.
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Table 2.1 Diagnostic test characteristics and definitions.
Positive test
Negative test
Disease Disease
present absent
Positive
predictive
value
a/(a+b)
Negative
predictive
value
d/(c+d)
a b
True False
positive positive
c d
False True
negative negative
Sensitivity Specificity
a/(a+c) d/(b+d)
CHAPTER 3
Materials, experimental methods, 
and preliminary experiments
3.1 Materials
3.1.1 Buffers and reagents
All chemicals were analytical grade and were obtained from 
BDH Chemicals Ltd., Poole, Dorset, England, unless 
otherwise stated.
3.1.1.1 Phosphate buffered saline (PBS)
PBS pH 7.4, lOmM phosphate buffer, containing 150mM NaCl.
3.1.1.2 Coating buffer (CB)
Carbonate-bicarbonate buffer prepared by dissolving 1.59g 
Na2C03, 2.93g NaHC03 and 0.2g NaN3 up to 1 litre of
distilled water. The pH was adjusted to 9.6 (titration 
with 1M HC1).
3.1.1.3 Incubation buffer (IB)
This was prepared by dissolving 8g NaCl, 0.2g KH2P04, 0.2g 
KC1, 1.44g Na2HP04 . 2 H20, 0.5g Tween 20 (SIGMA Chemical 
Company Ltd., Poole, Dorset), and lg lyophilised bovine 
serum albumin (BSA) (SIGMA) up to 1 litre distilled water 
(pH 7.4).
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In the case of the albumin sandwich ELISA, BSA was omitted 
and replaced by 5% (w/v) powder of proprietary milk
(MARVEL) (IB/M).
3.1.1.4 Wash buffer (PBST)
A stock solution of 10 times concentrated incubation buffer 
(nil BSA) was prepared. This was diluted 1/10 prior to 
use.
3.1.1.5 Substrate buffer (SB)
The substrate buffer was prepared by dissolving 0.95g 
citric acid and 1.4g Na2HP04 anhydrous in 100ml of distilled 
water (pH 5). 40mg of ortho-phenyldiamine (OPD) (SIGMA 
Chemical Company Ltd., Poole, Dorset) and 40^1 H202 were 
then added. The substrate buffer was prepared fresh just 
before use.
3.1.2 Stains
3.1.2.1 White blood cell diluting fluid
A stock solution was prepared by adding 0.lg crystal violet 
to 100 ml 1% glacial acetic acid. Prior to use this 
solution was diluted 1/10 with 1% glacial acetic acid.
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3.1.2.2 Leishman's stain
Leishman's stain (SIGMA) was prepared at 0.2 % w/v in
purified methanol.
3.1.3 Purified standards and antisera for enzyme 
linked immunosorbent assays (ELISA)
Purified a2-macroglobulin (a2-M), transferrin (TF), and 
albumin (Alb) were obtained from SIGMA. Lactoferrin (LF), 
a1-antitrypsin (al-AT) and polymorphonuclear leucocyte 
elastase were purchased from Calbiochem (Novabiochem Ltd., 
Nottingham) . All standards came in the form of lyophilised 
powders and were reconstituted according to the 
manufacturer's instructions. Goat and rabbit anti-a2-M, 
goat anti-TF and rabbit anti-Alb were obtained from SIGMA. 
Goat anti-Alb and anti-LF as well as rabbit anti-LF and 
anti-TF were obtained from Nordic Immunological 
Laboratories (Maidenhead, Berkshire) whereas goat and 
rabbit anti-al-AT were purchased from Calbiochem. The 
horseradish peroxidase (HRP) conjugated anti-rabbit IgG 
(goat) was purchased from ICN Immunobiologicals (Lisle, IL, 
USA). Finally, the sheep anti-TF and the HRP conjugated 
anti-sheep/goat IgG (donkey) were obtained from the 
Scottish antibody production unit (SAPU, Carluke, 
Lanarkshire, Scotland). Of the above antisera the rabbit 
antisera to a2-M, al-AT and Alb, the goat anti-TF and the 
HRP conjugates were fractionated. All reagents, after
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reconstitution (if required), were aliquoted and stored at 
-20°C until used. Reagents were replaced regularly to 
avoid deterioration.
3.2 Experimental methods and preliminary experiments
In this section, to aid clarity, methods as well as the 
preliminary experiments necessary to establish these 
methods, and the results will be presented and discussed 
together.
3.2.1 Calibration of the Periotron 6000
3.2.1.1 Determination of fluid type to be used for the 
calibration of the Periotron 6000
Prior to calibrating the Periotron 6000 for use in clinical 
trials a simple experiment was conducted in order to select 
the type of fluid to be used, and to determine the effect 
of fluid consistency on the digital readouts of the 
instrument. Three different types of fluid were evaluated: 
a) serum; b) serum/PBS at 1:1 dilution; and c) distilled 
water.
Volumes of 0.2 to l^ il in 0.2^1 increments were delivered 
onto Whatman grade 4 paper strips using a Hamilton 
microsyringe. The strips were inserted between the 
Periotron jaws up to the 8mm line. Measurements were
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performed six times for each volume and fluid type and the 
Periotron digital indication recorded. The mean of the six 
measurements was taken and plotted against the volume to 
obtain a calibration line for each fluid type as shown in 
Figure 3.1. Consistent with the observations of Van Der 
Bijl et a i m ,  (1986) the serum line was located below that 
of distilled water. These investigators attributed the 
lower readings obtained by serum when compared to distilled 
H20, to its lower dielectric dissipation. Following this 
experiment serum/PBS 1:1 was selected as the calibrating 
fluid and was used throughout these experiments, as, with 
respect to a major part of its constituents, GCF represents 
a dilution of serum.
3.2.1.2 Calibration of the Periotron 6000 for use in 
clinical trials
In initial experiments, prior to the commencement of a 
clinical trial a Periotron calibration curve was 
constructed, using the protocol described above and 
serum/PBS 1:1 as the experimental fluid. Linear regression 
analysis was used to fit the standard curve as shown in 
Figure 3.2, (a). GCF volumes could then be estimated froji 
Periotron values, using the linear function of the type 1= 
a + b x v, where 1= Periotron indication, v= volume, a= the 
intercept and b= the v coefficient (Fig. 3.2 (a)). This 
type of standard curve was used when assessing GCF volumes 
for the cross-sectional studies. In later experiments;
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Periotron indication
200
100
1.201.000.800.600.20 0.40
Volume ul
Serum • • •" Serum/PBS Distilled
water
Figure 3.1 Calibration lines of the Periotron 6000 using 
serum, serum/PBS at 1:1 dilution and distilled water. 
Periotron indication is plotted against fluid volume (pil) . 
Each point represents the mean of six measurements for each 
type of fluid. Variation between replicate measurements 
was very low and thus standard deviations are not shown 
(see also Fig. 3.2).
PBS: phosphate buffered saline
(a)
Periotron indication
0.2- 1ul
100
0.00 0.24 0.72 0.96 1.20
Voluma ul
<b)
Pariotron Indication
200
0.05-0.2ul
a=-4.33 
b=293.4 
r=0.999
100
0.00 a24 0.72 0.96 1.20
Volume ul
Figure 3.2 Calibration curves of the Periotron 6000 at the 
volume range of: (a) 0.2 to 1^ ,1 and (b) 0.05-1.2(0,1 where 
data were resolved in two lines, 0.05-0.2^1 and 0.2-1.2^1. 
Each point represents the mean of three measurements (±SD). 
Linear regression analysis was used to plot the best 
fitting lines and the regression coefficients are given.
a= the intercept; b= the volume coefficient 
r= Pearson correlation coefficient 
SD= standard deviation
volumes used for the calibration of the instrument were 
extended to the ultra low range. Calibration curves were 
thus constructed using Serum/PBS 1:1 at volumes of 0.05, 
0.1, 0.2, 0.4, 0.8, 1 and 1.2p,l. Measurements for each 
volume were performed in triplicate. In an effort to 
reduce daily variability and thus improve accuracy, the 
instrument was calibrated in the periodontal clinic each 
day samples were collected. The curve was split into an 
upper and a lower portion as described by Lamster et al., 
(1985) and two separate lines fitted by the regression 
method as shown in Figure 3.2, (b). The lower portion
included volumes of 0.05, 0.1 and 0.2^1 whereas the upper 
portion included all the remaining volumes. Determination 
of GCF volume from given Periotron indications was 
performed from the corresponding part of the Periotron 
calibration curve using the appropriate equation. If a 
sample yielded volume beyond the measuring range of the 
Periotron 6000, it was arbitrarily assigned a volume of 
1.3^1. However, this only occurred for 10 samples (2.6%) 
in the longitudinal study of periodontitis patients on 
maintenance care
3.2.2 Quantification of GCF constituents
a2-M, al-AT, TF, LF and Alb, in GCF were quantitated via 
the use of indirect, competitive or sandwich, solid phase 
immunosorbent assays (ELISAs). Competitive immunoassays 
were initially used for the quantitation of GCF a2-M and TF
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in the cross-sectional studies. Sandwich immunoassays were 
developed later, in an effort to improve detectability 
limits, and were used for GCF quantitation of al-AT and LF 
in all studies, and of a2-M and TF in the experimental 
gingivitis and longitudinal study of maintenance 
periodontitis patients. A sandwich ELISA was also used for 
assessing Alb in GCF samples from the longitudinal study of 
maintenance periodontitis patients.
In the cross-sectional studies on GCF, different samples 
were used for assessing a2-M, al-AT, TF and LF. In all 
other studies analysis for all four proteins was performed 
on the same GCF sample. In the longitudinal study of 
maintenance periodontitis patients, in addition to a2-M, 
al-AT, TF and LF, Alb was also assessed in the same GCF 
sample.
3.2.2.1 Competitive ELISA methodology
The competitive ELISA methods are modifications of the 
technique described previously by Altschuh and van
Regenmortel (1982). Briefly, as shown in Figure 3.3, the
antigen, human a2-M or TF, was coated onto the 96-well 
polystyrene microelisa plate (Immulon I, Dynatech 
Laboratories, Billinghurst, Sussex). The experimental 
samples and the corresponding antibody, goat anti-a2-M or 
sheep anti-TF, were then added. The principle of this
assay is that the solid and the liquid phase antigen will
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Coating with standard antigen
2
►
Incubate with standard/sample 
and antiserum
3 Add HRP anti-sheep/goat IgG
Figure 3.3 Competitive ELISA: basic principles.
HRP: horseradish peroxidase
compete for the binding of the antibody. This resulted in 
the sample concentration being inversely proportional to 
the amount of antibody bound onto the solid phase antigen, 
which in turn was quantified indirectly by the addition of 
the HRP conjugated anti-sheep/goat IgG. Visualisation was 
achieved by incubation with the substrate buffer and 
stopping the reaction with H2S04. The plate was read at 
490nm using a Dynatech Minireader II plate reader (Dynatech 
Laboratories, Alexandria, VA) and the optical densities 
(OD) were obtained.
Each plate included serial two-fold dilutions of purified 
a2-M or TF, resulting in a total of 10 standard solutions, 
at the concentration range 2xl04 to 39ng/ml. This 
permitted construction of a standard curve from which 
sample antigen quantities could be estimated. Only the 
central wells (60 in total) were used on each plate for 
standards or samples, which were run in triplicate, in 
order to avoid the so-called edge-effect (increased 
variability in the periphery of the plate) (Tijssen, 1985). 
The peripheral wells were used for running the controls 
which are as shown in Table 3.1. All controls were assayed 
in duplicate with the exception of the zero-antigen (number 
14; Table 3.1) which was assayed in quadruplicate. A 
detailed outline of the method is given in Table 3.2.
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Table 3.1 Control tests for competitive and sandwich 
ELISAs. For volumes and concentrations of reagents refer 
to tables 3.2 and 3.3 respectively. When the addition of 
a reagent was omitted the equivalent volume of the 
respective buffer alone was added. Coating refers to 
antigen or goat antiserum for the competitive or sandwich 
ELISAs respectively. Standard was added at 2~5 dilution of 
its starting concentration. In the case of the competitive 
ELISAs, standard and antiserum were added in a single step. 
For the sandwich ELISAs antiserum refers to the second 
antibody (rabbit).
Control STEP
Coating Standard Antiserum
HRP
Conjugate
1.
2. +
— — —
3. - + — —
4. - — + —
5. - — — +
6. + + — -
7. + - + —
8. + — - +
9. — + + -
10. — + — +
11. — — + +
12. + + + —
13. + + — +
14. + — + +
15. — + + +
Table 3.2 Steps and reagents for the a2-macroglobulin (a2- 
M) and transferrin (TF) competitive ELISAs. The respective 
standards and antisera were used for each assay. Samples 
were eluted in 1ml of IB.
COMPETITIVE ELISAs
STEPS REAGENTS
1. Wash with 200p,l/well CB thrice 
and dry.
2. Coat with lOOpil/well standard 
antigen. Incubate overnight 
at 4°C.
Standard a2-M or TF: 
lug/ml in CB.
3. Wash with 200nl/well PBST, 3x6 
times and dry. Removal of 
excess and loosely coated 
antigen.
4. Add 50p,l/well standard antigen 
or eluted sample, and 
50^1/well specific antiserum. 
Incubate for 2h at 37°C.
standard a2-M or TF: 
2xl04 -39ng/ml in IB 
antiserum:
goat anti-a2-M or 
s heep a n t i - T F  
1/ (4xl04) in IB.
Wash with 200nl/well PBST, 3x6 
times, and dry. Removal of 
free antigen, excess antibody 
and liquid phase antigen- 
antibody complexes.
6. Add lOOjxl/well HRP conjugated 
anti-IgG. Incubate for 90min 
at 37°C.
HRP anti-sheep/goat 
IgG (donkey): 1/1000 
in IB
7. Wash with 200nl/well PBST, 3x6 
times and dry. Removal of 
excess HRP-anti-IgG.
8. Add lOO^l/well SB. Incubate 
for approximately 15min at 
22°C. Stop colour development 
with 50pil/well 1M H2S04. Read 
at 490nm.
CB= coating buffer 
PBST= wash buffer 
IB= incubation buffer 
HRP= horseradish peroxidase
3.2.2.2 Preliminary experiments and establishment of the
competitive ELISAs
In order to establish the a2-M and TF competitive assays, 
different concentrations of antigen coating (lO^g/ml, 
lug/ml and lOOng/ml) as well as antiserum and HRP conjugate 
(serial chess-board type dilutions) were used. The optimal 
conditions, as described in the previous section, were thus 
defined for both assays, bearing in mind, that the specific 
antiserum should not be in excess of the solid or liquid 
phase antigen. Overnight incubation at 4°C was used for 
coating plates with the antigen as this gives more uniform 
results. Incubation for 2h, 3J*h or 4h with the 
standard/specific antiserum gave similar standard curve 
resolution and 2h incubation was selected for this step. 
Finally, incubation with the conjugate at 1/1000 dilution 
in incubation buffer for 90 min gave low non-specific 
binding (OD<0.05) in the absence of anti-a2-M or anti-TF 
(control 8; Table 3.1) and maximum OD in the lowest 
standard close to 1 after 15min incubation with the 
substrate. As non-specific binding in the absence of 
specific antiserum and antiserum/standard (controls 8 and 
13 respectively; Table 3.1) was very low, blocking during 
incubations with incubation buffer alone (containing 0.1% 
w/v BSA and 0.05% w/v Tween 20) was considered adequate.
Figures 3.4 (a) and (b) show typical standard curves for 
the a2-M and TF competitive assays respectively, at the
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Logn concentration ng/ml
•  a2-M
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<b)
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1
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Figure 3.4 Typical calibration curves for (a) a2-
macroglobulin (a2-M) and (b) transferrin (TF) competitive 
ELISAs at the concentration range of 2xl04 to 39 ng/ml. 
ODs (490nm) are plotted against logn concentration (ng/ml). 
The least squares method was used to plot the best fitting 
line and the regression coefficients are shown.
OD= optical density 
a= the intercept
b= the logn concentration coefficient 
r= Pearson correlation coefficient
concentration range of 2xl04 - 39ng/ml. As mentioned in 
the previous section, in these assays the amount of 
specific antiserum reacting with the solid phase antigen is 
inversely proportional to the liquid-phase antigen 
concentration, resulting in high ODs for low antigen 
standard or sample concentrations (Fig. 3.4). The 
detectability limit of the assay, defined as the lowest 
concentration of the standard antigen yielding ODs 
differing significantly from the buffer blank (control 14; 
Table 3.1) was beneath our lowest standard. Below or above 
however the quoted concentration range, experimental error 
became significant due to flattening of the curve.
Linear regression analysis was used to plot the best 
fitting line (a2-M: r2=-0.991; TFs r2=-0.986) and produce 
the linear function 0D= a + b x (lognc), where 0D= optical 
density, c= concentration, a= the intercept, b= the lognc 
coefficient from which sample antigen quantities with known 
ODs could be estimated (Fig. 3.4). A similar standard 
curve was produced, and a new line fitted, each time an 
assay was run.
Figures 3.5 (a) and (b), depict curves obtained by standard 
antigen and serum serial two fold dilutions for the a2-M 
and TF competitive assays respectively. Concentrations of 
standard a2-M and TF ranged from 2xl04 to 39ng/ml in 
incubation buffer. Serum dilution range was 1/100 to 
1/6400 in incubation buffer for both assays. As serum
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Figure 3.5 Standard and serum dilution curves for (a) 
a2-macroglobulin (a2-M) and (b) transferrin (TF) 
competitive ELISAs. Starting concentration of standard 
for both assays was 2xl04 ng/ml and of serum 1/100 in IB. 
10 serial two fold dilutions of the initial solution were 
assayed for standard and 7 for serum. Initial dilution 
factor was arbitrarily termed 1 and two-fold dilution 
factors thereafter, 2'1 to 2"9 for standard and 2'1 to 2~6 
for serum. ODs are plotted against logn dilution factor. 
Linear regression was used to plot the best fitting 
lines.
OD= optical density; IB= incubation buffer
antigen (a2-M and TF) concentration was not known, initial 
dilution factor for standard and serum was arbitrarily 
termed 1 and two fold dilution factors thereafter 2_1 to 2~9 
for the standard, and 2*1 to 2~6 for serum. ODs of standard 
and serum antigen were plotted against logn dilution factor 
and linear regression was used to plot the best fitting 
lines (Fig. 3.5). As depicted in Figure 3.5 serial two­
fold dilutions of serum gave curves parallel to the highly 
purified standard for both a2-M and TF competitive assays. 
This demonstrates that these proteins in serum, respond in 
a similar way to the highly purified standard, and that no 
interference by other serum components occurs.
Finally, a number of GCF samples eluted in 1ml of 
incubation buffer were assayed and yielded concentrations 
within the range of the competitive assays, and 1ml was 
therefore established as the elution volume for GCF in the 
studies where the competitive assays were used. This 
resulted in a detection limit of total a2-M and TF in GCF 
samples of 39 ng.
3.2.2.3 Sandwich ELISA methodology
The five sandwich ELISAs (a2-M, al-AT, TF, LF and Alb) are 
based on the technique described by Hetherington et al., 
(1983). In summary (Fig. 3.6), the 96-well polystyrene 
microplate (Immulon IV, Dynatech Laboratories, 
Billinghurst, Sussex) was coated with the first antibody,
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1 Coating with goat antiserum
•4
add standard/sample antigen
3 4l4
incubate with rabbit antiserum
4 Add HRP anti-rabbit IgG
Figure 3.6 Sandwich ELISA: basic principles.
HRP: horseradish peroxidase
a goat antiserum specific to the antigen to be quantified. 
The eluate of the sample was then added and any antigen 
present was captured by the immobilized antibody. 
Incubation with the second specific antiserum, developed in 
rabbit, followed. Finally, the HRP conjugated anti-rabbit 
IgG (goat) was added. Visualisation was achieved by
incubation with the substrate and stopping the reaction
with H2S04 • The plate was read at 490nm, and ODs obtained
using the Dynatech Minireader II.
In the sandwich assays the amount of antigen present in the 
sample is directly proportional to the amount of the second 
antiserum (rabbit), which was quantified indirectly by the 
addition of the HRP conjugated anti-rabbit IgG, resulting 
in high ODs for high antigen concentrations. The method is 
described in detail in Table 3.3. Plates included 10 
serial two-fold dilutions of purified antigen for the
construction of a standard curve. The working range for 
each assay is given in Table 3.4. Only the central wells 
were used when running standards or samples (in triplicate) 
in an effort to avoid the edge-effect. The peripheral 
wells were used for assaying the controls which were as 
shown in Table 3.1. All controls were run in duplicate 
except for the zero-antigen (control 14; Table 3.1) which 
was run in quadruplicate.
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Table 3.3 Steps and reagents for the transferrin (TF), 
lactoferrin (LF), a2-macroglobulin (a2-M), al-antitrypsin 
(al-AT) and albumin (Alb) Sandwich ELISAs. The respective 
standards and antisera were used for each assay. Standard 
concentration range is given in table 3.4.
SANDWICH ELISAs
STEPS REAGENTS
1.
2 .
3.
4.
5.
6.
7.
8.
9.
10.
Wash with 200nl/well 
thrice and dry.
CB
Coat with lOO^l/well specific 
antiserum. Incubate
overnight at 4°C.
Wash with 200jxl/well PBST, 
3x6 times, and dry. Removal 
of excess and loosely coated 
antibody.
Add 100^ ,1/well standard 
antigen or eluted sample. 
Incubate for 2h at 37°C.
Wash with 200nl/well PBST, 
3x6 times, and dry. Removal 
of free and loosely bound 
antigen.
Incubate with lOOjil/well 
second specific antiserum 
overnight at 4°C.
Wash with 200p,l/well PBST, 
3x6 times, and dry. Removal 
of free and loosely bound 
antigen.
Add lOOjil/well HRP conjugated 
anti-IgG. Incubate for 90min 
at 37°C.
Wash with 200nl/well PBST, 
3x6 times and dry. Removal 
of excess HRP-anti-IgG.
Add lOO^l/well SB. Incubate 
at 22°C (a2-M, al-AT and TF 
assay for -15min. LF assay 
*20 min) and stop colour 
development with 50nl/well 1M 
H2S04. Read at 490nm.
goat antisera to:
TF, LF, a2-M and Alb 
1/6000 in CB? al-AT 
1/3000 in CB.
standard TF, LF, 
a2-M, Alb or al-AT 
in IB*.
rabbit antisera to: 
TF, LF, a2-M, Alb or 
al-AT 1/4000 in IB*.
HRP anti-rabbit IgG 
(goat): 1/4000 in IB*
* In the case of the Alb ELISA, IB was replaced by IB/M 
CB= coating buffer, PBST= Wash buffer
IB= incubation buffer, IB/M= IB nil BSA, plus 5% MARVEL, 
HRP= horseradish peroxidase
Table 3.4 Working range of the standard antigen for the 
a2-macroglobulin (a2-M), al-antitrypsin (al-AT),
transferrin (TF), lactoferrin (LF) and albumin (Alb) 
sandwich ELISAs. This was produced by serial two fold 
dilutions of the standard antigen in the appropriate 
buffer, resulting in 10 standard solutions for the 
construction of a standard curve.
Assay Working range 
ng/ml in IB*
a2-M 200 - 0.39
al-AT 100 - 0.19
TF 50 - 0.09
LF 125 - 0.24
Alb 500 - 0.98
a In the case of the Albumin ELISA,
IB= incubation buffer
IB/M= IB nil BSA, plus 5% MARVEL
IB was replaced by IB/M
3.2.2.4 Preliminary experiments and establishment of the
sandwich ELISAs
(a) Selection of microtitre plate type for the 
sandwich ELISAs
Five different types of Immulon (Dynatech Laboratories) 
microelisa plates (one of each: I, M129 (A)/G, M129 (B)/G, 
III and IV) were tested in order to check if they conform 
with the claims of the manufacturer. These types of plates 
are supposed to have low variability among their wells and 
therefore be suitable for quantitative ELISAs.
The plates were washed with 200p,l/well coating buffer 
thrice and dried. They were then incubated with whole goat 
serum (SAPU) at 1/104 in coating buffer (lOO^l/well), for 
2h at 37°C. Only the 60 inner wells were used, whereas the 
peripheral wells were treated with coating buffer alone. 
Following this coating step, each plate was washed with 
200nl/well PBST, (3 sets of 6 washes each), and dried. All 
plates were then incubated with HRP conjugated anti­
sheep/goat IgG at 1/1000 dilution in incubation buffer 
(lOOjxl/well) for 90min at 37 °C and subsequently washed as 
above with PBST. The substrate buffer (100[xl/well) was 
then added and the plates incubated at room temperature for 
a suitable time depending on the plate being tested. The 
reaction was stopped with 50nl/well 1M H2S04 and the plate 
read at 490 nm.
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The coefficient of variation (CV % = SDxlOO/ mean OD) was 
then calculated for each plate. This represents a measure 
of variability among repeated tests (in this case the OD 
readings obtained for the 60 wells of the plate). As shown 
in Table 3.5, Immulon III gave the highest CV= 25.3%, 
whereas all the other plates gave CVs ranging between 3.3 
to 7.3%. The exceptionally high CV obtained with the 
Immulon III plate was surprising as this plate is 
advertised by the manufacturer as having certified CV of 
below 6%. This plate was, therefore, retested at two 
different concentrations of goat serum (1/104 and l/(5xl04) 
in coating buffer) and overnight incubation at 4°C for the 
coating step. Although overnight coating at 4°C and a 
higher dilution of goat serum improved the CV for the 
Immulon III plate (19.2% and 11% at the 1/104 and l/(5xl04) 
dilutions respectively) it still remained much higher than 
that obtained with all other types of plates. Following 
this experiment Immulon IV plates were selected for the 
sandwich ELISAs.
(b) Establishing the a2-M, al-AT, TF and LF sandwich 
ELISAs
A series of experiments were conducted in order to 
establish the best conditions for each of the four sandwich 
ELISAs. The standard chess-board type dilutions were used 
for defining the optimal goat, rabbit and HRP conjugated
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Table 3.5 Coefficient of variation (CV) obtained with 5 
different Immulon plates (Dynatech Laboratories). Mean OD 
± SD of the central 60 wells for each plate is given. % CV 
is defined as (SD x 100)/ mean OD.
Immulon Plate 
type
OD ± SD CV
1/ M129 1.229 ± 0.09 7.3%
M129 A/(G) 1.188 ± 0.06 5.0%
M129 B/(G) 1.656 ± 0.07 4.2%
III 0.831 ± 0.21 25.3%
IV 1.21 ± 0.04 3.3%
OD= optical density 
SD= standard deviation
antiserum dilutions and these were as discussed in section 
3.2.2.3, Table 3.3.
Overnight incubation at 4°C was used to coat the plates as 
it was shown to reduce within plate variation. Incubation 
for 2h at 37°C, or overnight at 4°C, after the antigen or 
rabbit antiserum was added, did not significantly alter the 
resolution of the standard curve. Overnight incubation at 
4°C with the rabbit antiserum, however, lowered the 
background in the absence of the antigen (control 14; Table 
3.1), and was preferred. In all assays, incubation with 
the HRP anti-rabbit IgG at 1/4000 for 90min was shown to 
give maximum ODs between approximately 1 and 1.8 (depending 
on the assay), and very low non-specific binding (OD<0.05) 
in the absence of the rabbit antiserum or the antigen 
(OD^O.08 depending on the assay) (controls 13 and 14 
respectively; Table 3.1). Therefore, blocking with 
incubation buffer only, (containing 0.1% w/v BSA and 0.05% 
w/v Tween 20) during incubations, was judged to be 
sufficient.
The precision ranges of each of the four sandwich ELISAs 
are shown in Table 3.6. Precision range was defined as the 
linear part of the working range (Table 3.4). A 
prerequisite was that the OD of the lowest standard (mean 
± SD) of the precision range differed significantly from 
that of the zero antigen control (mean ± SD) (control 14; 
Table 3.1). Outwith the precision range, experimental
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Table 3.6 Precision range of the standard antigen for the 
a2-macroglobulin (a2-M), al-antitrypsin (al-AT),
transferrin (TF) and lactoferrin (LF) sandwich ELISAs. 
Precision range was defined the linear part of the working 
range (table 3.4)._______________________________________
Assay Precision range 
ng/ml in IB
a2-M 100 - 1.56
al-AT 25 - 0.78
TF 25 - 0.78
LF 31.25 - 0.49
IB= incubation buffer
error increased due to the typical flattening of the curve.
Figure 3.7 (a to d) shows typical standard curves 
(precision ranges) for the a2-M, al-AT, TF and LF sandwich 
ELISAs. The least squares method was used to plot the best 
fitting line and r2>0.99 were obtained for all assays. 
Linear functions of the type lognOD = a + b x (lognc), where 
0D= optical density, c= concentration, a= the intercept and 
b= the lognc coefficient were thus produced, and used for 
the determination of sample antigen quantities. A similar 
standard curve was generated and a new line fitted each 
time an assay was run.
In an attempt to investigate if serum and standard antigen 
responded in a similar way, serial two-fold dilutions of 
serum in incubation buffer were assayed in each of the four 
sandwich ELISAs in the following dilution ranges (depending 
on the assay):
i) a2-M assay: l/(4xl04) to l/(256xl04);
ii) al-AT assay: l/(8xl04) to l/(256xl04);
iii) TF assay: l/(16xl04) to l/(512xl04); and
iv) LF assay: 1/24 to 1/1536.
The initial dilution was arbitrarily termed 1 for both 
standard and serum antigen and the two fold dilution 
factors thereafter, 2_1 to 2'6 for the a2-M and LF assays
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Figure 3.7 Typical calibration curves for the (a) a2- 
macroglobulin (a2-M), (b) al-antitrypsin (al-AT), (c)
transferrin (TF) and (d) lactoferrin (LF) sandwich ELISAs 
(precision range; Table 3.6). Logn ODs (490nm) are 
plotted against logn concentration (ng/ml). The least 
squares method was used to plot the best fitting line and 
the regression coefficients are shown.
OD= optical density; a= the intercept 
b= the logn concentration coefficient 
r= Pearson correlation coefficient
and 2_1 to 2'5 for al-AT and TF. Logn ODs were plotted 
against logn dilution factors for both standard and serum 
and linear regression was used to plot the best fitting 
lines (Fig. 3.8). As shown in Figure 3.8 serum and 
standard dilution curves were parallel at least as far as 
a2-M, al-AT and TF were concerned, illustrating that serum 
and standard respond in a similar way for these proteins 
(Fig. 3.8 (a) to (c)). This was not, however, the case for 
LF as shown in Figure 3.8 (d). LF is present in only very 
low concentrations («300ng/ml) in serum (Oloffson et al., 
1977). It, therefore, required a much lower starting serum 
dilution (only 1/24 in incubation buffer compared to 
l/(4xl04) to l/(16xl04) used for the other proteins). This 
could account for the interference observed, as other serum 
components would be in much higher concentrations than LF 
in the eluate. TF, which is structurally related to LF and 
occurs in much higher concentrations in serum (104 fold 
higher than LF), could also be responsible for a degree of 
the interference observed.
In order to investigate if serum components would interfere 
when assaying GCF LF, and thus influence the reliability of 
the assay, serum at 1/1000 dilution in incubation buffer 
was added in the LF standards and the resolution of the 
standard curve examined. The 1/1000 dilution of serum was 
used for the following reasons: a) GCF samples are eluted 
in a minimum of 1ml of incubation buffer; b) assuming a 
maximum of approximately lpl of GCF and a consistency
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Figure 3.8 Standard and serum dilution curves for the (a) 
a2-macroglobulin (a2-M), (b) al-antitrypsin (al-AT), (c) 
transferrin (TF) and (d) lactoferrin (LF) sandwich ELISAs. 
Standards were assayed at the precision range (Table 3.6). 
Starting dilution of serum was l/(4xl04) for a2-M, l/(8xl04) 
for al-AT, l/(16xl04) for TF and 1/24 for LF. 7 serial two 
fold dilutions for the a2-M and LF assays and 6 for the al- 
AT and TF assays, for standard and serum were tested. Logn 
ODs are plotted against logn dilution factor. Linear 
regression was used to plot the best fitting lines.
OD= optical density; IB= incubation buffer
similar to that of serum, the maximum concentration of 
serum components in the experimental eluate would be 1/1000 
of their original concentrations in serum. As shown in 
Figure 3.9 addition of 1/1000 serum in our standards did 
not influence the resolution of the standard curve for LF. 
Moreover, when TF and LF were substituted for each other in 
their sandwich ELISAs, they gave results similar to the no 
antigen control for the whole width of their dilution 
ranges.
Finally, GCF samples (a2-M, al-AT, TF: n=5; LF: n=4)
originally eluted in 1ml of incubation buffer were diluted 
a further 1/5 in incubation buffer and two serial two-fold 
dilutions in incubation buffer produced which were assayed 
for a2-M, al-AT, TF and LF. As shown in Table 3.7, 
acceptable dilution profiles were obtained for each one of 
the proteins in all the samples. This confirmed that the 
four proteins in GCF respond in a similar way to the highly 
purified standard and that the assays developed could be 
used for their quantitation in GCF.
The above experiment provided some information on the 
elution/dilution procedure required for GCF which was to be 
used for analysis of a2-M, al-AT, TF and LF by the sandwich 
ELISAs. A larger number of GCF samples were then tested 
and the elution/dilution procedure for GCF was established. 
It was observed that a dilution of GCF samples of 
approximately l/(25xl03) to l/(5xl04) for a2-M, l/(5xl04)
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Figure 3.9 Standard curve for the lactoferrin (LF) 
sandwich ELISA (precision range; 31.25 to 0.49 ng/ml) with 
and without the addition of serum (final concentration of 
serum in standard solutions, 1/1000 of its original 
concentration). Logn ODs are plotted against logn 
concentration of standard.
OD= optical density
Table 3.7 a2-macroglobulin (a2-M), al-antitrypsin (al-AT), 
transferrin (TF) and lactoferrin (LF) as determined in 
serial dilutions of GCF eluate. Samples were initially 
eluted in 1 ml of IB and further diluted in IB as shown 
below. Results are expressed in ng/ml of the resulting 
eluate. 'Low' or 'over' refers to samples that yielded ODs 
below or above the precision range of the respective assay.
Assay
Sample GCF
Hi
Dilution
factor
a2-M al-AT TF LF
Concentration in eluate 
(ng/ml)
1/5 5.2 14.8 12.3 6.1
1. 0.192 1/10 2.8 6.2 5.4 3.4
1/20 1.6 2.6 2.6 1.9
1/5 1.9 5.8 5.8 5.3
2. 0.107 1/10 low 2.4 2.7 3.0
1/20 low 1.4 1.2 1.6
1/5 31.0 over over 5.6
3. 0.476 1/10 15.3 15.4 18.9 3.2
1/20 7.3 7.2 10.5 1.6
1/5 17.5 over over 12.1
4. 0.464 1/10 9.1 19.0 22.3 7.1
1/20 4.5 8.2 12.5 3.9
1/5 52.5 over over *
5. 0.350 1/10 24.9 20.0 21.7
*
1/20 11.6 9.2 12.7 ★
GCF= gingival crevicular fluid 
IB= incubation buffer 
0D= optical density 
*= not done
to 1/105 for al-AT and LF, and 1/105 to l/(2xl05) for TF 
would yield concentrations in the eluate within the 
precision range of each ELISA. In order to achieve these 
dilutions, GCF samples were eluted in 1ml (or equivalent*) 
of incubation buffer and then further diluted in incubation 
buffer depending on their original volumes as shown in 
Table 3.8. However, if a GCF sample, yielded ODs below the 
precision range of the assay, it was re-run at the minimum 
of 1/2.5 dilution of the eluate for a2-M and 1/5 for al-AT, 
TF and LF. This resulted in a similar detectability limit 
of total protein in GCF samples for all assays. This was 
3.9ng for a2-M, al-AT and TF and 2.45ng for LF. Comparing 
this to the competitive ELISAs, there was a 10-fold 
improvement in the detection limit of total a2-M and TF. 
This was particularly advantageous and the main reason for 
developing the sandwich ELISAs. The competitive assays, 
although suitable for assessing a2-M and TF in GCF samples 
obtained from diseased sites, failed in many cases to 
detect a2-M and TF in GCF samples obtained from healthy 
sites during the experimental gingivitis study when the 
samples were eluted in the standard way (1ml of incubation 
buffer). This was very important as it made the 
quantitation of these proteins in health and during the 
initial stages of inflammation impossible. The sandwich 
assays proved to be more sensitive and to have lower 
detectability limits allowing the standard elution
GCF elution procedure was slightly modified in the 
longitudinal study of periodontitis patients on 
maintenance; refer to section 3.2.3.1.
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Table 3.8 GCF sample dilution procedure prior to assaying 
by the a2-macroglobulin (a2-M), a1-antitrypsin (al-AT), 
transferrin (TF) and lactoferrin (LF) sandwich ELISAs. 
Samples were originally eluted in 1ml of IB and further 
diluted, depending on their original GCF volume (v), as 
shown below in IB, to yield a final dilution of 
approximately at the range of: a) l/(25xl03) to l/(5xl04) 
for a2-M; b) l/(5xl04) to 1/105 for al-AT and LF; and c) 
1/105 to 1/ (2xl05) for TF.
Assay
GCF volume (v) 
in \il
a2-M al-AT and LF TF
Dilution factor
v s; 0.1 1/2.5 1/5 1/10
0.1 < v £ 0.2 1/5 1/10 1/20
•oVI>VCN•o 1/10 1/20 1/40
00•oVI>V•o 1/20 1/40 1/80
0.8 < v 1/40 1/80 1/160
GCF= gingival crevicular fluid 
IB= incubation buffer 
v= GCF volume
procedure of GCF samples to be maintained and in addition 
less eluate volume to be used, thus preserving material for 
other assays.
(c) Establishing the albumin sandwich ELISA
The standard chess board type dilutions were used to 
determine the best conditions for the goat, rabbit and HRP 
conjugated antisera as well as the standard for the Alb 
sandwich ELISA and these are as shown in section 3.2.2.3, 
Table 3.3. The standard incubation times, as used for the
other sandwich ELISAs, were examined and were found to be
/
satisfactory and hence used for the Alb sandwich ELISA. 
Incubation of standard, rabbit antiserum and conjugate in 
incubation buffer containing 0.1% w/v BSA had to be 
modified due to the cross-reactivity of the anti-human Alb 
antisera (rabbit and goat) with BSA. Incubations in PBST 
alone containing nil BSA were inadequate, as background OD 
was very high and no differentiation between serial 
standard Alb dilutions could be achieved. Incubation in 
IB/M (incubation buffer containing 5% w/v MARVEL) lowered 
the background sufficiently (OD-O.3) and enhanced curve 
resolution. A separate lh blocking step with IB/M or 
gelatin at 37°C did not lower the background further and 
was thus omitted.
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The precision range of the Alb assay, defined as the linear 
part of the working range (Table 3.4), was 125 to 
1.95ng/ml.
Figure 3.10 shows a typical standard curve for the Alb 
sandwich ELISA. The least squares method was used to plot 
the best fitting line and produce the linear function of 
the type OD = a + b x (lognc), where 0D= optical density, 
c= concentration, a= the intercept and b= the lognc 
coefficient which was used for the determination of sample 
antigen quantities. A similar standard curve was generated 
and a new line fitted each time an assay was run.
In order to investigate if Alb in GCF and purified Alb 
standard responded in a similar way, GCF in the dilution 
range of 1/40 to 1/1280 in incubation buffer was assayed by 
the Alb sandwich ELISA. Initial dilution of standard 
(125ng/ml) and GCF was termed 1 and two fold dilution 
factors thereafter 2'1 to 2~6 for serum and 2'1 to 2'5 for 
GCF and ODs were plotted against logn concentration. 
Linear regression was then used to plot the best fitting 
line (Fig. 3.11). As shown in Figure 3.11, standard 
albumin and albumin in GCF gave very similar dilution 
profiles (superimposed), providing evidence that this assay 
can be reliably used for the quantitation of albumin in 
GCF.
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Figure 3.10 Typical calibration curve for the albumin 
(Alb) sandwich ELISA (precision range; 125 to 1.95ng/ml). 
ODs (490nm) are plotted against logn concentration. The 
least squares method was used to plot the best fitting line 
and the regression coefficients are shown.
OD= optical density 
a= the intercept
b= the logn concentration coefficient 
r= Pearson correlation coefficient
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Figure 3.11 Standard and gingival crevicular fluid (GCF) 
dilution curves for the albumin (Alb) sandwich ELISA. 
Starting concentration of standard was 125ng/ml in IB/M. 
GCF was eluted in 0.5ml of IB/M and further diluted 
starting at 1/40 in IB/M. 7 serial two fold dilutions of 
standard and 6 of GCF in IB/M were assayed. Initial 
dilution factor of standard and GCF was arbitrarily termed 
1 and two-fold dilution factors thereafter, 2_1 to 2-6 for 
standard and 2'1 to 2-5 for GCF. ODs are plotted against 
logn dilution factor. Linear regression was used to plot 
the best fitting lines.
IB/M= IB nil BSA, plus 5% MARVEL; OD= optical density
GCF samples were used to establish the dilution procedure 
prior to assaying for albumin. Samples eluted in 0.5ml of 
IB (nil BSA) were further diluted in IB/M as shown in Table 
3.9 depending on their original GCF volume. If a sample 
yielded ODs below the lower limit of the precision range of 
the assay, it would be retested at 1/50 dilution. This 
resulted in a detection limit of total Alb in GCF of 49ng.
3.2.2.5 a2-macroglobulin and al-antitrypsin binding to 
elastase: effect on their detection by sandwich 
ELISAs
This experiment was conducted in order to determine if 
variation of a2-M or al-AT molar ratio to a protease (in 
this case elastase) in the experimental solution would 
affect their detection by the sandwich ELISAs used in these 
studies.
Six solutions of a2-M/elastase in IB were prepared. a2-M 
at a final concentration of 200ng/ml and elastase ranging 
from 260ng/ml to 8ng/ml were used. In this way a total of 
six solutions of elastase/a2-M were obtained, at molar 
ratios of 16:1, 8:1, 4:1, 2:1, 1:1, and 1:2. An additional 
solution of a2-M in IB at a concentration of 200ng/ml and 
no elastase was prepared. All the above solutions were 
incubated for 2h at 37°C, in order to achieve complex 
formation, and then frozen at -30°C. All six solutions 
were thawed and assayed (in 1/16 dilution in IB) by the a2-
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Table 3.9 GCF sample dilution procedure prior to assaying 
by the albumin sandwich ELISAs. Samples were originally 
eluted in 0.5ml of PBST and further diluted, depending on 
their original GCF volume (v), as shown below in IB/M, to 
yield a final dilution of approximately at the range of 
1/106 to 1/ (2xl06)
Assay
GCF volume 
in p,l
(v) Albumin
Dilution factor
V  £ 0.1 1/50
0.1 < V  2S 0.2 1/100
0.2 < v £ 0.4 1/200
o • A < IA 0.8 1/400
0.8 < v 1/800
PBST= wash buffer= incubation buffer nil BSA 
IB/M= incubation buffer nil BSA, 5% MARVEL 
v= GCF volume
M ELISA. Percentage recovery was calculated relative to 
the a2-M solution containing no elastase.
A similar procedure was used for al-AT. Six 1ml solutions 
of al-AT/elastase in IB were prepared. al-AT at a final 
concentration of lOOng/ml and elastase ranging from 
lOOOng/ml to 25ng/ml were used. In this way six solutions 
of elastase/al-AT at molar ratios ranging between 20:1, 
10:1, 5:1, 2.5:1, 1:1 and 1:2 were obtained. An additional 
solution of 100 ng/ml al-AT in IB, containing no elastase 
was prepared. The resulting seven solutions were incubated 
at 37°C for 2h, in order to achieve complex formation, and 
then frozen at -30°C. Prior to assaying by the al-AT ELISA 
method the solutions were thawed, and a further 1/32 
dilution in IB was employed. Percentage recovery was 
calculated using the al-AT solution containing no elastase 
as a standard (Table 3.10).
Binding of elastase to a2-M did not significantly affect 
its detection (recovery rate; Table 3.10) in this 
experiment. This is probably due to the nature of the a2- 
M/ protease interaction. Only active enzymes react with 
a2-M, which cleave the tetramer in the bait region 
resulting in a conformational change of the molecule which 
then irreversibly entraps the endopeptidase and inactivates 
it. As a2-M is a relatively big molecule its antigenicity 
is seemingly not affected. The a2-M ELISA therefore 
assesses the total amount of the inhibitor present in the
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Table 3.10 Recovery rate of a2-macroglobulin (a2-M) and 
a1-antitrypsin (al-AT) (sandwich ELISAs) after binding to 
elastase. Prior to assaying a2-M and al-AT were incubated 
for 2h at 37C° with elastase, at the molar ratios shown 
below. Percentage recovery was calculated versus standard 
a2-M or al-AT which received the same treatment.
a2-macroglobulin al-antitrypsin
elastase:a2-M recovery elastase:al-AT recovery
16:1 101% 20:1 49%
8:1 97% 10:1 53%
4:1 86% 5:1 54%
2:1 110% 2.5:1 57%
1:1 100% 1:1 84%
1:2 116% 1:2 101%
crevice irrespective of the amount of proteases. In 
contrast, binding of elastase to al-AT resulted in
approximately 50% reduction of its recovery rate by the 
sandwich ELISA when molar ratios of elastase:al-AT ranging 
from 20:1 to 2.5:1 were used. al-AT has a molecular weight 
of 55kDa which is much lower than that of a2-M. Binding of 
the inhibitor to elastase could cause masking of some 
epitopes of the al-AT molecule and this could result in a 
reduction of the antigenicity of al-AT. However, at
elastase:al-AT ratios of 1:1 and 1:2 detection of al-AT 
returned to 84% and 101% respectively. Thus, it is
possible that under experimental conditions the amount of 
al-AT detected by the sandwich ELISA is approximately 50% 
of the total amount present in the crevice.
3.2.3 Gingival crevicular fluid elution
3.2.3.1 Gingival crevicular fluid elution technique
GCF samples were eluted in 1ml of incubation buffer for lh 
at room temperature. The strips were then discarded and 
the eluate was aliquoted (200^1) and stored in
microcentrifuge tubes at -70°C. In the longitudinal study 
of periodontitis patients on maintenance care the procedure 
was slightly modified. Samples were eluted in 0.5ml of 
PBST (incubation buffer with no BSA) for lh at 22°C. 
100p,l aliquot of the eluate was stored separately at -70°C 
for the subsequent quantitation of GCF Alb. The remaining
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0.4ml were diluted 1/2 in incubation buffer containing 0.2% 
BSA (instead of the usual 0.1%). The resulting eluate was 
aliquoted and stored at -70°C. In this way the standard 
dilution procedure of GCF samples for assaying for a2-M, 
al-AT, TF and LF could be maintained (Table 3.8) while 
obtaining material suitable for assessing GCF Alb.
3.2.3.2 Recovery rate of a2-macroglobulin, al- 
antitrypsin, transferrin and lactoferrin from 
Whatman grade 4 paper strips
With the development of the sandwich ELISAs it was possible 
to quantify all four proteins in the same GCF sample. It 
therefore became imperative to determine their recovery 
rate when absorbed on paper strips as this would influence 
the determination of their relative levels in GCF.
To achieve this, the following protocol was followed for 
a2-M, al-AT and TF; IjaI of serum was delivered by a 
Hamilton microsyringe either:
a) on Whatman grade 4 paper strips (n=7) which were 
subsequently eluted in 1ml of incubation buffer for lh at 
22°C using a rotatory mixer; or
b) directly (n=3) in 1ml of incubation buffer which was 
also rotated for lh at 22°C.
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The eluate was diluted further 1/250 in incubation buffer 
prior to assaying for al-AT and TF and 1/125 for a2-iM, in 
order to achieve concentrations in the eluate within the 
working ranges of the sandwich ELISAs. The concentration 
of each of the above proteins in the original 1ml eluate of 
the strips was compared against that in the 1ml eluate when 
direct delivery in buffer was used and the % recovery 
calculated (Table 3.11).
For LF, l^ il of 5mg/ml LF stock solution was delivered on 
paper strips (n=7) and eluted as above in 1ml of incubation 
buffer. The same stock solution was also delivered 
directly in 1ml incubation buffer (n=3) and rotated, like 
the strips, for lh at 22°C. The resulting eluate was 
diluted further 1/200 in incubation buffer and assayed by 
the sandwich ELISA. The LF concentration in the 1ml eluate 
of the strips was compared against the concentration of LF 
when direct delivery of the stock solution in the buffer 
was used, and the percentage LF recovery from the strips 
calculated (Table 3.11).
Finally, an experiment was performed in order to ensure 
that paper strips were not contaminated by any of the 
proteins to be tested, prior to their use on patients. 
Sterile paper strips (n=10), were eluted in the standard 
procedure and the 1ml eluate tested by the sandwich ELISAs 
for a2-M, al-AT, TF and LF. None of the strips yielded
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Table 3.11 Recovery rate of a2-macroglobulin (a2-M), al- 
antitrypsin (al-AT), transferrin (TF) and lactoferrin (LF) 
from paper strips. For a2-M, al-AT and TF l\il of serum and 
for LF IjaI of standard (5mg/ml) was delivered, either: a) 
on paper strips (n=7) which were subsequently eluted in 1ml 
IB; or b) directly in 1ml of IB (n=3). The mean
concentration in the 1ml eluate (± SD), resulting from both 
methods of delivery, is given together with % recovery.
Analyte
Concentration in 1ml 
eluate 
ng/ml
Recovery
rate
strip
<n=7)
IB
<n=3)
a2-M 1520 ± 52 1527 ± 53 99.5%
al-AT 1266 ± 72 1273 ± 41 99.4%
TF 2230 ± 100 2480 ± 82 89.9%
LF 3763 ± 232 4509 ± 81 83.4%
IB= incubation buffer 
SD= standard deviation
positive results at the lowest detectability limits of the 
assays.
3.2.3.3 Gingival crevicular sample elution for the 
recovery of polymorphonuclear leucocytes
Recently a method has been described for the approximate 
determination of PMN numbers in discrete GCF samples, 
collected with paper strips (Cimasoni & Giannopoulou, 
1988). This technique would appear to permit assessment of 
PMN constituent levels like LF, and PMN numbers from the 
same GCF sample.
A pilot study was, therefore, performed on a limited number 
of GCF samples in order to investigate if PMNs could be 
recovered from GCF samples collected with paper strips. 
Nine GCF samples with variable volumes were obtained in the 
periodontal clinic using the standard method (Whatman grade 
4 paper strips for 30s). These were divided into two 
groups and were processed as follows:
a) the first group (n=5) were eluted, as described by 
Cimasoni and Giannopoulou (1988), by vortexing for 30s in 
150^1 of PBST;
b) the second group (n=4) were processed as described by 
Ebersole et al.> (1984) for the recovery of GCF antibodies. 
A microceritrifuge tube cup was fitted at the upper third of
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a similar tube (400^ ,1). The inner cup was pierced to allow 
the passage of fluid through it, but not the passage of a 
paper strip. The paper strips were then set on top of this 
inner cup, soaked with 50^1 of PBST and microcentrifuged at 
3000rpm for 5s. This procedure was repeated twice 
resulting in a total elution volume of 150^ ,1.
50^1 of the eluate obtained by both methods was then 
cytocentrifuged at 70xg (Shandon Scientific Limited, U.K.) 
and stained by the Leishman method. No cells could be 
detected in any of the 9 samples. For this reason, we 
resorted to the semiquantitative method of GCWs for the 
determination of PMNs in the crevice and to obtain their 
relationship with crevicular LF.
3.2.4 Processing of gingival crevicular washings
3.2.4.1 Quantitation of lactoferrin in gingival 
crevicular washings
One jaI aliquot of the washing, obtained using a Hamilton 
Microsyringe, was eluted in 1ml of incubation buffer and 
the eluate was stored separately at -70°C for subsequent 
quantitation of GCW LF. This was performed by the LF 
sandwich ELISA. No further dilution of the sample was 
required.
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3.2.4.2 Total and differential white cell counts in 
gingival crevicular washings
Within thirty minutes of GCW collection a total cell count 
was performed on 5^1 of the sample. The sample was diluted 
1/2 with white blood cell diluting fluid and the total 
count performed on a Neubaur chamber. The total number of 
white blood cells per jxl GCW was thus assessed. A 
differential count of 200-300 cells into polymorphonuclear 
and mononuclear cells was carried out after 
cytocentrifuging the rest of the sample at 70g (Shandon 
Scientific Limited, U.K.) and staining the cells by the 
Leishman method. The % PMNs in the GCW was obtained. The 
number of PMN/^ il GCW was finally calculated using the 
formula: (total cell count x % PMNs)/100.
120
CHAPTER
Results
4.1 Lactoferrin as a marker of polymorphonuclear
leucocytes in the gingival crevice: a cross-
sectional study on gingival crevicular washings
This study was performed to examine if lactoferrin (LF) in 
the crevice correlated with the number of crevicular 
polymorphonuclear leucocytes (PMNs) and thus, has potential 
as a marker of PMN migration into the crevice.
Gingival crevicular washings (GCWs) were obtained from a 
total of 63 sites. The mean MGI and PD of the sites 
sampled was 1.87 (SD:1.28) and 3.19mm (SD:2.2)
respectively. Both LF levels (ng/p,l GCW) and PMN numbers 
(PMNs/fil GCW) were determined in each sample. The 
relationship between GCW LF levels and PMN numbers was 
examined, the Pearson correlation coefficient was 
determined, and the least squares method used to plot the 
best fitting line as shown in Figure 4.1. LF demonstrated 
a positive and significant association (r=0.531, p<0.001, 
n=63) with PMN numbers in the crevice. The association 
between both GCW LF levels and GCW PMN numbers and the 
clinical indices was also assessed (Table 4.1) using the 
non-parametric Spearman rank correlation coefficient. GCW 
LF levels and PMN numbers correlated positively and 
significantly with both MGI and PD, but LF demonstrated 
consistently higher correlation coefficients than PMNs with 
both clinical indices (Table 4.1).
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Figure 4.1 Polymorphonuclear leucocytes (PMNs/jil GCW) as 
function of lactoferrin levels (LF ng/p,l GCW) in gingival 
crevicular washings (GCW). Both variables are transformed 
to log10. The Pearson correlation coefficient (r=0.531, 
p<0.001, n=63) was determined and the best fitting line 
plotted by the least squares method (regression analysis).
Table 4.1 Spearman rank correlation coefficients (r) 
between clinical indices and lactoferrin (LF) levels and 
polymorphonuclear (PMN) numbers in gingival crevicular 
washings (GCW) from 63 sites. Probability levels are shown 
in parenthesis.
Parameter LF
(ng/^l GCW)
PMNs 
(PMNs/pil GCW)
MGI r=0.452 (p<0.001) r= 0.279 (p<0.030)
PD r=0.513 (p<0.001) r= 0.388 (p<0.003)
MGI= modified gingival 
PD= pocket depth
index
4.2 Protease inhibitors and iron-binding proteins at
healthy, gingivitis and periodontitis sites: 
cross-sectional studies on gingival crevicular 
fluid
These studies were undertaken in order to determine the 
ability of protease inhibitors (a2-macroglobulin and al- 
antitrypsin) and iron-binding proteins (transferrin and 
lactoferrin) in gingival crevicular fluid (GCF) to 
distinguish between healthy, gingivitis and periodontitis 
sites. Different GCF samples were used for each protein. 
Results were expressed as total amounts (ng/30s) as well as 
concentrations (ng/pl GCF). One way analysis of variance 
(ANOVA) and individual two-sample t-tests were employed on 
the log10 transformed data in order to determine significant 
differences in GCF levels of each protein among the three 
clinical groups. The significance level for the t-tests 
was set at 0.025 in order to compensate for multiple 
comparisons (section 2.4).
4.2.1 a2-macroglobulin at healthy, gingivitis and
periodontitis sites
A total of 78 sites were sampled for the determination a2- 
macroglobulin (a2-M) levels in GCF. These sites were 
allocated into three clinical groups, healthy, gingivitis 
and periodontitis, based on their MGI and PD values and 
according to the criteria outlined in section 2.3.1. In
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healthy sites MGI ranged from 0 to 1 whereas PD between 1 
and 2mm. At gingivitis sites MGI ranged between 2 and 4, 
and PD between 1 and 3mm. Finally at periodontitis sites 
MGI ranged between 2 and 4 and PD between 4 and 10mm. The 
sample size, clinical indices and GCF volumes (mean ± SE) 
for each of the three clinical groups are shown in Table 
4.2. Figures 4.2 and 4.3 demonstrate the geometric mean 
and 95% confidence intervals for GCF a2-M in the three 
clinical groups, expressed as absolute amounts and 
concentrations respectively. One way ANOVA demonstrated 
that significant differences existed within the three 
clinical groups using both methods of expressing the 
results (absolute amount and concentration) (p<0.001). 
Further analysis, using two-sample t-tests, revealed 
significantly higher absolute amounts of a2-M (ng/30s) in 
GCF samples from gingivitis and periodontitis when compared 
to healthy sites (p<0.001). There was no significant 
difference (p=0.09) however, in a2-M levels (ng/30s) 
between gingivitis and periodontitis sites although the 
latter demonstrated higher mean total a2-M (Fig. 4.2). 
When results were expressed on a concentration basis (ng/^ il 
GCF), a2-M showed a statistically significant increase at 
gingivitis and periodontitis over healthy sites (p<0.01; 
two sample t-tests) but again no significant difference 
could be demonstrated in a2-M concentration in GCF between 
gingivitis and periodontitis sites (Fig. 4.3).
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Table 4.2 Mean clinical indices (± SE) and gingival 
crevicular fluid (GCF) volume, at sites used for GCF a2- 
macroglobulin determination (see also Figs 4.2 & 4.3). 
Sample size is given under each clinical category in 
parenthesis•
a2-macroglobulin
Site
Healthy Gingivitis Periodontitis
<n«25) <n=25) (n=28)
Parameter
MGI 0.28 ± 0.09 2.64 ± 0.14 3.39 ± 0.13
PD 1.12 ± 0.07 2.28 ± 0.15 4.89 ± 0.28
GCF (nl) 0.28 ± 0.03 0.35 ± 0.04 0.43 ± 0.04
MGI= modified gingival index
PD= pocket depth
ng/30s
1800n
1440-
1080"
720“
360-
H G P
Clinical categogy
Figure 4.2 Total a2-macroglobulin (ng/30s) in gingival 
crevicular fluid from healthy (H, n=25), gingivitis (G, 
n=25) and periodontitis (P, n=28) sites. Geometric mean 
and 95% confidence intervals are shown.
* Significantly different from healthy sites p<0.001
ng/ul
5000n
4000-
3000"
2000"
1000-
H P
Clinical category
Figure 4,3 a2-macroglobulin concentration (ng/^ il) in 
gingival crevicular fluid from healthy (H, n=25),
gingivitis (G, n=25) and periodontitis (P, n=28) sites. 
Geometric mean and 95% confidence intervals are shown.
* Significantly different from healthy sites p<0.01
4.2.2 al-antitrypsin at healthy, gingivitis and 
periodontitis sites
Sixty eight GCF samples were assayed for al-antitrypsin 
(al-AT). These samples were obtained from sites which were 
allocated into the three clinical groups i.e. healthy, 
gingivitis and periodontitis. MGI ranged between 0 and 1 
in the healthy group, 2 and 4 in the gingivitis group and 
1 and 4 in the periodontitis group. PD ranged between 1 
and 2mm in the healthy group, between 2 and 3mm in the 
gingivitis group and 4 and 10mm in the periodontitis group. 
Mean (±SE) clinical indices and GCF volumes, and sample 
size for each of the three clinical groups are shown in 
Table 4.3. Figure 4.4 demonstrates total GCF al-AT at 
healthy, gingivitis and periodontitis sites whereas Figure 
4.5, depicts GCF al-AT concentrations (geometric means and 
95% confidence intervals) . One way ANOVA demonstrated that 
significant differences existed among the three clinical 
groups when results were expressed as absolute amounts 
(ng/30s) (p<0.001) but not as concentrations (p=0.183). As 
shown in Figure 4.4, gingivitis and periodontitis sites 
demonstrated higher total GCF al-AT than healthy sites and 
this increase was statistically significant (p<0.005 and 
p<0.001 respectively; two sample t-tests). Although 
periodontitis sites demonstrated higher mean levels than 
gingivitis sites, this increase was not statistically 
significant.
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Table 4.3 Mean clinical indices (± SE) and gingival 
crevicular fluid (GCF) volume at sites used for GCF al- 
antitrypsin determination (see also Figs 4.4 & 4.5). 
Sample size is given under each clinical category in 
parenthesis.
al-antitrypsin
Site
Healthy Gingivitis Periodontitis
(n-24) (n-22) (n=22)
Parameter
MGI 0.17 ± 0.08 2.64 ± 0.12 3.14 ± 0.17
PD 1.04 ± 0.04 2.32 ± 0.10 5.02 ± 0.30
GCF (|il) 0.18 ± 0.03 0.27 ± 0.04 0.37 ± 0.07
MGI= modified gingival index
PD= pocket depth
ng/30s
200
150“
100-
50-
H G P
Clinical category
Figure 4.4 Total al-antitrypsin (al-AT) (ng/30s) in 
gingival crevicular fluid from healthy (H, n=24),
gingivitis (G, n=22) and periodontitis (P, n=22) sites. 
Geometric mean and 95% confidence intervals are shown.
* Significantly different from healthy sites p<0.005
** Significantly different from healthy sites p<0.001
800
ng/ul
640
480
320
160
H
I
G 
Clinical category
Figure 4.5 al-antitrypsin concentration (ng/|xl) in 
gingival crevicular fluid from healthy (H, n=24), 
gingivitis (G, n=22) and periodontitis (P, n=22) sites. 
Geometric mean and 95% confidence intervals are shown.
Consistent with the results of the one way ANOVA, no 
significant differences could be demonstrated when two 
sample t-tests were employed on the GCF al-AT concentration 
data of the three clinical groups, although there was a 
tendency for increasing al-AT GCF concentration at 
gingivitis and periodontitis over healthy sites (Fig. 4.5).
4.2.3 Transferrin at healthy, gingivitis and 
periodontitis sites
Transferrin (TF) was assayed in a total of 92 GCF samples 
from discrete sites which were allocated into the healthy, 
gingivitis and periodontitis groups. In the healthy group 
MGI ranged between 0 and 1, and PD between 0 and 2mm. In 
the gingivitis group MGI ranged between 2 and 4, and PD 
between 1 and 3mm. Finally, in the periodontitis group MGI 
ranged between 2 and 4, and PD between 4 and 12mm. Table
4.4 demonstrates the mean (± SE) clinical indices and GCF 
volumes, and sample sizes in each one of the three clinical 
groups. Figures 4.6 and 4.7 demonstrate the levels of TF 
in GCF (geometric mean and 95% confidence intervals) in 
each of the three clinical categories for both methods of 
expressing the results (total and concentration 
respectively) . Similarly to a2-M and al-AT, one way ANOVA 
demonstrated that the clinical grouping of the site had a 
significant effect (p<0.001) when total GCF TF was 
examined. When individual groups were tested for
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Table 4.4 Mean clinical indices (± SE) and gingival 
crevicular fluid (GCF) volume at sites used for GCF 
transferrin determination (see also Figs 4.6 & 4.7).
Sample size is given under each clinical category in 
parenthesis.
Transferrin
Site
Healthy Gingivitis Periodontitis
(n=29) (n=31) (nss32)
Parameter
MGI 0.45 ± 0.09 2.61 ± 0.12 3.34 ± 0.11
PD 1.13 ± 0.08 2.39 ± 0.13 5.30 ± 0.36
GCF (\il) 0.27 ± 0.03 0.38 ± 0.04 0.45 ± 0.04
MGI= modified gingival index
PD= pocket depth
ng/30s
800n
640“
480“
320“
H G P
Clinical category
Figure 4.6 Total transferrin (TF) (ng/30s) in gingival 
crevicular fluid from healthy (H, n=29), gingivitis (G, 
n=31) and periodontitis (P, n=32) sites. Geometric mean 
and 95% confidence intervals are shown.
* Significantly different from healthy sites p<0.005
** Significantly different from healthy sites p<0.001
1500
ng/ul
1200
900
600
300
H
Clinical category
Figure 4.7 Transferrin concentration (ng/ul) in gingival 
crevicular fluid from healthy (H, n=29), gingivitis (G, 
n=31) and periodontitis (P, n=32) sites. Geometric mean 
and 95% confidence intervals are shown.
differences, using two sample t-tests, gingivitis and 
periodontitis sites demonstrated significantly elevated 
levels over healthy sites (p<0.005 and p<0.001 
respectively). Once again no significant difference could 
be demonstrated between gingivitis and periodontitis sites 
as far as total GCF TF was concerned, although mean total 
TF was higher at the latter (Fig. 4.6). When results were 
expressed as concentrations one way ANOVA failed to 
demonstrate significant differences (p=0.067) among the 
clinical groups and this was also the case when two-sample 
t-tests were performed on the data. The increase however 
of GCF TF concentration at periodontitis over healthy sites 
almost reached significance at the Bonferroni corrected 
significance threshold of 0.025 level (p=0.03; two sample 
t-test) (Fig. 4.7).
4.2.4 Lactoferrin at healthy, gingivitis and 
periodontitis sites
Lactoferrin (LF) was examined in GCF samples from 71 sites 
which were designated into the three clinical groups 
(healthy, gingivitis and periodontitis). MGI scores ranged 
between 0 and 1 in the healthy group, between 2 and 3 in 
the gingivitis group, and 1 and 4 in the periodontitis 
group. PD ranged between 1 and 2mm in the healthy group, 
between 2 and 3mm in the gingivitis group and between 4 and 
9mm in the periodontitis group. Sample sizes and mean 
(±SE) clinical indices and GCF volumes for each of the
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three clinical categories are shown in Table 4.5. Figure 
4.8 depicts total LF at healthy, gingivitis and 
periodontitis sites while Figure 4.9 demonstrates LF 
concentration (geometric mean and 95% confidence 
intervals). One way ANOVA demonstrated that significant 
differences existed (p=0.004) among healthy, gingivitis and 
periodontitis sites as far as total GCF LF was concerned. 
As shown in Figure 4.8 total LF was significantly higher at 
gingivitis (p=0.012) and periodontitis (p=0.0023) when 
compared to healthy sites (two sample t-tests). Consistent 
with the other proteins, periodontitis sites exhibited 
higher mean total LF than gingivitis sites but this was not 
statistically significant. In contrast, however, to GCF 
a2-M, al-AT and TF, mean GCF LF concentration appeared to 
drop at diseased (gingivitis and periodontitis) compared to 
healthy sites (Fig. 4.9), although this was just outwith 
statistical significance when tested by one way ANOVA 
(p=0.055). When two sample t-tests were performed to 
compare GCF LF concentration between clinical groups, 
according to the one way ANOVA results, the drop between 
GCF LF at healthy and gingivitis or periodontitis sites, 
although close, failed to reach significance at the 
Bonferroni corrected 0.025 level (p=0.049 and p=0.031 
respectively).
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Table 4.5 Mean clinical indices (± SE) and gingival 
crevicular fluid (GCF) volume at sites used for GCF 
lactoferrin determination (see also Figs 4.8 & 4.9).
Sample size is given under each clinical category in 
parenthesis.
Lactoferrin
Site
Healthy Gingivitis Periodontitis
(n=26) <n=21) <n=24)
Parameter
MGI 0.38 ± 0.10 2.57 ± 0.11 2.46 ± 0.17
PD 1.54 ± 0.10 2.71 ± 0.10 5.04 ± 0.29
GCF (\xl) 0.09 ± 0.02 0.32 ± 0.06 0.35 ± 0.06
MGI= modified gingival index 
PD= pocket depth
ng/30s
480"
360“
240-
120“
H
Clinical category
Figure 4.8 Total lactoferrin (ng/30s) in gingival 
crevicular fluid from healthy (H, n=26), gingivitis (G, 
n=21) and periodontitis (P, n=24) sites. Geometric mean 
and 95% confidence intervals are shown.
* Significantly different from healthy sites p<0.02
** Significantly different from healthy sites p<0.003
ng/ul
3000-
2000“
1000-
H G P
Clinical category
Figure 4.9 Lactoferrin concentration (ng/jil) in gingival 
crevicular fluid from healthy (H, n=26), gingivitis (G, 
n=21) and periodontitis (P, n=24) sites. Geometric mean 
and 95% confidence intervals are shown.
4.3 Gingival crevicular fluid protease inhibitors
and iron-binding proteins during the development 
of gingival inflammation: an experimental
gingivitis study
This study was undertaken to examine the changes of 
protease inhibitors (a2-M and al-AT) and iron-binding 
proteins (TF and LF) in GCF during experimentally induced 
gingival inflammation. In this study a2-M, al-AT, TF and 
LF levels were assessed in the same GCF sample and results 
were expressed as total amounts in ng/30s.
4.3.1 Clinical Indices
Figure 4.10 illustrates the changes of the whole mouth MGI 
(WMGI) and PI (WPI) scores of the six subjects, during the 
experimental gingivitis trial. At the initial appointment, 
10 days prior to the commencement of the experimental 
gingivitis study, the WMGI and WPI were low. Subjects were 
then given oral hygiene instruction and prophylaxis which 
resulted in a slight drop in the WMGI and WPI at baseline 
(day 0) of the experimental gingivitis trial (Fig. 4.10). 
After the withdrawal of oral hygiene measures, plaque 
accumulated rapidly as shown by the steep increase of the 
WPI whereas WMGI lagged behind. Both WMGI and WPI peaked 
on day 21 of the experimental gingivitis trial. With the 
reinstitution of oral hygiene measures WPI dropped rapidly 
and the WMGI followed, remaining however, slightly higher
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MGI and PI
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Figure 4.10 Whole mouth MGI and PI scores of the 6 
subjects during the experimental gingivitis trial. The 
mean and standard error at each time point are shown.
MGI= modified gingival index 
PI= plaque index
than baseline levels at day 35 of the experimental 
gingivitis trial. The changes in clinical indices for the 
6 subjects at the sites sampled for GCF (n=6 subjects) are 
shown in Figure 4.11. Clinical indices at these sites 
behaved in the same way as the full mouth scores, with the 
PI rising first and the MGI lagging behind. GCF volume 
followed the initial changes of the clinical indices (Fig. 
4.11) and rose with the accumulation of plaque and the 
development of gingival inflammation. GCF volume reached 
its peak on day 14 of the experimental gingivitis episode 
and remained higher than baseline after the reinstitution 
of oral hygiene measures.
4.3.2 GCF protease inhibitors and iron-binding 
proteins during the experimental gingivitis 
trial
As mentioned in section 2.4 repeated measures analysis of 
variance (MANOVA) was used to determine significant 
differences in a2-M, al-AT, TF and LF levels over time 
during the experimental gingivitis trial. Each protein was 
tested separately. Analysis was performed on the log10 
transformed data considering both the site and subject as 
the experimental unit. When the subject was considered as 
the unit, sites within each subject were averaged and one 
score was produced per subject (section 2.4). In an 
attempt to investigate which days demonstrated 
significantly elevated GCF levels of protease inhibitors
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Figure 4.11 (a) MGI, PI and (b) GCF volume at the sites 
sampled during the experimental gingivitis trial. The mean 
and standard error (n=6 subjects) at each time point are 
shown.
MGI= modified gingival index
PI= plague index
GCF= gingival crevicular fluid
and iron-binding proteins since baseline, individual paired 
t-tests were employed on the log10 transformed data, 
comparing baseline levels of a2-M, al-AT, TF and LF to each 
subsequent day (n=6 subjects). The accepted significance 
level for the t-tests was set at 0.02 (Bonferroni 
correction; section 2.4).
GCF a2-M level changes over time for the 6 subjects enroled 
in the experimental gingivitis trial are depicted in Figure 
4.12 (mean ± SE). Repeated measures MANOVA revealed that 
GCF a2-M levels changed over time during the experimental 
gingivitis episode both when the subject (p=0.015) and site 
(p=0.033) were considered as the experimental unit. When 
GCF a2-M levels on individual days were tested for 
differences from baseline using paired t-tests (n=6 
subjects), a2-M was significantly elevated on day 14 of the 
experimental gingivitis episode (p=0.013). On day 21 
although mean GCF a2-M was higher than baseline (Fig. 4.12) 
the increase failed to reach statistical significance at 
the stringent Bonferroni corrected 0.02 level (p=0.042). 
Interestingly, GCF a2-M was significantly elevated compared 
to baseline, even during the recovery period, on days 28 
and 35 of the experimental gingivitis trial (Fig. 4.12), 
that is one and two weeks after the reinstitution of oral 
hygiene measures. More precisely, although on day 28 GCF 
a2-M was significantly higher than baseline (p=0.009), on 
day 35 mean GCF a2-M levels were still higher than baseline 
but this was not significant at the Bonferroni corrected
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Figure 4.12 Total a2-macroglobulin (a2-M) changes in 
gingival crevicular fluid, during the experimental 
gingivitis trial. The mean and standard error (n=6 
subjects) at each time point are shown.
*** Significantly different from baseline p<0.01 
** Significantly different from baseline p<0.02 
* Difference from baseline failed to reach significance 
at p<0.02 but p<0.05
0.02 significance level (p=0.026). Similar but significant 
results were obtained when the site was considered as the 
experimental unit for the paired t-tests, although 
significance was in most cases stronger (p^O.Ol on days 14 
and 21) and thus the null hypothesis for difference between 
days 0 and 21 could be rejected at the 0.02 level.
Figure 4.13 demonstrates GCF al-AT changes (mean ± SE) for 
the 6 subjects during the experimental gingivitis study. 
Repeated measures MANOVA revealed that a significant day 
effect existed on GCF al-AT levels when both the subject 
and site were considered as the experimental unit (p=0.012 
and p=0.018 respectively). When GCF al-AT levels on 
individual days were compared to baseline (paired tests, 
n=6 subjects) day 14 demonstrated significantly elevated 
GCF al-AT levels (p=0.002), whereas on days 21, 28 and 35 
the increase in GCF al-AT just failed to reach significance 
at the Bonferroni corrected 0.02 significance level 
(p=0.034, p=0.039 and p=0.04 respectively) (Fig. 4.13). 
Similar results were obtained when the site was considered 
as the experimental unit for the paired t-tests (p=0.001 
and p=0.008 for days 14 and 21 respectively).
GCF TF mean response for the 6 subjects during the 
experimental gingivitis study demonstrated a similar 
picture to a2-M and al-AT as shown in Figure 4.14 (mean ± 
SE). Repeated measures MANOVA on GCF TF levels considering 
the subject as a unit demonstrated that significant
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Figure 4.13 Total al-antitrypsin (al-AT) changes in 
gingival crevicular fluid during the experimental 
gingivitis trial. The mean and standard error (n=6 
subjects) at each time point are shown.
** Significantly different from baseline p<0.02 
* Difference from baseline failed to reach significance 
at p<0.02 but p<0.05
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Figure 4.14 Total transferrin (TF) changes in gingival 
crevicular fluid during the experimental gingivitis trial. 
The mean and standard error (n=6 subjects) at each time 
point are shown.
* Significantly different from baseline p<0.02
differences existed among days (p=0.02). Interestingly 
however, when the site was considered as the experimental 
unit, repeated measures MANOVA failed to detect differences 
in GCF TF levels among days (p=0.264), demonstrating that 
overall variability was somewhat greater when results were 
analysed in this way. On the follow-up analysis, GCF TF on 
individual days was compared against baseline (paired t- 
tests, n=6 subjects) and as shown in Figure 4.14, GCF TF 
appeared significantly elevated compared to baseline on 
days 14 (p=0.012), 28 (p=0.014) and 35 (p=0.019). Again 
although mean GCF TF was higher than baseline on day 21 of 
the experimental gingivitis episode, this increase failed 
to reach statistical significance (p=0.082). When results 
were analysed on the site basis slightly lower significance 
levels were obtained when GCF TF on days 14, 21 and 35 was 
compared to baseline and these differences did not reach 
significance at the 0.02 level (but p<0.05).
GCF LF mean response by time for the 6 subjects 
demonstrated a different picture (Fig. 4.15) compared to 
the previously described GCF constituents (a2-M, al-AT and 
TF). LF rises and similarly to the other proteins plateaus 
between days 14 and 21 of the experimental gingivitis 
episode. One week after the reinstitution of oral hygiene 
measures however, LF drops to almost baseline levels. When 
repeated measures MANOVA was applied to the log10 
transformed data, it demonstrated that a significant day 
effect existed on GCF LF levels, when both the subject and
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Figure 4.15 Total lactoferrin (LF) changes in gingival 
crevicular fluid during the experimental gingivitis trial. 
The mean and standard error (n=6 subjects) at each time 
point are shown.
* Significantly different from baseline p<0.02
ng/30s (Iog10)
I
site were treated as the experimental unit (p=0.001 and 
p=0.003 respectively). Subsequent analysis, using paired 
t-tests and the subject as the experimental unit, revealed 
that GCF LF levels on day 14 were significantly elevated 
compared to baseline p=0.009 whereas on day 21, although 
GCF LF was still higher than baseline this was just outwith 
statistical significance (p=0.062). On days 28 and 35 GCF 
LF mean levels had dropped and demonstrated no difference 
from baseline (p>0.3). When the site was considered as the 
experimental unit, significant differences since baseline 
were, similarly, obtained on days 14 (p=0.001) and 21
(p=0.001).
The pattern of the mean response for the six subjects is 
clearer when the z scores of a2-M, a 1 - AT, TF and LF are 
plotted against time (Fig. 4.16). The z scores for each 
protein are produced by subtracting each data value from 
the grand mean of the protein and dividing by its standard 
deviation (section 2.4). In this way differences in 
overall level among the four proteins are removed and 
focusing on the pattern of change is allowed. As shown in 
Figure 4.16 a2-M, al-AT and TF present a similar pattern 
rising and remaining high until at least day 28, one week 
after the reinstitution of oral hygiene measures. In 
contrast, the changes in LF levels over time are different, 
demonstrating a drop on day 28, soon after subjects resumed 
oral hygiene procedures.
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Figure 4.16 Total a2-macroglobulin (a2-M), al-antitrypsin 
(al-AT), transferrin (TF) and lactoferrin (LF) changes in 
gingival crevicular fluid; average (n=6 subjects) z-scores 
of the log10 transformed data during the experimental 
gingivitis trial.
Figures 4.12 to 4.16 focused on the mean response of the 6 
subjects by time for each of the protease inhibitors (a2-M 
and al-AT) and iron-binding proteins (TF and LF) during the 
trial. Significant variability however existed among 
subjects. This is illustrated in Figures 4.17 through to 
4.20 (a to f) which show each individual's response by time 
during the experimental gingivitis episode (each point 
represents the average of two sites per subject).
4.4 GCF protease inhibitors, iron-binding proteins
and clinical parameters in relation to 
periodontal attachment loss: a longitudinal
study of periodontitis patients on maintenance 
care
The main aim of this study was to investigate whether 
incipient periodontal breakdown could be related to changes 
in protease inhibitor (a2-M and al-AT) and iron-binding 
protein (TF and LF) levels in GCF. In addition, the 
association of clinical parameters with attachment level 
change was examined.
4.4.1 Clinical findings
The 38 maintenance periodontitis patients enrolled in this 
study yielded a total of 384 sites. Clinical indices were 
recorded and GCF sampled at the baseline and recall 
appointments. A minimum of 6 and a maximum of 15 non-
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Figure 4.17 (a) to (f) : Total a2-macroglobulin changes in
gingival crevicular fluid for each of the six subjects
during the experimental gingivitis trial.
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Figure 4.18 (a) to (f): Total al-antitrypsin changes in
gingival crevicular fluid for each of the six subjects
during the experimental gingivitis trial.
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Figure 4.19 (a) to (f): Total transferrin changes in
gingival crevicular fluid for each of the six subjects
during the experimental gingivitis trial.
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Figure 4.20 (a) to (f): Total lactoferrin changes in
gingival crevicular fluid for each of the six subjects
during the experimental gingivitis trial.
adjacent sites (mean 10 sites) were obtained per subject 
participating in this study.
The baseline mean clinical indices of the sites sampled are 
presented in Table 4.6. The frequency distribution of the 
different scores of MGI and PI at baseline are given in 
Figures 4.21 (a, b). Mean MGI was low (2.05) (Table 4.6) 
and as shown in Figure 4.21 most sites yielded scores 
between 1 and 3. No sites demonstrated MGI score of 4. PI 
was also low and approximately 72% of all sites 
demonstrated scores of 0 or 1 (Fig 4.21). Most sites bled 
on probing (60%) whereas the incidence of suppuration was 
low (3.4%). One of the prerequisites for sites to be 
selected for this study was that they had to exhibit 
pocketing ^4mm when measured using a PC 12 periodontal probe 
on a pre-baseline recruiting appointment (section 2 .2 .3 .3) . 
Pocketing assessed using the Florida Probe was generally 
less than conventional probe readings.
Two attachment level measurements were taken at each time 
point from each of the 384 sites. This experimental design 
was used to provide a measure of examiner error during the 
study and also provide the appropriate measures for the use 
of the tolerance method for detecting attachment level 
changes (method detailed in section 2.2.1.4). Standard 
deviation values of the differences of replicate 
measurements for the 38 subjects studied, varied from
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Table 4.6 Baseline clinical indices at the 384 sites 
selected for the longitudinal study on maintenance 
periodontitis patients. The mean and standard deviation 
(SD) of all sites is given.
Clinical indices in n-384 sites
Mean SD
Parameter
MGI 2.05 0.81
PI 1.03 0.96
PD (mm) 4.44 1.35
GCF (nl) 0.31 0.29
MGI= modified gingival index 
PI= plague index 
PD= pocket depth 
GCF= gingival crevicular fluid
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Figure 4.21 Frequency distribution of baseline (a) MGI and
(b) PI scores at the 384 sites examined during the 
longitudinal study of periodontitis patients on 
maintenance.
MGI= modified gingival index 
PI= plaque index
0.196 to 0.608 with a mean of 0.423mm. The population 
threshold was therefore set at 0.85mm (2 x Mean SD).
During the study, 15 sites (3.9%) demonstrated significant 
attachment loss, taking into account all three thresholds, 
and were classified as grade 5 sites (most deterioration; 
section 2.2.1.5). These sites were widely distributed, 13 
sites occurring each in different individuals, whereas 2 
sites only were obtained in the same individual (14 
individuals in total). Attachment loss at these sites 
ranged from 0.9mm to 3.8mm (mean 1.91mm). The site 
demonstrating the minimum attachment loss of 0.9mm was the 
only site exhibiting significant attachment loss below 1mm, 
although exceeding all three thresholds (site, subject and 
population). All other sites exhibited attachment loss of 
^1.2mm. Another 13 sites (3.4%) demonstrated significant 
attachment gain as defined by the tolerance method and were 
classified in the grade 1 category (most improvement; 
section 2.2.1.5). Attachment gain in these sites ranged 
between 1.3 and 2.5mm (mean 1.82mm). Ten of these
thirteen attachment gain sites were from 3 subjects (2, 3 
and 5 sites from each) and the remaining 3 sites were 
obtained from different individuals.
When a much less stringent threshold for determining 
attachment level change, specifically of ^lmm between the 
two appointments without any other thresholds being taken 
into account (section 2.2.1.4), was applied, another two
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grades of attachment level change were produced. 17 sites 
(4.4%) were classified as grade 2 (gain ^lmm) and 23 sites 
(6%) as grade 4 (loss ^lmm). All other sites (n=316; 
82.3%) which were considered to be stable were classified 
as grade 3 sites (section 2.2.1.5). The frequency 
distribution and percentages of attachment level grading 
for all sites are shown in Table 4.7.
4.4.2 Clinical parameters in relation to attachment 
level changes
In order to investigate if baseline clinical parameters 
could be associated with attachment level changes when 
considering the subject as a unit, mean clinical indices 
(MGI, PI, PD), GCF volume, bleeding on probing (BOP) and 
suppuration (S), were obtained for all sites within each 
subject (section 2.4). Subjects were ranked according to 
their mean attachment level scores (rank 1= most 
improvement= mean attachment gain 0.80mm; rank 38= most 
deterioration=mean attachment loss 0.76mm) as well as their 
mean baseline MGI, PI, PD, BOP and S scores and rank 
correlations obtained as shown in Table 4.8. With the 
exception of subject mean initial PD which showed a 
positive and significant association (r=0.380; p=0.019) 
with mean attachment level changes, all other correlations 
were low and failed to reach statistical significance. In 
order to examine if true associations were being masked by 
the inclusion of a large number of stable sites the two
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Table 4.7 Distribution and percentages of attachment level 
(AL) change grading in n=384 sites. Grading ranged from 1 
(significant attachment gain) to 5 (significant attachment 
loss) as described in section 2.2.1.5.
Attachment level grade frequency distribution
Grade Frequency Percentage
1  significant AL gain 13 3.4
2 gain t last 17 4.4
3 atabla 316 82.3
4 loss l l M 23 6.0
5 significant AL loss 15 3.9
Total 384 100
Table 4.8 Spearman rank correlation coefficients (r) 
between baseline subject mean clinical indices and 
attachment level change in 38 patients. The value of r and 
significance level (p-values) are given.
Mean attachment level 
(n=38 subjects)
change
r p-value
Parameter
MGI 0.136 p=0.416
PI 0.084 p=0.615
PD 0.380 p=0.019
BOP 0.083 p=0.620
S 0.004 p=0.981
GCF (\il) 0.120 p=0.472
MGI= modified gingival index 
PI= plague index; PD= pocket depth 
BOP= bleeding on probing; S= suppuration 
GCF= gingival crevicular fluid
Table 4.9 Clinical indices (mean ± SE) for best and worst 
sites for all subjects (n=38). Clinical indices for the 2 
best (most improvement; greatest attachment level gain) and 
2 worst sites (most deterioration; greatest attachment 
level loss) were averaged for each subject and used to 
compute mean best and worst scores within each individual. 
Significance levels (p-values) of paired tests to compare 
best and worst sites are shown.
Baseline Clinical Indices
mean ± SE, n-38 subjects paired tests
best sites worst sites p-value
Parameter
MGI 2.065 ± 0.10 2.056 ± 0.11 0.839a
PI 1.011 ± 0.14 1.018 ± 0.11 1.000a
PD (mm) 4.704 ± 0.16 4.329 ± 0.17 0.405a
GCF (jxl) 0.279 ± 0.03 0.232 ± 0.02 0.229b
* paired sign test; b paired t-test 
MGI= modified gingival index 
PI= plague index; PD= pocket depth 
GCF= gingival crevicular fluid
best and two worst sites per patient were compared. The 
baseline scores MGI, PI, PD and GCF volume, for the two 
best and two worst sites per patient were averaged and 
paired tests (t-test for GCF volume; sign tests for 
clinical indices) were used to compare for differences 
between best and worst sites within each subject. The mean 
scores of the 38 patients for the clinical indices of their 
2 best and 2 worst sites are shown in Table 4.9. None of 
the clinical indices differed significantly between best 
and worst sites (Table 4.9). These results were left 
unchanged when Wilcoxon sign paired rank tests were used 
instead of sign tests to test for differences in MGI, PI 
and PD for best and worst sites.
This lack of association was confirmed when the sites were 
considered as independent (n=384) and rank correlations run 
between attachment level grading and the clinical indices 
(MGI, PI and PD) and GCF volume. As shown in Table 4.10 
all correlations were very low and none was statistically 
significant despite the large number of sites used to test 
for associations. Moreover, bleeding on probing did not 
demonstrate significant association with attachment level 
grading (chi-square= 7.957; p=0.09). Finally, grade 1
(most improvement) and grade 5 (most deterioration) sites 
were treated assuming independence and compared using the 
Mann-Whitney test. Table 4.11 shows the clinical indices 
at grade 1 and grade 5 sites. No statistically significant 
differences (Mann-Whitney test; Table 4.11) were observed
138
Table 4.10 Spearman rank correlation coefficients (r) 
between baseline clinical indices and attachment level 
grade in n=384 sites. The value of r and significance 
level (p-value) are given.
Attachment level grade
(n=384 sites)
r p-value
Parameter
MGI 0.021 p=0.685
PI 0.034 p=0.509
PD -0.078 p=0.127
GCF (nl) 0.010 p=0.420
MGI35 modified gingival index 
PI= plague index 
PD= pocket depth 
GCF= gingival crevicular fluid
Table 4.11 Baseline clinical indices (mean ± SE) at grade 
1 and grade 5 sites (significant attachment gain and loss 
respectively). Sample size is given under each category in 
parenthesis. Differences in clinical indices between the 
two groups were tested by the Mann-Whitney test. 
Significance levels (p-values) are given.
Baseline Clinical Indices
mean ± SE Mann-Whitney
Grade 1 sites Grade 5 sites 
(n=13) (n=15)
p-value
Parameter
MGI 1.92 + 0.24 2.27 + 0.18 0.269
PI 0.85 + 0.22 1.20 + 0.22 0.261
PD 5.2 + 0.33 4.64 ± 0.40 0.230
GCF (|il) 0.26 + 0.07 0.28 ± 0.08 0.695
MGI= modified gingival index 
PI= plague index 
PD= pocket depth 
GCF= gingival crevicular fluid
for any of the clinical indices between grade 1 and grade 
5 sites. In addition, no association could be demonstrated 
between BOP and classification of a site as grade 1 or 
grade 5 (chi-square= 0.817; p=0.366).
4.4.3 GCF protease inhibitors and iron-binding 
proteins at periodontally active versus stable 
sites
A total of 15 sites demonstrated significant attachment 
loss (tolerance method) during the 3 month observation 
period (section 4.4.1). Two of these active sites were 
observed in the same individual, and the worst site only 
(most deterioration) was selected for GCF analysis. In 
this way, a total of 14 active sites in 14 individuals were 
enrolled in this study and were analysed for GCF protease 
inhibitors and iron-binding proteins. In this way a 
balanced design was obtained facilitating statistical 
analysis. The site excluded from subsequent analysis was 
also the site demonstrating attachment loss of 0.9mm, the 
minimum significant attachment loss obtained during the 
three month observation period (section 4.4.1). Each 
active site was paired, within each individual, to a non­
progressive stable site demonstrating comparable baseline 
MGI and PD. Results were expressed in two ways: i) as
total amounts in ng/30s and ii) corrected for the levels of 
albumin (Alb) in GCF (ng/[ig Alb).
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Table 4.12 shows the mean clinical indices at active and 
stable sites. No significant differences were obtained 
when paired tests were used to compare active and stable 
sites at baseline as far as MGI and PD are concerned, and 
even when PI and GCF volume were compared (paired sign 
test: MGI, PI, PD; paired t-test: GCF volume).
The levels (geometric mean and 95% confidence intervals) of 
a2-macroglobulin (a2-M), al-antitrypsin (al-AT), 
transferrin (TF) and lactoferrin (LF) (ng/30s) at active 
and stable sites at baseline are given in Table 4.13. 
Active versus stable sites were compared using paired t- 
tests on the log10 transformed data. No significant 
differences were obtained for any of the proteins under 
investigation, between active and stable sites at baseline 
(Table 4.13).
The levels of protease inhibitors and iron-binding proteins 
in GCF (ng/30s) from active and stable sites were also 
assessed at the recall appointment. No significant 
differences could be detected when paired t-tests were used 
(on the log10 transformed data) to test for differences 
between active and stable sites at the recall appointment 
as far as their GCF protease inhibitor and iron-binding 
protein levels were concerned (Table 4.14).
Similar findings were obtained when these protein levels 
were corrected for albumin in GCF (ng/\ig Alb) and compared
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Table 4.12 Clinical indices (mean ± SE) at active and 
stable sites (n=14) used for the assessment of GCF a2- 
macroglobulin, al-antitrypsin, transferrin and lactoferrin 
levels. Differences in clinical indices were tested using
paired tests. Significance levels (p-values) are given.
Baseline Clinical Indices
mean ± SE paired
(na14) tests
Active sites Stable sites p-value
Parameter
MGI 2.21 ± 0.19 2.00 ± 0.21 0.375*
PI 1.14 ± 0.23 1.21 ± 0.24 1.000a
PD 4.54 ± 0.42 4.89 ± 0.24 0.267a
GCF (|Lil) 0.291 ± 0.08 0.306 ± 0.10 0.819b
a paired sign test 
b paired t-test
MGI- modified gingival index 
PI= plaque index; PD= pocket depth 
GCF= gingival crevicular fluid
Table 4.13 Baseline a2-macroglobulin (a2-M), al- 
antitrypsin (al-AT), transferrin (TF) and lactoferrin (LF) 
levels (ng/30s) in gingival crevicular fluid (GCF) from 
periodontally active and stable sites. Sample size, 
geometric mean and 95% confidence intervals are given. 
Paired t-tests were performed to compare for differences 
between active and stable sites. Significance levels (p- 
values) are shown.
Baseline GCF a2-M, al-AT, TF and LF levels (ng/30s)
mean (95% confidence interval) 
(n=14)
paired
t-test
Active sites Stable sites p-value
Parameter
a2-M 38 (20-72) 31 (14-69) 0.556
al-AT 81 (41-157) 87 (51-147) 0.831
TF 54 (22-130) 47 (15-139) 0.754
LF 135 (64-281) 107 (49-232) 0.468
Table 4.14 Recall a2-macroglobulin (a2-M), al-antitrypsin 
(al-AT), transferrin (TF) and lactoferrin (LF) levels 
(ng/30s) in gingival crevicular fluid (GCF) from 
periodontally active and stable sites. Sample size, 
geometric mean and 95% confidence intervals are given. 
Paired t-tests were performed to compare for differences 
between active and stable sites. Significance levels (p-
values) are shown.
Recall GCF a2-M, al-AT, TF and LF levels (ng/30s)
mean (95% confidence intervals) 
(n=14)
paired
t-test
Active sites Stable sites p-value
Parameter
a2-M 39 (22-70) 34 (21-55) 0.591
al-AT 86 (53-139) 80 (52-124) 0.772
TF 90 (43-186) 56 (31-101) 0.213
LF 141 (78-254) 128 (74-220) 0.761
between active and stable sites at both baseline and recall 
appointments. Total albumin in jig/30s in GCF at active 
(n=14) and stable sites (n=14) on baseline was 1.7 (0.5- 
2.9) and 1.5 (0.7-2.3) respectively (geometric mean and 95% 
confidence intervals). Similarly, on recall total albumin 
at active and stable sites was 1.7 (0.6-2.8) and 1.1 (0.4- 
1.8) pg/30s respectively. Tables 4.15 and 4.16 give the 
levels of a2-M, al-AT, TF and LF expressed in ng/pig Alb 
(geometric mean and 95% confidence intervals) and the 
results of the paired tests (run on the log10 transformed 
data) to compare between active and stable sites at 
baseline and recall appointments respectively. None of the 
differences were statistically significant.
These results were confirmed when multivariate repeated 
measures analysis of variance (repeated measures MANOVA on 
the log10 transformed data) was used to test for all four 
proteins (a2-M, al-AT, TF and LF) simultaneously for 
differences between active and stable sites at the baseline 
and recall appointments for both ways of expressing the 
results (ng/30s Table 4.17; nq/\ig Alb Table 4.18). Two 
separate MANOVA procedures were run to test for differences 
at the baseline and recall appointments.
Finally, repeated measures MANOVA and a model incorporating 
the four proteins while testing simultaneously for site 
(stable versus active), appointment (baseline versus 
recall) and site by appointment effects was run on the log10
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Table 4.15 Baseline a2-macroglobulin (a2-M), al-
antitrypsin (al-AT), transferrin (TF) and lactoferrin (LF) 
levels (ng/p,g Alb) in gingival crevicular fluid (GCF) from 
periodontally active and stable sites. Sample size, 
geometric mean and 95% confidence intervals are given. 
Paired t-tests were performed to compare for differences 
between active and stable sites. Significance levels (p- 
values) are shown.
Baseline GCF a2-M, al-AT, TF and LF levels (ng/ixg Alb)
mean (95% confidence interval) paired 
_____________ (n=14)_________________t-test
Active sites Stable sites p-value
Parameter
a2-M 47 (31-71) 30 (16-57) 0.240
al-AT 98 (65-150) 80 (54-120) 0.450
TF 58 (26-129) 45 (17-120) 0.505
LF___________163 (89-301) 98 (47-206)______ 0.161
Table 4.16 Recall a2-macroglobulin (a2-M), al-antitrypsin 
(al-AT), transferrin (TF) and lactoferrin (LF) levels 
(ng/ng Alb) in gingival crevicular fluid (GCF) from 
periodontally active and stable sites. Sample size, 
geometric mean and 95% confidence intervals are given. 
Paired t-tests were performed to compare for differences 
between active and stable sites. Significance levels (p- 
values) are shown.
Recall GCF a2-M, al-AT, TF and LF levels (ng/^g Alb)
mean (95% confidence intervals) paired 
______________ (n-14)__________________t-test
Active sites Stable sites p-value
Parameter
a2-M 43 (35-53) 42 (31-56) 0.870
al-AT 94 (66-135) 98 (70-138) 0.826
TF 98 (70-137) 69 (50-95) 0.099
LF 154 (83-286) 156 (98-248) 0.959
Table 4.17 Multivariate repeated measures analysis of 
variance (MANOVA) for a2-macroglobulin, al-antitrypsin, 
transferrin and lactoferrin (ng/30s) in GCF from active 
versus stable sites for the baseline and recall 
appointments. Multivariate results (Pillai's test) for 
each appointment are shown. The value of the test (value), 
the approximate F (Appr. F), the hypothesis and error 
degrees of freedom (Hyp. DF and Error DF respectively) and 
the significance level (p) are given.
Repeated Measures MANOVA: Pillai' s test
Value Appr.
F
Hyp.
DF
Error
DF
P
Effect:
active versus stable
Baseline 0.286 1.001 4 10 0.451
Recall 0.170 0.514 4 10 0.727
Table 4.18 Multivariate repeated measures analysis of 
variance (MANOVA) for a2-macroglobulin, al-antitrypsin, 
transferrin and lactoferrin (ng/fig Alb) in GCF from active 
versus stable sites for the baseline and recall 
appointments. Multivariate results (Pillai's test) for 
each appointment are shown. The value of the test (value), 
the approximate F (Appr. F), the hypothesis and error 
degrees of freedom (Hyp. DF and Error DF respectively) and 
the significance level (p) are given.
Repeated Measures MANOVA: Pillai's test
Value Appr.
F
Hyp. Error p 
DF DF
Effect:
active versus stable
Baseline 0.280 0.972 4 10 0.464
Recall 0.224 0.722 4 10 0.596
transformed data (section 2.4). Of the above, the most 
interesting is the site by appointment effect, as it 
compares the change (6) in protease inhibitor and iron- 
binding protein levels (ng/30s) between baseline and recall 
at active versus stable sites (section 2.4). As shown in 
Table 4.19 (ng/30s) and 4.20 (ng/jxg Alb) none of these
effects were significant, confirming that in this study no 
difference could be detected in GCF levels of a2-M, a1-AT, 
TF and LF levels between periodontally active and
stable sites when expressing the results either as ng/30s 
or ng/jig Alb.
The above results suggest that it is not possible to 
differentiate periodontally active from stable sites using 
a diagnostic test based on the levels of protease 
inhibitors or iron-binding proteins in GCF. In order to 
illustrate this, data from the recall appointment (ng/30s; 
Table 4.14) were used to assess specificity, sensitivity as 
well as predictive values. A combined test based on the 
values of the four proteins a2-M, al-AT, LF and TF was 
used. Thus, the test was considered positive when a site 
demonstrated a2-M  ^ 39ng/30s, al-AT  ^ 86ng/30s, TF £
90ng/30s and LF  ^ 141ng/30s. These threshold values
represent the geometric means of a2-M, al-AT, TF and LF 
levels (ng/30s) at active sites, as shown in Table 4.14. 
All four conditions should apply simultaneously in order 
for the test to be considered positive, whereas if the 
levels of any one of the proteins dropped below the
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Table 4.19 Multivariate repeated measures analysis of 
variance (MANOVA) for a2-macroglobulin, a1-antitrypsin, 
transferrin and lactoferrin (ng/30s) in GCF from active 
versus stable sites at baseline and recall appointments. 
Multivariate results are shown. The value of the test 
(value), the approximate F (Appr. F), the hypothesis and 
error degrees of freedom (Hyp. DF and Error DF 
respectively) and the significance level (p) of the main 
effects and their interactions are given.
Repeated Measures MANOVA; Pillai's test_____
Value Appr. Hyp. Error p
F DF DF
Effect
Appointment:
Baseline versus 0.162 0.483 4 10 0.748
recall
Site:
Active versus 0.246 0.817 4 10 0.542
stable
Appointment by 0.129 0.371 4 10 0.824
site
Table 4.20 Multivariate repeated measures analysis of 
variance (MANOVA) for a2-macroglobulin, a1-antitrypsin, 
transferrin and lactoferrin (ng/pg Alb) in GCF from active 
versus stable sites at baseline and recall appointments. 
Multivariate results are shown. The value of the test 
(value), the approximate F (Appr. F), the hypothesis and 
error degrees of freedom (Hyp. DF and Error DF 
respectively) and the significance level (p) of the main 
effects and their interactions are given.
Repeated Measures MANOVA: Pillai's test
Value Appr.
F
Hyp. Error 
DF DF
P
Effect
Appointment: 
Baseline versus 
recall
0.151 0.445 4 10 0.774
Site:
Active versus 
stable
0.230 0.746 4 10 0.582
Appointment by 
site
0.160 0.478 4 10 0.752
designated values the test was considered negative. As 
shown in Table 4.21 sensitivity was low (28%), whereas 
specificity reached approximately 86%. Positive and 
negative predictive values were low. In 33% of the cases 
a positive test would have misclassified an inactive site 
as being active. Similarly, in 46% of the cases a negative 
test would have misclassified an active site as being 
inactive.
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Table 4.21 Characteristics of a diagnostic test based on 
the levels (ng/30s) of a2-macroglobulin (a2-M), al- 
antitrypsin (al-AT), transferrin (TF) and lactoferrin (LF) 
at the recall appointment. Sensitivity, specificity and 
positive and negative predictive values are shown.
Positive test
a2-M & 39ng/30s & 
al-AT 2 86ng/30s & 
TF a 90 ng/30s £ 
LF a 141 ng/30s
Negative test
a2-M < 39ng/30s or 
al-AT < 86ng/30s or 
TF < 90 ng/30s or 
LF < 141 ng/30s
Active
site
Stable
site
4 2
10 12
Positive
predictive
value
67%
Negative
predictive
value
54%
Sensitivity Specificity
28% 86%
CHAPTER 5
Discussion
5.1 Considerations on methodology
5.1.1 Quantification of gingival crevicular fluid 
iron-binding proteins and protease inhibitors
The use of enzyme linked immunosorbent assays (ELISA) for 
the assessment of constituents in biological fluids is 
common practice today and it has replaced methods such as 
radial immunodiffusion and radioimmunoassays. The
advantages of the ELISA methodology are considerable. It 
provides precision and low detectability limits in 
conjunction with eliminating radiation dangers associated 
with the use of radioimmunoassays. Preliminary experiments 
and results for the establishment of the ELISAs used in 
this thesis have been presented and discussed in chapter 3. 
The methods were validated and proven suitable for the 
quantification of protease inhibitors and iron-binding 
proteins in GCF.
The use of ELISA methodology, however, for the 
quantification of protease inhibitors in GCF could be 
criticised for its inability to distinguish between bound 
and free forms of the inhibitor. GCF is rich in enzymes 
which are excreted mainly from degranulating PMNs (chapter 
1; Table 1.5). Thus, it is highly likely that protease 
inhibitors reaching the crevice would readily bind to 
proteases. Within the tissues any binding of a protease to 
a2-M or al-AT results in the rapid removal of the complex
144
by monocytes/ macrophages (Ohlsson & Laurell, 1976; Feldman 
et al., 1983). Thus, inhibitor /proteinase complexes 
within the gingivae would be present for only very short 
periods of time and would not, therefore, be readily 
detected. In contrast, in the gingival crevice where 
macrophages/monocytes are scarce (Skapski & Lehner, 1976), 
proteinase/inhibitor complexes would persist for longer 
time periods. Some investigators (Condacci et al., 1982; 
Skaleric et al., 1986) have suggested that studying the 
free/bound inhibitor ratio in the crevice would provide 
information on the protease inhibiting potential of GCF 
and, therefore, be of more relevance to periodontal 
disease status. However, if one is interested in the 
situation within the gingival tissues, then the total 
amount of the inhibitors in GCF would be more 
representative due to the considerations mentioned above.
The total (free and bound) amounts of a2-M could in 
addition reflect the numbers of mature macrophages within 
the gingival tissues, as it has been shown that transition 
of monocytes into macrophages is followed by a strong 
induction in a2-M production (Bauer et al., 1988). As 
reviewed recently by Page (1991), mature macrophages are 
one of the key cells contributing to periodontal tissue 
damage by release, upon activation, of their potent 
proteases within the tissues (Chapter 1; Fig. 1.1 & 1.2). 
Total GCF a2-M could perhaps reflect monocyte/macrophage 
functional state within the gingivae.
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In addition to the previous considerations, techniques used 
for the assessment of the free and bound form of a2-M and 
al-AT have the following disadvantages:
a) as far as a2-M is concerned, the use of isoelectric 
focusing and crossed immunoelectrophoresis for the 
assessment of its free and bound form (Ohlsson & Skude,
1976) requires large GCF sample volumes and excludes the 
simultaneous assessment of other constituents in the same 
sample. For example Condacci et al. (1982) and Skaleric et 
al. (1986), in order to obtain sufficient GCF sample 
volumes, employed long sampling times (paper strips for 3-5 
min) and the use of microcapillaries for the collection of 
GCF respectively. Such procedures could, however, cause 
irritation of the gingival tissues and induce serum leakage 
from the subepithelial microvasculature thus altering GCF 
constituents (Cimasoni, 1983; Persson & Page, 1990). In 
addition, in order to compensate for the lack of 
sensitivity of the technique, the whole GCF sample was 
required for the assessment of free and bound form of the 
inhibitor, despite the large volumes obtained when using 
the above mentioned sampling protocols. Thus, no other GCF 
components could be investigated.
b) examining al-AT/elastase complexes by ELISA methodology 
as performed by Huynh et al. (1992) and Zafiropoulos et al. 
(1991) represents elastase concentration in GCF. This is 
because elastase will bind avidly to al-AT whereas the
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inhibitor will, in addition, bind to other available serine 
proteinases like Cathepsin G and plasminogen activator, or 
metalloproteinases like collagenase (Ohlsson & Olsson,
1977). Thus assessment of al-AT/elastase complexes in GCF 
will only partly reflect the bound form of the inhibitor 
and will not provide information on the true bound/free al- 
AT ratio.
5.1.2 Gingival crevicular fluid data reporting
Traditionally, constituent activities/amounts present in 
biological fluids have been expressed as concentrations 
(activity or amount per unit volume). As Lamster et al. 
(1986) initially pointed out, this method may not be 
applicable to GCF. GCF is an inflammatory exudate or 
proinflammatory transudate and is unique in properties, 
differing from most other biological fluids. Microamounts 
of GCF are produced in an open environment, the gingival 
crevice, and are constantly cleared towards the oral 
cavity. Thus, in contrast to most other biological fluids 
a large pool of fluid does not exist. Usually, sampling 
means that the total or most of the amount of fluid present 
in the gingival crevice is removed. If sampling time is 
standardised then expression of the results as total 
amounts per time may be preferable. Reporting GCF 
constituents as total amounts has additional advantages as 
it avoids the calculation of GCF volume in its 
determination. GCF volumes are usually below 1^ ,1 rendering
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their precise measurement particularly difficult. Although 
the Periotron is considered accurate in the assessment of 
GCF volume, minimal errors in the estimation of the latter 
would result in disproportionately large alterations in the 
concentration of GCF constituents (Lamster et al., 1988a). 
In the ultra low range of GCF volumes, losses from 
evaporation could easily occur both during sampling and 
transfer of the sample to the Periotron, even if the 
instrument is located chairside. Most investigators seem 
to agree that expression of GCF constituent data as total 
amounts is preferable (Lamster et al., 1986, 1988a; Wolff 
et al., 1988; Cao & Smith, 1989; Persson & Page, 1990; 
Page, 1992; Smith & Geegan, 1991) although others seem to 
have reservations and usually report results both as 
concentrations and total amounts (Huynh et al., 1992; Eley 
& Cox, 1992; Cox & Eley, 1992a, 1992b; Giannopoulou et al., 
1992).
5.1.3 Gingival crevicular washings
Gingival crevicular washings (GCW) were used in order to 
sample crevicular LF and PMNs and investigate the 
relationship between them. Recently a method has been 
described for the approximate determination of PMN numbers 
in discrete GCF samples, collected with paper strips 
(Cimasoni & Giannopoulou, 1988). This technique would 
appear to permit assessment of LF levels and PMN numbers 
from the same GCF sample. However, in a pilot study
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performed in our clinics and laboratories on a limited 
number of GCF samples (section 3.2.3.3), no PMNs could be 
recovered from the strips, either when vortexing (Cimasoni 
& Giannopoulou, 1988) or centrifuging the sample (Ebersole 
et al., 1984). Thus, we resorted to the semiquantitative 
method of gingival crevicular washings (GCWs) to determine 
numbers of PMNs in the crevice and their relationship with 
LF. LF levels and PMN numbers in gingival crevicular 
washings were expressed as concentrations (ng/jxl GCW, 
PMNs/jil GCW respectively), which are directly proportional 
to their absolute amounts present within the crevice.
5.2 Cross-sectional studies
5.2.1 Lactoferrin as a marker of polymorphonuclear 
leucocytes in the gingival crevice
This study was performed to investigate whether lactoferrin 
(LF) could act as a marker of crevicular polymorphonuclear 
leucocytes (PMN) in the crevice. The reasoning behind the 
choice of LF as a PMN marker includes the following: a) LF
is contained specifically and in abundance in PMN secondary 
granules (Spitznagel et al., 1974) but not in other 
leucocytes (Bennett & Kokocinski, 1978) and only in trace 
amounts in serum (Hetherington et al., 1983); b) PMN 
secondary granules are more numerous than primary granules 
(Falloon & Gallin, 1986) and their contents are released 
earlier and more readily during in vitro PMN stimulation
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(Bentwood & Henson, 1980); c) PMN secondary granules have 
been shown to be preferentially released, over primary 
granules, during both adherence in vitro and migration 
through epithelium in vivo (Wright & Gallin, 1979); d) 
finally, Wilton (1986) summarised the stimuli for PMN 
degranulation in the crevice (section 1.5.2) and concluded 
that PMN secondary granule release is more likely in vivo. 
GCF LF, therefore, is a good candidate as a marker of PMN 
emigration in the crevice (Fine & Mandel, 1986, Curtis et 
al., 1989).
When the relationship between PMN numbers and LF levels in 
gingival crevicular washings from discrete sites was 
examined a positive (r=0.531) and significant (p<0.001) 
association was obtained (section 4.1). The moderately 
strong relationship between LF levels and crevicular PMNs 
could be due to the LF contribution by degranulating PMNs 
within the subepithelial gingival connective tissue. The 
connective tissue or intra-epithelial PMNs would not have 
been accounted for in our assessment of PMNs, as gingival 
crevicular washings would only harvest leucocytes already 
present in the crevice.
When associations between clinical indices and LF 
concentration or PMN numbers in gingival crevicular 
washings from specific sites were examined positive 
correlations were obtained (section 4.1). PMN numbers 
increase in the gingival crevice with the development of
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experimental gingivitis (Kowashi et al., 1980; Thurre et 
al., 1984) and more PMNs are found in periodontitis 
compared to control sites (Thurre et al., 1984). 
Therefore, a positive association of PMN numbers and LF 
levels with clinical indices is expected.
The correlation of LF in gingival crevicular washings with 
the clinical indices was higher than that obtained for 
crevicular PMNs. This may reflect lower errors in the 
measurement of LF than PMN numbers in the crevice. In 
addition, as LF may reflect activated PMNs in the area, it 
suggests that measuring PMN activation may be more 
pertinent when assessing disease status. LF may, 
therefore, prove a better test of periodontal disease 
status than crevicular PMNs at a specific site. This 
effect would, however, be optimised if care is taken to 
separate the cellular components of the GCW/GCF sample 
prior to freezing or eluting and subsequent assaying for LF 
in order to avoid disruption of the PMNs present in the 
sample.
In conclusion, our data support the view that LF may prove 
a useful marker of PMN emigration and/or activation in the 
crevice. LF determination in GCF is more accurate and 
simpler to perform than the enumeration of PMNs using GCWs 
or styroflex strips and may provide a simple and effective 
marker of crevicular PMNs.
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5.2.2 Protease inhibitors and iron-binding proteins at 
healthy, gingivitis and periodontitis sites
In these studies, a2-macroglobulin (a2-M), al-antitrypsin 
(al-AT), transferrin (TF) and lactoferrin (LF) were 
assessed in different GCF samples. The data from these 
studies demonstrate that higher absolute amounts (ng/30s 
sample) of protease inhibitors (a2-M, al-AT) and iron- 
binding proteins (TF, LF) are present in gingival 
crevicular fluid from diseased sites (gingivitis and 
periodontitis), than from clinically healthy sites (section 
4.2). As mean MGI, PD and GCF volume were higher in 
diseased sites (gingivitis and periodontitis) the influence 
each factor has on the levels of these proteins is unclear. 
However, a2-M, al-AT and TF are mainly serum derived and, 
therefore, increased amounts in diseased sites could be ac­
counted for by increased crevicular fluid flow as a result 
of increased vascular permeability following gingival 
inflammation. This is strongly suggested by the higher GCF 
volume readings obtained from diseased sites. However, the 
possibility of increased local production within the 
gingival tissues can not be excluded. In vitro studies 
have shown that these proteins could be produced from cells 
residing within the periodontal tissues. Gingival 
fibroblasts are capable of producing a2-M (Condacci et al., 
1988) and monocytes/macrophages can produce a2-M (Hovi et 
al., 1977; White et al., 1980; Bauer et al., 1988), al-AT 
(Perlmutter et al., 1985, Bauer et al., 1988) and TF
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(Stecher & Thorbecke, 1967). In addition, al-AT is 
produced and stored within PMN primary granules (Mason et 
al., 1991) whereas inducer T-lymphocytes may contribute to 
TF synthesis within the tissues (Lum et al., 1986).
The increase in LF levels (ng/30s sample) in diseased when 
compared to healthy sites is probably governed by different 
mechanisms. As LF is contained in only trace amounts in 
serum (Hetherington et al., 1983), its higher levels in GCF 
from gingivitis and periodontitis sites cannot be accounted 
for solely by increased vascular permeability. Migration 
of PMNs in the gingival crevice and degranulation therein 
must be the major factor contributing to increased GCF LF 
levels. As mentioned previously, PMN numbers increase in 
the gingival crevice with the development of experimental 
gingivitis (Kowashi et al., 1980; Thurre et al., 1984) and 
more PMNs are found in periodontitis compared to control 
sites (Thurre et al., 1984). The higher PMN numbers in the 
crevice at diseased sites would, therefore, lead to higher 
LF levels. However, a proportion of LF may be released by 
the PMN infiltrate present within the gingival tissue 
underlying the junctional epithelium area and may be 
passively transferred into the crevice by GCF flow.
The mean absolute amounts of protease inhibitors (a2-M, al- 
AT), and iron-binding proteins (TF, LF) were not found to 
differ significantly between gingivitis and periodontitis 
sites. There was, however, a marked tendency for increased
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levels at periodontitis over gingivitis sites. In this 
cross-sectional study probing depths were the 
differentiating factor between gingivitis and periodontitis 
sites. Probing depth measurements taken at one point in 
time should, however, be primarily regarded as history of 
previous periodontal destruction. In addition, they 
provide a measure of the inflammatory status of the 
supracrestal connective tissue due to deeper probe 
penetration at more inflamed sites (Armitage et al., 1977; 
Caton et al., 1981). Thus, it should be realised that 
increased probing depths do not reflect active periodontal 
destruction and this was considered to have a bearing on 
the inability to distinguish between gingivitis and 
periodontitis sites.
We could not detect the same statistically significant 
differences when results were expressed on a concentration 
basis. This is a reflection of the higher variability 
observed when the results are expressed in this way and 
supports the views of previous investigators that total 
amounts may be a preferable way of expressing GCF 
constituent data (section 5.1.2). al-AT exhibited a 
tendency for increasing values from health to disease (gi­
ngivitis and periodontitis), although none of the differen­
ces were significant and this was also the case for TF. 
The increase in TF concentration in periodontitis over 
healthy sites almost reached significance at 0.025 level 
(p=0.03) and could be associated with increased numbers of
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helper T-lymphocytes at periodontitis sites (Lum et al., 
1986; Malberg et al., 1992). In contrast, GCF a2-M 
concentration was significantly increased at both gingi­
vitis and periodontitis sites when compared to healthy 
sites. As mentioned above, in addition to
monocytes/macrophages, a2-M is produced by gingival 
fibroblasts (Condacci et al., 1988), one of the most 
abundant cells of the gingivae, and this could contribute 
to the significant elevation in GCF a2-M concentration in 
diseased sites. Alternatively, this increase could simply 
reflect lower variability in GCF a2-M concentration in 
comparison to the other proteins.
A different overall picture, compared to a2-M, al-AT and TF 
was observed when GCF LF results were expressed as 
concentrations. Although just outwith statistical 
significance (p=0.065), GCF LF concentration demonstrated 
a clear drop with increasing disease severity, from healthy 
to gingivitis and periodontitis sites. The different 
pattern in GCF LF concentration changes with increasing 
disease severity, reflects the different origin of this 
protein in GCF when compared to a2-M, al-AT and TF. As 
mentioned above LF is locally produced, solely by 
degranulating PMNs (Spitznagel et al., 1974). Serum 
contribution would be minimal due to its very low LF 
concentration (Hetherington et al., 1983). A closer look 
at our results reveals, that although both total LF and GCF 
volume increases in diseased crevices, the latter increases
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by approximately a factor of 3 to 4 whereas LF increases 
only by a factor of 2. This is in contrast to the response 
of the primarily serum derived TF which has a similar 
molecular weight (80 kDa). Although different GCF samples 
were used for the quantification of the two iron-binding 
proteins, in these studies, it is clear that TF increased 
proportionately to GCF crevicular fluid volume (both 
increased by approximately a factor of 2). As LF 
correlates with PMN numbers in the crevice, it seems that 
a disproportionate increase in GCF volume compared to PMN 
numbers, results in dilution of the locally produced LF. 
This is consistent with the observation of Kowashi et al. 
(1980) who demonstrated that crevicular PMN numbers in 
gingival washings increased by a factor of 2 after 21 days 
of plaque accumulation, during experimental gingivitis. 
During the same period, GCF flow demonstrated an increase 
by approximately a factor of 5. PMN migration is regulated 
by chemotactic factors whereas GCF flow induction, by 
vasoactive substances and although they could be observed 
simultaneously they are clearly under different control. 
Decreasing concentration of gingival crevicular fluid 
lysosomal enzymes with increasing periodontal disease 
severity has been reported by some investigators (Lamster 
et al., 1986), the majority of reports have, however, 
demonstrated increased levels with the severity of 
periodontal pathology (Chapter 1; Table 1.5). However, 
none of the enzymes investigated is contained specifically
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in PMNs and other cells of the periodontium could 
contribute and thus change the overall picture.
Of the GCF proteins examined in this study, a2-M is the one 
studied most extensively in the past. Our results are 
consistent with previous investigations on the absolute 
amounts of a2-M. Thus, Condacci et a l .  (1982) and Sengupta 
et al. (1988) demonstrated that the absolute amounts of a2- 
M increased at sites with higher degrees of gingival 
inflammation. When, however, Condacci et a l .  (1982), 
Skaleric et a l .  (1986) and, in a more recent report, Sibraa 
et a l .  (1991) expressed their results on a concentration 
basis, they reported, in contrast to our results, that the 
specific content of the inhibitor decreased at sites with 
increased periodontal pathology. Thus, an apparent 
inconsistency exists, between our study, demonstrating that 
the specific content of the inhibitor increases at diseased 
sites, and the above mentioned reports. This could be due 
to the different methods of GCF collection employed: 
Condacci et a l .  (1982) collected GCF using filter paper 
strips for 3 to 5 min; Sibraa et a l .  (1991) used filter 
paper strips for an undefined period of time (or until 1/3 
of the paper strip was visibly wet); finally Skaleric et 
a l .  (1986) sampled using microcapillary tubes and collected 
2\il of GCF. These methods of GCF collection are thought to 
irritate the gingival tissues (Cimasoni, 1983; Persson & 
Page, 1990) and could thus increase vascular permeability 
in the area which could adversely affect GCF a2-M
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concentration in an uncontrollable manner. In our study we 
used a less invasive method of GCF collection (paper strips 
for 30s) that minimises irritation and microleakage of the 
subepithelial microvasculature and reflects better the GCF 
constituent concentrations. Our findings are consistent 
with recent investigations (Giannopoulou et al., 1990; 
Giannopoulou et al., 1992), where a GCF collection protocol 
identical to ours was employed. Although these reports 
refer to experimental gingivitis studies and did not 
examine sites with increased probing depths, they do 
confirm that GCF a2-M concentration increases at sites with 
higher degree of gingival inflammation. This demonstrates 
how easily different methodologies of GCF collection could 
affect concentrations of its constituents, and again 
supports the view that reporting results as absolute 
amounts with standardised sampling times is preferable.
Few investigations exist on GCF al-AT (Ohlsson et al., 
1974; Scheinken & Genco, 1977; Tollefsen & Saltvedt, 1980; 
Asman et al., 1981; Zafiropoulos et al., 1991; Huynh et 
al., 1992), TF (Scheinken & Genco, 1977; Asman et al., 
1981) and LF (Friedman et al., 1983). As detailed in 
sections 1.7 and 1.8 these studies differ substantially in 
methodology to the present study and, therefore, comparison 
of the results is difficult. Some of these reports are 
comparative studies between serum and GCF (Scheinken & 
Genco, 1977; Tollefsen & Saltvedt, 1980; Asman et al., 
1981). In other cases either pooled samples were used
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(Friedman et al., 1983) or 'crevicular material' was 
sampled (Ohlsson et al., 1974).
As mentioned previously, the recent reports by Zafiropoulos 
et al. (1991) and Huynh et al. (1992) have focused on the 
detection of al-AT/elastase complexes and, therefore, are 
more representative of elastase levels in GCF rather than 
al-AT (section 5.1.1).
The present cross-sectional studies on GCF a2-M, al-AT, TF 
and LF clearly indicate that their absolute amounts 
increase at sites with periodontal pathology. However, 
cross-sectional studies can offer little information on the 
involvement and dynamic changes of the above GCF 
constituents during the development of gingival 
inflammation or probing attachment loss. Longitudinal 
studies were, thus, conducted to investigate these issues.
5.3 Experimental gingivitis study
5.3.1 Clinical findings
Whole mouth clinical indices (WPI and WMGI) demonstrated 
the standard pattern (section 4.3.1). WPI rose first and 
WMGI lagged behind, indicating that plaque accumulation 
precedes clinically detectable gingival inflammation. 
Clinical indices at the teeth sampled for GCF followed the 
same pattern, demonstrating that these teeth were
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representative of the whole mouth. The increase in GCF 
volume during the trial is consistent with early 
experimental gingivitis studies designed to investigate the 
relationship of GCF flow with gingival inflammation (Loe & 
Holm-Pedersen, 1965; Egelberg & Attstrom, 1973). After the 
reinstitution of oral hygiene GCF volumes dropped slightly 
remaining, however, higher than baseline.
5.3.2 Protease inhibitors and iron-binding proteins in
gingival crevicular fluid during the development 
of gingival inflammation
The sandwich ELISA methodology applied in this study 
permitted the quantification of protease inhibitors (a2-M, 
al-AT) and iron-binding proteins (TF, LF) in the same GCF 
sample. This offered the major advantage of allowing to 
follow the changes of these proteins simultaneously. This 
served well the aim of this investigation which was to 
determine the dynamics of protease inhibitors and iron- 
binding proteins in GCF during the development of 
experimental gingivitis.
In this study results were reported as absolute amounts in 
ng/30s sample. The rationale for expressing results of GCF 
constituents as total amounts (ng/30s) has been already 
discussed in section 5.1.2. When data from the cross- 
sectional studies were expressed as absolute amounts and 
concentrations, a much greater variability was observed
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with the latter method. Moreover, GCF volumes collected 
during the experimental gingivitis trial were in the ultra 
low range, thus supporting the view that minimal errors in 
GCF volume assessment could create disproportionate flaws 
in concentrations of constituents (Lamster et al., 1988a).
a2-M, al-AT and TF demonstrated a very similar pattern 
during the experimental gingivitis period reflecting their 
common origin in GCF (section 4.3.2). Their levels rose in 
the crevice with the development of experimental 
gingivitis. This rise could be attributed to increased 
vascular permeability and is supported by the simultaneous 
rise of GCF volume. Accumulation of plaque in the gingival 
crevice stimulates an inflammatory response in the region, 
which in turn results in increased vascular permeability. 
In addition, as mentioned previously (section 5.2.2), 
increased local production could also contribute to the 
higher amounts of these proteins in the crevice. Thus, 
monocytes/ macrophages could be responsible for the 
combined production of a2-M, al-AT and TF within the 
tissues (Stecher & Thorbecke, 1967; Hovi et al., 1977; 
White et al., 1980; Perlmutter et al., 1985; Bauer et al.,
1988). The proportion (and absolute numbers) of activated 
macrophages in the gingivae increases during the 
development of experimental gingivitis (Topoll et al.,
1989), and this might be of significance for the production 
of a2-M, al-AT and TF. In addition, it has been shown that 
the percentage of inducer/helper T-lymphocytes increases
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with the degree of gingival inflammation in gingival 
biopsies from periodontitis patients (Malberg et al., 1992) 
and these cells could contribute to higher amounts of TF in 
the crevice (Lum et al., 1986).
The dynamics of a2-M, al-AT and TF during the healing 
period, after the reinstitution of oral hygiene measures, 
reveals a similar pattern still. Despite the drop in MGI 
and PI (section 4.3.1) the levels of these proteins remain 
high after the reinstitution of oral hygiene measures 
(section 4.3.2). This finding suggests that the resolution 
of gingival inflammation occurs faster at the clinical when 
compared to the biochemical level as far as a2-M, al-AT and 
TF are concerned. It has recently been shown that clinical 
improvement precedes the histological resolution of 
gingival inflammation after 21 days of plaque accumulation 
(Brecx et al., 1988b). In the present study vascular 
permeability was maintained after the reinstitution of oral 
hygiene measures, and this is depicted by the fact that GCF 
volume demonstrated only a slight drop after the 
reinstitution of oral hygiene. Vascular permeability would 
have contributed in the maintenance of the levels of a2-M, 
al-AT and TF in the crevice. In addition, resident cells 
of the periodontium which are induced to produce a2-M, al- 
AT and TF may continue to do so, after the reinstitution of 
oral hygiene measures. In the case of protease inhibitors 
lower degradation rates by microorganisms in the crevice 
(Carlsson et al., 1984) or lower clearance rates (after
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binding to proteases) by macrophages/monocytes within the 
tissues, would have also contributed to the sustained 
levels of these proteins in the crevice.
GCF LF demonstrated a different overall pattern. The PMN 
derived LF follows closely the changes in the clinical 
indices, rising with the development of gingival 
inflammation and dropping after the reinstitution of oral 
hygiene measures (section 4.3.2). The rise in GCF LF 
levels with the development of gingival inflammation could 
be attributed to increasing PMN emigration and 
degranulation within the crevice rather than increased 
exudation from serum. LF drops rapidly after the 
reinstitution of oral hygiene measures. This probably 
reflects the removal of chemotactic agents (dental plaque) 
(Hellden & Lindhe, 1973) which results in a drop in PMN 
emigration rates and thus LF in the crevice.
The above discussion is based on the pattern of change of 
the mean response of protease inhibitors and iron-binding 
proteins in GCF. As in any clinical trial, and more likely 
so during experimental gingivitis, considerable variability 
existed among subjects. This is demonstrated by the 
relatively weak overall significance levels obtained 
(section 4.3.2) and is more clearly depicted when one 
examines protease inhibitor and iron-binding protein 
responses in GCF for each subject individually (Fig. 4.17 
to 4.20; section 4.3.2) during the experimental gingivitis
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trial. Although most subjects maintained the pattern 
conveyed by the mean responses it is obvious that some did 
not. Individual variability is a drawback of the 
experimental gingivitis model and it was recognised as 
early as the first experimental gingivitis trial ever 
reported (Loe et al., 1965). Loe and coworkers (1965) had 
clearly stated that clinical signs of gingival inflammation 
are visible only 10 days after cessation of oral hygiene 
measures in some subjects, whereas others require 15 to 21 
days of plaque accumulation until inflammation develops.
Experimental gingivitis studies on GCF constituents are 
relatively scarce, and this is probably due to the 
difficulty of obtaining volunteers. In a recent report, 
which used similar methodology to the present study, GCF 
a2-M and al-AT absolute amounts were shown to increase with 
the development of experimental gingivitis (Giannopoulou et 
al., 1992). In addition, elastase, a PMN primary granule 
constituent, also rose. In a fashion resembling total LF 
changes in the present study, elastase dropped readily to 
baseline levels after the reinstitution of oral hygiene 
measures. a2-M and al-AT demonstrated a more gradual drop, 
but in contrast to the present study, 8 days after the 
reinstitution of oral hygiene had returned to baseline 
levels. The authors also reported that GCF volume had 
similarly dropped to baseline levels 8 days after the 
reinstitution of oral hygiene measures. Thus, vascular 
permeability was controlled earlier in the study of
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Giannopoulou and coworkers (1992) than in the present 
report and this may account for the discrepancy observed.
No investigations have been performed on the longitudinal 
changes of iron-binding proteins in GCF during 
experimentally induced gingivitis.
Collagen loss is one of the early events during 
experimental gingivitis (Page & Schroeder, 1976; Payne et 
al., 1975) and is mediated by the release of proteases in 
the gingival tissues. As mentioned above, LF is contained 
within PMN secondary granules (Spitznagel et al., 1974) 
which also contain lysozyme and collagenase (Baggiolini et 
al., 1978). Collagenase is a potent proteinase which is 
released in the crevice simultaneously with LF during PMN 
degranulation and once activated could contribute to the 
development of inflammation and cause surrounding tissue 
damage. In addition, proteases contained within PMN 
primary granules could be released during adherence of PMNs 
on non-phagocytosable surfaces, regurgitation during 
feeding and after cell death. Such enzymes include the
Cathepsins (G, B, D) and elastase which could,
simultaneously with inducing direct tissue damage, activate 
secreted PMN and fibroblast type collagenase and result in 
specific collagen breakdown (chapter 1; Table 1.6). Thus, 
although LF may have properties beneficial to the host 
(section 1.8), simultaneous release of other PMN
constituents may cause damage to the tissues. Moreover, LF
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could directly cause damage to host cells due to its 
strongly cationic charge.
a2-M and al-AT are the major protease inhibitors and their 
presence in the crevice demonstrates their involvement in 
the regulation of proteases including those referred to 
above. For damage to occur, a localised imbalance of 
proteinase/ inhibitor levels is required. Numerous recent 
reports have demonstrated protease activity in the gingival 
crevice both during experimental gingivitis and in cross- 
sectional studies (section 1.6; Table 1.5). However, in 
many of these reports low molecular weight substrates were 
used in order to assess protease activity (Eisenhauer et 
a l . ,  1983; Cox & Eley, 1989a & b; Cox & Eley, 1992; 
Beighton & Life, 1989; Beighton et a l . ,  1990; Eley and Cox, 
1992a & b) . Such substrates would not distinguish between 
free and bound form of the enzyme, as proteases bound to 
a2-M would retain their activity against low molecular 
weight peptides (Starkey & Barrett, 1977). One would not 
therefore be able to conclude with certainty, based only on 
the above quoted reports, that protease/inhibitor imbalance 
occurs in the crevice. In addition, a recent report has 
shown that at least during experimental gingivitis no free 
elastase can be detected in the crevice and that the enzyme 
is totally inactivated by the combined function of a2-M and 
al-AT (Giannopoulou et a l . ,  1992). Nevertheless, other 
studies which assessed collagenase activity using native 
collagen as substrate clearly demonstrate the presence of
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active collagenase in the crevice (Kowashi et al., 1980; 
Larivee et al., 1986). The presence of active collagenase 
in GCF indicates that a relative imbalance of 
protease/inhibitor amounts is possible in the crevice. 
This imbalance could be due to disproportionate release of 
enzymes by degranulating PMNs, increased degradation of 
protease inhibitors by bacteria (Carlsson et al., 1984), 
and finally inactivation of the protease inhibitors by 
oxidative mechanisms (Matheson et al., 1979; Carp & Janoff, 
1980) .
The mechanisms leading to protease/inhibitor imbalance and 
subsequent periodontal damage within the tissues could be 
different. If inhibitors were bound to proteases within 
the gingival tissues they should be readily removed 
(Ohlsson & Laurell, 1976; Feldman et al., 1983) by cells of 
the monocyte/macrophages lineage. The increase of protease 
inhibitors in the crevice during the development of 
experimental gingivitis suggests that their exudation/ 
production rate within the tissues and through to the 
crevice is higher than their clearance rate after binding 
to proteases. It seems, therefore, that protease inhibitor 
levels within the tissues are in excess of proteases during 
the development of experimental gingivitis. Whether, the 
ratio of proteases to inhibitors in the tissues, is 
suitable for optimal protease inhibition is, however, 
unknown. In addition, PMN derived proteinases may display 
their destructive function, when the PMN is closely
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attached to its substrate (host-tissue surfaces). The 
close contact would inhibit the accessibility of substances 
of molecular weight greater than 50 kDa (Wright & 
Silverstein, 1984). a2-M (Mwt: 725 kDa) would thus be
completely excluded form the site of activity, whereas even 
if small amounts of al-AT (Mwt:55 kDa) could reach, they 
could be readily inactivated by oxidative mechanisms 
(Wilton 1986; Matheson et al., 1979; Carp & Janoff, 1980). 
In this context protease inhibitors within the tissues may 
act as homeostatic regulators, functioning when PMNs 
release their contents in open interphases, preventing 
excessive tissue damage.
The present study has provided information on protease 
inhibitor and iron-binding protein changes in GCF during 
the development of experimentally induced gingivitis in 
humans. The following stage in this investigation was to 
examine the changes of the same proteins during the 
development of periodontal attachment loss.
5.4 Longitudinal study of periodontitis patients on
maintenance care
5.4.1 Clinical findings
In the present study, probing measurements of pocket depth 
and attachment level were performed using an electronic 
pressure sensitive periodontal probe, the Florida Probe
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(Gibbs et al., 1988). The Florida probe was originally 
described as having a force of 25g (Gibbs et al., 1988) but 
this was recently adapted to 20g which seemed to be the 
tolerance limit of the patients. Van der Velden (1979) 
suggested that a force of 0.75 N is optimal for the 
detection the most coronal dentogingival fibres when a 
probe tip diameter of 0.63mm is used. This is equivalent 
to approximately 30g when using a probe tip of 0.4mm in 
diameter. However, in a recent study a force of 0.25N was 
found to be optimal when used with a probe tip of 0.4mm 
diameter (Karayannis et al., 1992) and this is just 
slightly higher than the probing force applied in this 
study when using the Florida probe.
Initial selection of the sites in the present study was 
performed using a conventional manual probe (PC12). On 
subsequent assessment with the Florida probe, during the 
course of the study, probing pocket depths were in general 
shallower. This is in accordance with the observation of 
Magnusson et al. (1988b). Both the manual PC12 and Florida 
probes have a diameter tip of 0.4mm. Deeper probing 
readings, therefore, when using the conventional PC 12 probe 
compared to the Florida Probe, may reflect that higher 
probing forces than 20g, were applied when the PC12 probe 
was used.
Sites selected for this study demonstrated low to moderate 
MGI scores. This probably reflects the fact that patients
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participating had already received an extensive course of 
periodontal treatment and thus marginal gingival 
inflammation was controlled. This is also suggested by the 
low suppuration frequency. The 60% bleeding on probing 
incidence was somewhat unexpected as more sites bled on 
probing during the initial conventional pocket charting for 
the selection of the sites. This together with the deeper 
probing depths obtained when using the manual probe 
suggests, as already mentioned above, that manual probing 
forces greater than 20g were applied during conventional 
pocket charting. The low PI scores may simply reflect good 
oral hygiene practices just prior to the oral examination 
appointment. This is suggested by the persistence of some 
degree of gingival inflammation in most of the sites 
selected.
The use of precise electronic measurement, constant force, 
and an occlusal stent in the present study minimised 
probing errors (reviewed in section 1.3.4) and thus 
provided greater chance of detecting significant attachment 
level changes over a short period of time. Thus, the 
standard deviation of the difference of repeated 
measurements reported in this study was 0.423mm. This 
offered an approximately 50% improvement on standard 
deviations previously reported in the literature when using 
a manual probe and either an occlusal stent or the 
cementoenamel junction for assessment of probing attachment 
level (Haffajee et al., 1983b; Badersten et al., 1984).
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However, this value is higher than that previously reported 
by the manufacturers of the Florida probe. Magnusson et 
al. (1988a) reported 0.33mm standard deviation of 
attachment level duplicate measurements using the Florida 
probe 'stent' handpiece. Duplicate measurements were taken 
on different appointments by a periodontist on subjects 
with minimal signs of periodontal disease. In the same 
study and when measurements were taken on subjects with 
advanced periodontal disease during the same appointment an 
even lower standard deviation (0.20mm) was reported. This 
was surprising as lower reproducibility would have been 
expected at sites with greater periodontal pathology 
(Haffajee et al., 1983b) and suggests that the lower 
variability was due to the fact that measurements were 
taken during the same appointment. In the present study, 
duplicate measurements were also taken during the same 
appointment. However, care was taken to change patient 
position and remove and reapply the stent thus simulating 
the effect of different appointments. This together with 
the relative inexperience of the author could have 
contributed to the slightly higher variability observed 
between this and the study of Magnusson and coworkers 
(1988a). Simulation of different appointments was required 
because the variance of the duplicate attachment level 
measurements (taken on the same study appointment) would 
dictate whether the change of attachment level measurements 
between baseline and three months (that is on different 
appointments) exceeded measurement error. Underestimation
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of the variance of duplicate measurements would result in 
an increased false positive rate for detection of true 
attachment level change.
The variability observed between duplicate measurements in 
the present study is similar to that reported (0.46mm) for 
another newly developed periodontal probe, the Toronto 
Probe (Birek et al., 1987; Karim et al., 1990). An 
electronic probe which detects the cementoenamel junction 
has, however, been described to perform substantially 
better compared to both the Florida or the Toronto probe, 
rendering a standard deviation of differences of replicate 
measurements of 0.17mm (Jeffcoat & Reddy, 1991). 
Nevertheless, detection of the cementoenamel junction may 
be difficult if this is obstructed by restorations or 
calculus, even when this instrument is used.
The tolerance method was used in this study to detect 
significant attachment level change. The tolerance method 
offers the advantage of being sensitive to changes 
occurring over a short period of time (Haffajee et al., 
1983b) . In addition, it is the only method applicable when 
the design of the study allows for measurements only at two 
points in time. As detailed in section 2.2.1.4, the 
tolerance method takes into account the variance of 
duplicate measurements in the population, the subject and 
site. Therefore, the threshold to be exceeded in order for 
the investigator to declare significant attachment level
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change differs among individuals and sites. The lower 
variability offered by using the Florida Probe compared to 
the manual probe meant that an attachment level change of 
as little as 0.9mm could be declared as significant, 
although most of the attachment level changes in the 
present study were  ^1.2mm. During the three month
observation period, 3.9% of the 384 sites demonstrated 
significant attachment loss, whereas 3.4% demonstrated 
significant attachment gain. The sites demonstrating
attachment level gain represent sites that are in a state 
of remission whereas those losing attachment were in a 
state of exacerbation. When a much less stringent 
criterion of attachment level change of ^lmm was applied 
8.8% of the sites demonstrated attachment gain whereas 9.9% 
demonstrated attachment loss. In a recent 6 month duration 
longitudinal study Jeffcoat and Reddy (1991) reported 
approximately 15% incidence of attachment loss when a 
cumulative sum (cumsum; see section 1.3.5) threshold of 
change of 0.8mm was used. Despite the fact that the 
threshold in the present study refers to attachment level 
change whereas in the above mentioned report represents 
cumsum threshold, the percentage of sites demonstrating 
attachment loss is comparable. This suggests that many 
more sites than originally suspected (Lindhe et a l . ,  1983, 
Haffajee et a l . ,  1983b, Jenkins et a l . ,  1988) may actually 
lose attachment over shorter time periods. Reduction of 
the error of probing attachment level measurement is 
crucial in order to identify such sites.
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With the exception of mean subject probing pocket depth, 
other baseline clinical parameters failed to predict future 
attachment loss when the site or subject were used as the 
experimental unit. Neither could attachment loss sites be 
differentiated from those that gained attachment within the 
three month observation period on the basis of their 
baseline clinical indices. This confirms previous reports 
which have demonstrated the inability of clinical criteria 
to predict periodontal disease activity (Haffajee et al., 
1983a; Jenkins et al., 1989; Badersten et al., 1990) and 
which have been reviewed in section 1.2.6. The association 
of mean probing depth with future attachment loss is weak 
and the significance level obtained has not been adjusted 
for the effect of multiple comparisons. It is, however, in 
agreement with a recent investigation where it has been 
shown that mean probing depth of a subject could act as a 
risk indicator of future attachment loss (Haffajee et al., 
1991) .
In conclusion, the Florida Probe substantially reduced the 
variability of repeated measurements and thus reduced the 
threshold of attachment level change required to be 
exceeded in order to detect significant changes. In 
agreement with previous reports, baseline clinical indices 
could not be reliably used to predict future attachment 
loss.
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5.4.2 Gingival crevicular fluid protease inhibitors 
and iron-binding proteins at periodontally 
active versus stable sites
This study was conducted to investigate whether protease 
inhibitor (a2-M, al-AT) and iron-binding protein (TF, LF) 
levels in GCF could predict or diagnose incipient probing 
attachment loss at specific sites within an individual. No 
studies have been reported in the literature on the ability 
of GCF protease inhibitors (a2-M, al-AT) and iron-binding 
proteins (TF and LF) to differentiate between periodontally 
active versus stable sites.
As mentioned above, the tolerance method was used to 
identify active/loser sites. The tolerance method provides 
a stringent criterion for the detection of attachment level 
change, leading to the detection of a small number of sites 
demonstrating attachment loss. This is desirable, however, 
as a high threshold for attachment level change provides a 
low false positive rate for declaring true attachment loss. 
On the other hand, sites used as controls (stable) were in 
every case well below the crude 3 standard deviation 
threshold (1.2mm). This minimised the chance of false 
negatives and, therefore, the inclusion of loser sites in 
the group of stable sites. Stable sites were derived from 
the same individual as the active sites, thus negating 
subject effects, and were paired for baseline scores of 
gingival inflammation and probing depth. Pairing was
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successful as no significant differences could be detected 
for these indices at baseline, between active and stable 
sites (section 4.4.3). In addition, active and stable 
sites were similar as far as GCF volume and PI are 
concerned. In this way the effect of the parameter of
interest, namely probing attachment loss, was investigated 
in relation to GCF protease inhibitor and iron-binding 
protein levels while controlling for the possible 
confounding effects of other clinical parameters.
An additional innovation in this study was that GCF
constituent levels were reported as absolute amounts and as 
ng of constituent per p,g albumin. In this way the serum 
contribution to GCF protease inhibitor and iron-binding 
protein levels was taken into account. This method offers 
the advantage of assessing specific amounts of GCF
constituents relative to albumin. This avoids reliance on 
accurate assessment of GCF volume and thus avoids errors 
associated with its calculation.
GCF protease inhibitor (a2-M, al-AT) and iron-binding 
protein (TF, LF) levels failed to differentiate between 
active and stable periodontal sites. This was true both
prior to, and after the attachment loss episode. In
addition, longitudinal changes in a2-M, al-AT, TF and LF 
during the three month observation period did not differ 
between active and control sites. Earlier studies 
presented in this thesis have demonstrated that although
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periodontitis sites always have higher total amounts of 
these proteins than gingivitis sites this difference is not 
statistically significant. It was then hypothesised that 
the inability of these proteins to differentiate between 
gingivitis and periodontitis sites could be due to the 
inclusion of both active and inactive periodontitis sites. 
In addition, it has been shown that during the development 
of gingival inflammation the total amounts of a2-M, al-AT, 
TF and LF increase. The fact that probing attachment loss 
does not influence the levels of these proteins in the 
crevice suggests that gingival inflammation may be 
relatively more important in governing their dynamics. It 
could, therefore, be suggested that at least as far as the 
serum derived a2-M, al-AT and TF are concerned, vascular 
permeability due to gingival inflammation is the major 
factor affecting their GCF levels. Localised changes of 
a2-M, al-AT and TF levels at sites of probing attachment 
loss may be masked by the influx of these proteins in the 
area from the circulation. This is suggested by a recent 
study by Lamster and coworkers (1990) who reported high 
intraclass correlations of a2-M and immunoglobulins in GCF. 
The authors suggested that although these proteins might be 
locally produced their levels seem to be highly influenced 
by systemic factors, most probably their serum 
concentration. In addition, as mentioned previously, 
periodontal damage may occur at areas of close contact of 
the effector cells (PMNs, macrophages) with their substrate 
(host-tissue structures) (Wright & Silverstein, 1984), and
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where naturally occurring inhibitors like a2-M and al-AT 
would not have direct access. In this case, as mentioned 
previously, protease inhibitors present in the area of 
periodontal damage would act as homeostatic regulators, and 
their levels would not necessarily reflect active tissue 
destruction in the area.
The inability of LF to differentiate stable and active 
periodontal sites was in a sense unexpected as it has been 
shown that PMN primary granule constituents are elevated in 
GCF samples from active periodontitis sites (Lamster et 
al., 1988b; Huynh et al., 1992; Palcanis et al., 1992). 
These authors suggested that exuberant PMN activity is 
related to probing attachment loss. Our findings suggest 
that this is not the case when PMN secondary granule 
constituents are examined. Perhaps primary granule release 
and their array of different proteases may be responsible 
for direct tissue damage. In addition, the requirement of 
such proteases for the activation of PMN secondary granule 
collagenase suggests that PMN secondary granule release 
alone would not be sufficient to cause periodontal damage. 
Thus PMN secondary granule release may be related to the 
protective PMN function whereas PMN primary granule release 
may be indicative of PMN related tissue destruction 
(Wilton, 1986).
The inability of a2-M, al-AT, TF and LF to effectively 
differentiate active from stable periodontal sites was
178
demonstrated by the low positive and negative predictive 
values of a combined test based on the recall (three month) 
appointment data (section 4.4.3). The sensitivity of the 
test was also very low (only 28%) demonstrating a very high 
rate of false negatives. The relatively higher specificity 
value is probably due to the low overall number of positive 
tests and is probably an artifact.
Despite the inability of a2-M, al-AT, TF and LF to 
differentiate active and stable sites in the present study, 
it should be realised, that longitudinal studies of 
periodontal disease, aiming to identify attachment loss, 
rely upon repeated measurements (usually of probing 
attachment level) spaced at appropriate time intervals. 
Periodontal destruction may, however, occur during 
exacerbation episodes of small duration, accompanied by 
changes in protease inhibitor and iron-binding protein 
levels. The duration of such episodes may be much shorter 
than the interval at which attachment level measurements 
were taken in the present study and, therefore, the disease 
activity episode could have occurred at any point in time 
during the three month observation period. In this case 
any alterations in the local GCF a2-M, al-AT, TF and LF 
levels may have been missed. This is more likely for LF 
which is a local, PMN derived, acute phase reactant and 
whose changes have been shown to resolve readily during the 
healing phase of experimental gingivitis (section 4.3.2). 
In addition, the relatively low number of sites
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demonstrating attachment level change compromises the 
possibility to detect significant differences.
5.5 Future suggestions
The above studies have provided information on the changes 
of GCF protease inhibitors and iron-binding proteins in 
relation to periodontal disease status. However, studies 
aiming to identify mechanisms controlling their dynamics in 
the crevice are required.
Recent studies investigated the regulation of TIMP 
production by cytokines or mitogens like concanavalin A 
(Overall et al., 1989; Overall et al., 1991). The 
production of a2-M by gingival fibroblasts has also been 
demonstrated (Condacci et al., 1988). It would be of 
interest to investigate whether a2-M, al-AT and TF 
production by resident cells of the periodontium is under 
similar control.
Investigating the relative contribution of primary and 
secondary granules towards crevicular protease activity in 
vivo would help clarify the protective and/or destructive 
function of periodontal PMNs. It has been suggested that 
PMN primary granule release may be associated with 
periodontal damage whereas secondary granule release may be 
related to the protective PMN function (Wilton, 1986). 
Although some initial attempts have been made to identify
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stimuli from the gingival crevice leading to PMN primary or 
secondary granule release further research may provide 
information on the conditions leading to preferential 
release of each type of granule. The use of specific 
markers like PMN elastase and LF for primary and secondary 
granule release respectively, would facilitate this 
investigation. Moreover, immunolocalisation of LF and 
elastase in gingival biopsies may provide information on 
the circumstances under which primary and secondary granule 
release occurs within the gingival tissues.
Immunolocalisation could in addition be used to investigate 
the distribution of protease inhibitors and proteases in 
the gingival tissues. This would clarify whether protease 
release and periodontal damage actually occurs at closed 
interphases where naturally occurring protease inhibitors 
do not have direct access.
The Florida Periodontal probe is a powerful tool in the 
hands of the researching clinician. Studies of 
periodontal disease progression using instruments with 
higher accuracy than the conventional periodontal probe 
will allow for lower thresholds to be used for declaring 
significant attachment level change. Such studies are 
already underway (Jeffcoat & Reddy, 1991) and will provide 
a more precise picture of the pattern of periodontal 
disease progression to that obtained when conventional 
probing devices were used.
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